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Abstract 
The two major interfaces separating brain and blood have different primary roles. The choroid plexuses secrete 
cerebrospinal fluid into the ventricles, accounting for most net fluid entry to the brain. Aquaporin, AQP1, allows 
water transfer across the apical surface of the choroid epithelium; another protein, perhaps GLUT1, is important on 
the basolateral surface. Fluid secretion is driven by apical Na+-pumps. K+ secretion occurs via net paracellular influx 
through relatively leaky tight junctions partially offset by transcellular efflux. The blood–brain barrier lining brain 
microvasculature, allows passage of O2, CO2, and glucose as required for brain cell metabolism. Because of high 
resistance tight junctions between microvascular endothelial cells transport of most polar solutes is greatly restricted. 
Because solute permeability is low, hydrostatic pressure differences cannot account for net fluid movement; however, 
water permeability is sufficient for fluid secretion with water following net solute transport. The endothelial cells have 
ion transporters that, if appropriately arranged, could support fluid secretion. Evidence favours a rate smaller than, 
but not much smaller than, that of the choroid plexuses. At the blood–brain barrier Na+ tracer influx into the brain 
substantially exceeds any possible net flux. The tracer flux may occur primarily by a paracellular route. The blood–brain 
barrier is the most important interface for maintaining interstitial fluid (ISF) K+ concentration within tight limits. This 
is most likely because Na+-pumps vary the rate at which K+ is transported out of ISF in response to small changes in 
K+ concentration. There is also evidence for functional regulation of K+ transporters with chronic changes in plasma 
concentration. The blood–brain barrier is also important in regulating HCO3
− and pH in ISF: the principles of this 
regulation are reviewed. Whether the rate of blood–brain barrier HCO3
− transport is slow or fast is discussed critically: 
a slow transport rate comparable to those of other ions is favoured. In metabolic acidosis and alkalosis variations in 
HCO3
− concentration and pH are much smaller in ISF than in plasma whereas in respiratory acidosis variations in pHISF 
and pHplasma are similar. The key similarities and differences of the two interfaces are summarized.
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1  Background
The inorganic ions in brain fluids ultimately derive from 
the peripheral circulation. They are delivered across 
either of two major blood–brain interfaces: the choroid 
plexuses situated within the ventricles and the blood–
brain barrier lining the blood vessels dispersed through‑
out the brain parenchyma (see Fig.  1). The relative 
contributions of these two interfaces to production of 
brain fluids and to regulation of their ionic compositions 
are the key issues discussed in this review.
1.1  Overview of locations and functions of the choroid 
plexuses and the blood–brain barrier
The choroid plexuses constitute the interface between 
blood and cerebrospinal fluid (CSF) in the ventricles. 
There are four such plexuses protruding into the ventri‑
cles, one in each of the lateral ventricles, one in the IIIrd 
and one in the IVth ventricle (see Fig. 1a). As seen in the 
light microscope each choroid plexus has a frond‑like 
shape with many villi, each with a layer of cuboidal epi‑
thelial cells overlying blood microvessels of the fenes‑
trated type (see Fig.  1c). Even on this scale the epithelial 
layer appears to have a large surface area. Furthermore the 
apical brush border and basolateral in foldings make the 
actual membrane area of the epithelial cells much greater 
still (see [1, 2]). As described in detail by Cserr [3] and 
more recently by Damkier et al. [4] the epithelial layer has 
all the hallmarks of a “leaky” secretory epithelium designed 
to produce a large volume of nearly isosmotic fluid.
The blood–brain barrier is in some ways a more com‑
plicated structure than the choroid plexus. It separates 
blood from interstitial fluid (ISF) and cells of the brain 
parenchyma. The barrier, so‑called because it greatly 
restricts movements of many substances between brain 
and blood, consists of the endothelial lining of almost the 
entirety of the brain microvascular network (see Fig. 1b). 
However, the transfers the barrier permits are at least as 
important as those it hinders. It is ideally placed both 
to deliver substrates for brain cell metabolism and to 
remove the corresponding wastes. It is also important in 
regulating ISF ionic composition.
The lining of the brain microvessels differs from that of 
peripheral vessels in that the endothelial cells are joined 
together by tight junctions that greatly restrict free, paracel‑
lular movement of substances (see Fig. 1d), the exceptions 
to this being the parts of the vasculature supplying the cho‑
roid plexuses and the circumventricular organs. The perme‑
ability of the blood–brain barrier to ions such as Na+ and 
Cl− is low, not much larger than the permeability of many 
cell membranes (see Sect. 4). While the low passive perme‑
ability to these ions as judged from unidirectional tracer 
fluxes may reflect primarily paracellular movements, the 
net fluxes can still reflect transcellular transport through the 
cells (see Sect. 4.3.4). The endothelial layer is surrounded by 
a basement membrane and pericytes all closely enveloped 
by astrocyte (glial) endfeet (see Fig. 1d) [5–7]. The pericytes 
have a contractile function (see Sect. 2.3) as well as a role in 
inducing and maintaining barrier properties [8–10]. There 
are also nerve cells close by within the parenchyma. This 
whole assembly is called the neurovascular unit. All the var‑
ious components of the neurovascular unit may influence 
fluid movement into and out of the brain but the major ele‑
ments to be considered are endothelial cells and astrocytes.
The astrocyte endfeet are connected together by gap junc‑
tions but the clefts between them are not sealed by tight 
junctions and thus are routes for passage of water and solutes 
including markers as large as horseradish peroxidase [11, 12] 
between the basement membrane and the interstitial spaces. 
However, there is evidence that movement through the clefts 
can be slow compared to that along the basement membrane 
and that, at least under some circumstances the endfoot layer 
can present a major barrier to transport between the blood 
and the brain parenchyma [13, 14]. The extent to which the 
astrocytes and pericytes cover the endothelial tube has been 
calculated by Mathiisen et al. [5] from serial sections of the 
CA1 layer of rat hippocampus. They found that the clefts 
available for diffusion away from the tube to the interstitium 
occupy only 0.3% of the surface area.
Consideration of the structures and locations of the cho‑
roid plexuses and the blood–brain barrier suggests that 
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barrier is a much more diffuse structure with parts of it 
close to every cell in the brain (see Fig. 1b). This is essential 
to its primary role in supplying O2, CO2 and glucose and 
removing waste products as the distance that these sub‑
stances have to diffuse between blood and brain cells must 
be kept small (see Sect. 2). Whether it has a secondary role 
in providing fluid to the brain remains controversial (see 
Sect. 4.1).
This review is mainly concerned with transport of Na+, 


































Fig. 1 Locations and functions of the choroid plexuses and the blood brain barrier. a The choroid plexuses are discrete structures located in the 
cerebral ventricles, which are filled with cerebrospinal fluid. Fluid can flow from the ventricles into the cisterna magna and from there to the suba-
rachnoid spaces of the brain and spinal cord. b A cast of the vascular system of a human brain. The blood–brain barrier, which comprises the lining 
of the smallest and most numerous branches of the vascular system, the microvessels, is present almost everywhere in the brain. c Diagram of a 
cross section of part of a single villus of a choroid plexus as would be seen by light microscopy. The apical brush border is well separated from most 
of the basolateral membrane. d Diagram of a cross section of a microvessel wall and adjacent parenchyma as could be seen in an electron micro-
graph. Note the difference in scales in c and d. a–d are reproduced with permission: a from [26] as relabelled in [15], b from [536] (promotional and 
commercial use of the material in print, digital or mobile device format is prohibited without the permission from the publisher Wolters Kluwer. 
Please contact healthpermissions@wolterskluwer.com for further information), c, d from [15]. For an image of part of a choroid plexus see Fig. 5
they fulfil different roles in fluid regulation. The choroid 
plexuses are well defined structures located within the 
ventricles surrounded by the fluid they secrete. This posi‑
tions them to provide the brain as a whole with a fluid of 
controlled composition that gives buoyancy and provides a 
route for removal of wastes by bulk flow of fluid through 
the routes of outflow. Bulk movement of CSF between 
brain and spinal cord also allows compensation for changes 
in blood volume within the skull during the cardiac and 
respiratory cycles (see discussion in [15]). The blood–brain 
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consideration is also given in  Sect. 2 to transfer of glu‑
cose, CO2, O2 and amino acids. The mechanisms for ion 
and water transport are discussed in Sects.  3 for the 
choroid plexuses and 4 for the blood–brain barrier. Sec‑
tions 5 and 6 consider the roles of transport across both 
interfaces in the regulation of [K+] and [HCO3−] in ISF 
and CSF. Sect. 7 summarizes the main points of compari‑
son between the two interfaces. Finally Sect. 8 indicates 
the major conclusions concerning the roles of the cho‑
roid plexuses and the blood–brain barrier and highlights 
areas of inadequate knowledge for future investigation.
1.2  Previous reviews
The present review is the second part of a survey of work 
on the extracellular fluids of the brain. The first part [15] 
considered the basic processes, including secretion, fil‑
tration, diffusion and bulk flow; the use of markers (e.g. 
radiotracers or fluorescent molecules) to follow fluid 
movements; the pathways available for transfers within 
the brain; and recent work on the patterns of flow.
There have been a number of reviews of the topics 
considered in this the second part. Cserr’s “The Physi‑
ology of the Choroid Plexus” [3] and Bradbury’s “The 
Concept of the Blood–brain barrier” [16] are both still 
important resources more than 35  years after they 
were written. Davson and Segal’s book [17] provides 
encyclopaedic coverage up to the mid‑1990s roughly 
the time when the focus of research shifted from func‑
tion in  vivo towards molecular and cellular mecha‑
nisms. Recent, major reviews are available for studies 
on the choroid plexus [2, 4], the blood–brain barrier 
[18, 19], and the functions of CSF and fluid move‑
ments within the brain [20, 21]. Major reviews on the 
transport of HCO3− and regulation of brain extracel‑
lular fluid pH are cited in Sect. 6.
There have also been a number of reviews of related 
material not covered in this review including the 
development of the blood–brain barrier, its structural 
basis, the extent to which it restricts penetration by a 
large variety of substances, and the efforts that have 
been made to circumvent the barrier function. Inter‑
ested readers are directed to [22–30].
1.3  Notation and conventions for expressing 
concentrations, partial pressures and other values
Throughout this review, enclosing the symbol for a sub‑
stance in square brackets, e.g. [HCO3−], is used to stand 
for the concentration of that substance as a molality 
defined as the number of moles per kilogram of solvent, 
i.e. with units mol  kg−1. However when concentra‑
tions have been reported as molarities, mole per litre 
of solution with units mol  l−1 the same symbol is used. 
Molality is preferable when referring to intracellular 
concentrations or concentrations in plasma but when 
referring to the extracellular fluids of the brain, which are 
almost protein free, either is suitable. Subscripts are used 
to indicate location, e.g. [HCO3−]CSF is the concentration 
of HCO3− in cerebrospinal fluid. A lower case “p” preced‑
ing the symbol for a substance means partial pressure, 
e.g. pCO2, is the partial pressure of CO2. Finally, unless 
otherwise stated values are scaled to those that would be 
found in a human with a 1400 g brain.
2  Transfers of water, O2, CO2 and major nutrients 
between blood and brain parenchyma
The largest transfers of substances into or out of the brain 
parenchyma are those of water, glucose, O2, CO2 and to 
a lesser extent amino acids taken collectively. Most of the 
fluxes of these substances must be across the blood–brain 
barrier because the blood flow to the choroid plexuses is 
insufficient to supply or remove the amounts needed. 
Although blood flow per unit mass of tissue is much 
greater in the choroid plexuses than in cerebral cortex, 
~9.8‑fold in dogs and rabbits [31] and 2.8‑ to 5.5‑fold in 
different studies in rats [32–34], the mass of the combined 
choroid plexuses is only a small fraction of that of the brain 
as a whole, 0.0012, 0.0029 and 0.0021 in dog, rabbit and rat 
[35]. Thus the proportion of cerebral blood flow that goes 
to the choroid plexuses is less than ~1% while the percent‑
ages of water, glucose and O2 entering the brain are much 
larger as described in Sects. 2.1, 2.2 and 2.3.
2.1  Water movement at the blood–brain barrier 
and choroid plexuses
Measurements with tritiated water have shown that 
70–90% of the water molecules in the blood perfusing the 
brain cross the blood–brain barrier and enter the brain 
tissues in a single pass ([chapter 4 in 16], [36–42]). If cer‑
ebral blood flow is 800  ml  min−1 [43] then brain blood 
water flow, the water flow along the capillaries, is per‑
haps 0.85 ×  800  ml  min−1 =  680  ml  min−1 (the rest is 
made up of solutes such as haemoglobin). Of that ~0.7 
× 680 ml min−1 = ~476 ml min−1 = ~685 l day−1 enters 
the brain, mostly across the blood–brain barrier. This is 
37,700 mol/day! However, (see Fig. 2) everywhere in the 
brain the influx is balanced by an almost equal efflux 
primarily because the very large concentration of water, 
~55 M, is almost the same on the two sides of the inter‑
faces. A figure 1000‑fold smaller than the unidirectional 
movement, i.e. 685  ml  day−1 rather than 685  l  day−1, 
would be a high estimate of the total net movement of 
water into the brain per day across the blood–brain inter‑
faces (see Sects. 3.2 and 4.1 and section 2.6 in [15]). The 
mechanisms for water movement are considered in Sects. 
3.4.2 and 4.3.6.
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There have been repeated attempts to base descriptions 
of CSF production and reabsorption on measurements of 
tracer fluxes of water [44–47] but these have been ill con‑
ceived. As explained in detail elsewhere (section  2.6 of 
[15]) and illustrated in Fig. 2, unidirectional tracer fluxes 
of water far exceed net fluxes. These measurements have 
never been sufficiently accurate that they could be used 
to determine either the magnitude or the site of net flux 
of water (or flow) into or out of any tissues including 
those of the CNS.
2.2  O2 and CO2 transfer at the blood–brain barrier 
and production of metabolic water
About 90–95% [48] of the metabolism of ~0.6  mol of 
glucose day−1 in the brain [49, 50] is complete oxidation 
consuming ~3.3 mol day−1 of O2 and producing the same 
daily amounts of CO2 and water. The diffusion distances 
to and from the capillaries are small and O2 and CO2 eas‑
ily diffuse across the membranes of the blood–brain bar‑
rier endothelial cells (see item (3) in Sect. 6.4.2, [51] and 
for early references [52]). Thus they can be transferred 
to and from the blood driven by their concentration 
gradients.
2.3  Importance of neurovascular coupling for O2 and CO2 
transfer at the blood–brain barrier
Increased neuronal activity in the brain is associated with 
increased blood flow, an example of functional hyper‑
aemia common to all tissues. In the brain this is called 
neurovascular coupling. Blood flow in the brain can be 
increased by dilation of small arterioles, which are the 
principal site of resistance, but also more locally by dila‑
tion of capillaries brought about by changes in pericyte 
activity [53–55]. How the activities of these effectors are 
coupled to neural activity and the nature of the signals 
involved have been the subjects of much discussion.
During neuronal activity more O2 enters the brain 
parenchyma to supply part of that needed for increased 
metabolism (see [56, 57] for references). The amount of 
O2 stored within the brain is limited and even the resting 
rate of metabolism can deplete it within seconds. How‑
ever, delivery of O2 in the blood is strongly “buffered” 
by haemoglobin in the red blood cells, and it may be 
that even normal blood flow is adequate to support the 
O2 requirements of activity [58]. There is little evidence 
that falls in pO2 either in arterial blood or within the 
brain are directly involved in stimulating the increased 
cerebral blood flow until these falls are substantial [59–
63]. Similarly relatively large changes in [glucose]plasma 
appear to have no effect on neurovascular coupling [64]. 
By contrast it is clear that even small increases in pCO2 
of arterial blood or decreases in pH in CSF can produce 
marked vasodilation and decreases in pCO2 or increases 
in pH can produce vasoconstriction ([59, 61, 65–68] and 
clinical consequences [69]). This cerebrovascular reactiv‑
ity is closely related to the oldest hypothesis of the mech‑
anism of neurovascular coupling: that it results from the 
effects of acidic products of metabolism, e.g. CO2 and 
lactic acid, and the associated fall in pH [70].
Suggestions that the control of blood flow is actually not 
just in response to changes in pO2, pCO2 and pH began 
with the observation that the increase in blood flow reflects, 
at least in part, arteriolar dilation at some distance upstream 
along the blood vessels from the site of O2 consumption and 
CO2 release [71]. (The involvement of astrocytes in neuro‑
vascular coupling may provide the mechanism for the sig‑
nals to spread from the immediate site of the neural activity 
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Fig. 2 Comparison of a blood water flow and b, c transfers of water 
across the blood–brain barrier and the choroid plexuses. For the 
choroid plexus flow and transfers in and out of the brain are shown 
through a ×10 magnifying glass. The very much smaller net flows 
of water across both barriers are shown magnified ×1000. Arrow 
lengths are an approximate guide to sizes of the transfers. The water 
flow along the blood vessels, ~85% of blood flow, is ~100-fold greater 
than that to the choroid plexuses. Because the transfers of water 
across the interfaces are blood flow limited, the transfers in and out 
of the brain are also ~100-fold greater at the blood–brain barrier. By 
contrast because net transfers reflect active secretion of fluid, the very 
much smaller net transfer of water is almost certainly greater across 
the plexuses than across the blood–brain barrier
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changes or can actually increase, presumably as a conse‑
quence of the increased flow, rather than decrease as would 
be required for it to be the cause [53, 71–74]. Furthermore 
the change in pH during neural activity while clearly pre‑
sent [75] was too slow to account for the initiation of the 
increased blood flow [53, 71, 73, 76] and initially it could 
even be in the wrong direction [77]. However, it should not 
be forgotten that based on the evidence from the effects of 
changes in arterial pCO2 and CSF pH, the fall in pH that 
occurs with sustained neuronal activity is likely to have an 
effect to increase blood flow.
There is a strong teleological argument in favour of a 
more complicated mechanism of control than simple 
feedback. With simple feedback based on monitoring 
pCO2 (or pH of the ISF, see e.g. [59]), in order to stim‑
ulate increased blood flow, the pCO2 would have to be 
increased throughout the period of increased neural 
activity (see Fig.  3a). Better regulation can be produced 
if nervous activity releases other mediators. This can be 
either directly from neurons or, as now thought to be 
more important, from astrocytes. These mediators affect‑
ing the smooth muscle of arterioles and pericytes provide 
a feed forward system in which the increased activity is 
signalled to the blood vessels independently of changes in 
pCO2 and pH (see Fig. 3b).
There are many possible regulatory signals (S2 in 
Fig.  3b) that can couple nerve activity to vasodilation 
and there is now an extensive literature, comprehensively 
reviewed elsewhere, on the roles of astrocytes, elevation 
of Ca2+ in their endfeet and the release of arachidonic 
acid metabolites, NO and K+ in neurovascular coupling 
[53–55, 78–88].
While it is clear that changes in blood flow are impor‑
tant in the supply of O2 and removal of CO2, they are 
thought to be less important for supplying glucose (see 
Sect.  2.4.1). However, recent attention has been given 
to the consequences of redistributing blood flow and it 
has been found that this can change the proportions of 
both O2 and glucose extracted from the blood [89, 90]. 
Variations in blood flow are unlikely to have significant 
effects on fluid secretion at the blood–brain barrier. This 
is because the net rates of ion and water transfers are 
relatively small compared to the rates of delivery in the 
blood, i.e. blood flow is not limiting.
2.4  Glucose and amino acid transfer at the blood–brain 
barrier
2.4.1  Glucose
Glucose consumption by the brain [49, 50] amounts 
to ~0.6  mol  day−1 almost all of which must cross the 
blood–brain barrier. The blood flow to the brain, 
~800  ml  min−1 [43] delivers ~400  ml  min−1 of plasma 
containing ~5  mmol  l−1 glucose, which equates to 
~2 mmol min−1 =  2.9 mol day−1, which corresponds to 
extraction of ~0.6/2.9 × 100% = ~20% of the arriving glu‑
cose. Experimentally measured extractions for physiologi‑
cal [glucose]plasma vary between 15 and 35% [39, 91–93].
Glucose transport is stereo‑selective with that of 
d‑glucose (usually called just “glucose”) being very rapid 
while that of l‑glucose is slow, comparable to that for 
other polar solutes like sucrose and mannitol [39, 91–
94]. Glucose transport across the blood–brain barrier 
is passive but mediated by specific, saturable GLUT1 
transporters expressed in both the luminal and ablumi‑
nal membranes of the endothelial cells [95–98]. Substan‑
tial amounts of the transporters are also found within the 
endothelial cell cytoplasm [99], presumably on vesicular 
membranes acting as a reservoir (see below).
The influx of glucose from blood to brain exceeds 
the efflux from brain to blood leaving a relatively large 
inward net flux, about 30% of the measured influx (see 
e.g. [100, 101]). At a simple level this would be expected 
from a lower [glucose] in ISF than in blood plasma. 
However, if the fluxes were by simple diffusion across a 
single barrier, the measured concentrations, ca. 1  mM 
[102] or even less [103] in ISF and at least 4  mM in 
blood plasma, would predict efflux less than one‑fourth 
of influx rather than the roughly two‑thirds observed. 
At least part of the explanation is that the fluxes occur 
by a saturable mechanism (as reviewed in [102]) such 
that the unidirectional fluxes increase less than linearly 
with concentration, hence the difference between influx 
and efflux will not be as large as for simple diffusion 
across a single barrier. This will have the effect of limit‑
ing the impact on the brain of changes in [glucose]plasma.
An additional factor is that glucose after crossing the 
















Fig. 3 Diagram illustrating possible schemes for neurovascular 
coupling, i.e. regulation of blood flow changes associated with nerve 
activity. Two forms of control are shown, a simple feedback based on 
the signal to be regulated, e.g. pCO2, and b feedback plus feed-for-
ward. The feed-forward element, signal2, possibly from astrocytes in 
b, allows blood flow to increase with smaller changes in the primary 
quantity to be regulated, signal1
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than diffusing away through the clefts between them. 
At least some of this glucose can be transported back 
out of the endfeet and across the endothelial cells con‑
tributing to the efflux.1 At least three scenarios for 
transport from blood into the brain can be envisaged 
(see Fig. 4): (1) water or solute may cross the endothe‑
lium, diffuse (or be moved by flow) within the basement 
membrane parallel to the endothelial surface until it 
reaches a cleft and then diffuse or flow outwards 
through the cleft; (2) it could cross the endothelium 
and basement membrane and then enter an astrocyte 
endfoot; or (3) it could enter the basement membrane 
both from the endothelial cells and from the endfeet 
and leave by way of the clefts. Combinations of these 
are also possible. Which of the above occurs will 
depend upon the transporters available and on the con‑
centrations within the basement membrane. Scenarios 
1 and 3 will be considered later in conjunction with 
transport of Na+, Cl− and water (see Sect.  4.6.4) and 
scenario 2 for transport of K+ (see Sect.  5). Transport 
of glucose is likely to be an example of scenario 2.
Part of the concentration gradient for glucose between 
blood and ISF leads to a net flux across the endothelial 
1 Glial endfeet, hexokinase and glucose fluxes across the blood–brain bar‑
rier Exchange of glucose across the blood–brain barrier between blood 
and astrocyte endfeet rather than between blood and interstitial fluid 
(see  Sect. 2.4.1) can lead to larger efflux relative to influx. This is possible 
because the endfeet express the glucose transporter GLUT1, which allows 
fluxes in both directions [102, 104, 105]. Thus there could be a large unidi-
rectional flux back out of the endfeet if there is a significant [glucose] within 
the astrocytes. That in turn would require a relatively slow rate of phospho-
rylation of glucose by hexokinase. This requirement is consistent with the 
view, said to originate with Betz [112], that net uptake of glucose into the 
brain is limited by its rate of phosphorylation by hexokinase.
cells into the basement membrane and part must lead 
to transport from the basement membrane into the rest 
of the brain. Barros et  al. [102] calculated for glucose 
that in order for even the full concentration difference 
between blood and interstitial fluid to drive diffusion at 
the observed rate through the clefts between the endfeet, 
the clefts would need to occupy at least 0.2% of the sur‑
face area. Thus in view of the finding that only 0.3% of 
the area is cleft (see Sect. 1.1), barely more than the mini‑
mum they calculated, it is likely that much of the glucose 
enters the endfeet via GLUT1. This transporter is promi‑
nently expressed in the endfeet [102, 104, 105] (see also 
footnote 1). The extent to which glucose is metabolized 
to lactic acid within astrocytes rather than being passed 
on directly to the neurons is beyond the scope of this 
review. It has been the subject of a large literature; see 
[57, 97, 102, 106–108] for references.
Glucose supply to the brain is increased during sus‑
tained neural activity [102, 109–111]. Barros et al. [102] 
discuss the evidence that this requires stimulation of 
both hexokinase within the brain [112] and transport 
across the endothelial cells (see also footnote 1). Part of 
the increase in transport may reflect redistribution of 
GLUT1 from the cytoplasm to plasma membranes in the 
endothelial cells [99]. Redistribution of blood‑flow [90, 
113] is also thought to affect the proportion of glucose 
extracted from the blood [94, 114].
Although this review is primarily concerned with fluid 
movement and transport of inorganic ions, glucose has 
been discussed here because so much is transported and 
the principal glucose carrier at the blood–brain barrier, 
GLUT1, may allow movement of water.
2.4.2  Amino acids
Likewise transfer of amino acids needs to be mentioned 
because amino acid efflux from the brain into the endothe‑
lial cells is primarily Na+‑coupled and the Na+ flux 
involved is larger than, and in the opposite direction to, the 
net flux needed to support fluid secretion. As a historical 
note, the first demonstration of functional polarity of the 
blood–brain barrier was for amino acid transport [115].
The blood–brain barrier greatly restricts influx of some 
amino acids including the neurotransmitters glutamate 
and glycine, but allows rapid, passive but saturable influx 
of many others including all those classified as essential 
[92, 116, 117]. For instance from the data in [92], it is evi‑
dent that more than 30% of phenylalanine arriving in the 
blood enters the brain. Smith and Stoll [118] list the 
influx rates in perfused dog brains observed from mix‑
tures of amino acids at concentrations only a bit less than 
normal. The total rate of influx for those listed, 
72 nmol min−1 g−1 (which scales to 145 mmol day−1 for a 
1400 g human brain), is balanced by a nearly equal total 
2) 3) 1) 
Fig. 4 Scenarios for transport from blood into the brain. Substances 
are transported across the endothelial cells (left) into the basement 
membrane. In scheme (1) net onward transport is entirely via the 
clefts between the astrocyte endfeet (right). This may be the pattern 
for Na+ and Cl−. In scheme (2) net onward transport occurs both via 
the clefts and across the endfoot membrane into the astrocytes. This 
may be the pattern for glucose and K+. In scheme (3) net transport 
across the endfoot membrane is from the astrocyte into the base-
ment membrane. The combination of substances arriving across 
the endothelial cells and from the astrocytes then enters the ISF via 
the clefts. This may be the pattern for water. There are other possible 
schemes, e.g. with the directions reversed which may occur when K+ 
is being transported from the brain to the blood
Page 9 of 69Hladky and Barrand  Fluids Barriers CNS   (2016) 13:19 
efflux [119].2 This efflux is driven uphill across the ablu‑
minal membranes of the endothelial cells from the brain 
by the coupled movement of Na+ [120]. As mentioned 
above, this Na+ movement is in the opposite direction to 
that for net secretion of Na+ into the brain.
Most, perhaps almost all, of the Na+‑linked amino acid 
transporters are on the abluminal side extracting amino 
acids from the brain [120] (but see [121, 122] and 3). The 
net Na+ flux into the endothelial cells by these Na+‑
linked transporters must be balanced by a net Na+ flux 
out of the cells via the Na+‑pump. These fluxes cannot be 
ignored when considering net Na+ flux across the barrier, 
see Sect. 4.6.1.
2.5  Transfers of glucose and amino acids across the 
choroid plexuses
Transport of glucose [123, 124] and amino acids [125, 
126] also takes place across the choroid plexuses. 
For glucose the net flux can be estimated as roughly 
1.4 mmol day−1 from the rate of formation of CSF in the 
ventricles, ~400 ml day−1 and (glucose) in the secretion, 
~3  mM. This is much less than the net flux of glucose 
across the blood–brain barrier, about 600  mmol  day−1. 
2 Balance between total rates of influx and efflux of amino acids Felig [467] 
lists the differences in arterial and venous plasma concentrations for a num-
ber of amino acids in the cerebral circulation of human volunteers. The 
sum of these differences is 125 µmol  l−1. If it is assumed that for a 1400 g 
brain, the plasma flow is 0.4  l  min−1, this corresponds to a net uptake of 
35 nmol min–1 g−1. However, Felig’s list notably lacks entries for glutamine 
and glutamate for which, see Sect. 2.4.2, there are likely to be substantial net 
releases. Thus these data do not challenge the view that total influx of amino 
acids is nearly balanced by the total efflux.
Betz and Gilboe [468] list net uptakes for a number of amino acids for per-
fused dog brains in the presence of methoxyflurane or halothane for which 
the total uptakes are 5 and −5 nmol min−1 g−1 neither of which is signifi-
cantly different from zero. Thus these results are also consistent with total 
influx of amino acids being nearly balanced by total efflux.
It is worth noting that the efflux to blood of glutamine and of glutamate and 
NH4+ produced from them in the endothelial cells is the major route for 
export of amino-group-derived nitrogen from the brain [120, 469].
3 Location of Na+-coupled amino acid transporters Smith et al.  [470] dem-
onstrated using in situ brain perfusion protocols and a number of radiola-
belled neutral amino acids, including glutamine that there was a saturable 
uptake of amino acids into the brain. Ennis et al. [122] extended the results 
for glutamine and demonstrated that the influx rate was reduced by 62% 
when the [Na+] in the perfusion fluid was reduced from 138 to 2.4  mM. 
Based on this dependence they proposed that roughly 60% of the transport 
across the luminal membrane was via system N, which is a Na+-dependent 
transporter. However, Lee et  al. ([471], reviewed in [120, 472, 473]) found 
using fractionated membrane vesicles that the luminal membrane contained 
system n, a Na+-independent carrier, while system N was present only in 
the abluminal membrane. There is evidence from studies using hepatocytes 
that two such systems exist [474–478]. Furthermore it is now known that 
there are far more genes for amino acid transporters than were envisaged 
when the system N, A, L etc. nomenclature was developed [479].
One part of the explanation of the apparent discrepancy concerning the 
Na+ dependence of glutamine transport across the luminal membrane [122, 
471] may be that the methods used by Hawkins and coworkers do not com-
pletely exclude mixed expression of the transporters on the two sides of the 
cells. Another part may arise because the unidirectional flux from perfusate 
into the brain is measured across a cell layer rather than a single membrane.
Footnote 3 continued
In order for glutamine to cross from plasma or perfusate to the interstitial 
fluid of the brain, it must cross the luminal membrane, diffuse across the cell 
cytoplasm, cross the abluminal membrane and then diffuse across the base-
ment membrane and outwards either through or around the astrocyte endfeet 
(compare Sect. 5). Only then does it count as part of the unidirectional influx 
into the brain. Transport across the luminal membrane will be primarily Na+-
independent, system n, and hence bidirectional while that across the ablumi-
nal membrane will be primarily Na+-dependent, system N, and hence biased 
towards movement from basement membrane into the cell cytoplasm. When 
the perfusate has a normal [Na+], the [Na+] within the endothelial cell will be 
substantial (perhaps >30 mM, compare with values in Table 2) and system N 
will mediate some efflux of glutamine from the cell to the basement membrane 
(compare [480]), and in addition glutamine may leave the cell via another trans-
porter, system L1, that is known to be present. Some of the glutamine reaching 
the basement membrane will be transported back into the cell via system N, the 
rest will escape into the interstitial fluid of the brain and be part of the measured 
unidirectional flux from perfusate to brain. When the [Na+] in the vascular per-
fusate is greatly reduced, that inside the endothelial cells will also be reduced 
and there will be a larger gradient of [Na+] between the basement membrane 
and the cell interior. This may decrease glutamine efflux from the cells into the 
basement membrane via system N and increase glutamine influx in the reverse 
direction. Both of these effects would reduce the measured unidirectional flux 
from perfusate to brain. Thus the finding that Na+ removal decreases the tracer 
flux of glutamine into the brain does not in itself prove that there is a Na+-
dependent amino acid transporter for glutamine in the luminal membrane.
The passive glucose transporter, GLUT1 is expressed 
in the choroid plexuses with greater amount found 
in the basolateral membrane than in the apical mem‑
brane [127–132]. This suggests that it may be primarily 
involved either with supply of glucose for metabolism 
within the epithelial cells [133] or with another function 
such as increasing the water permeability of the basolat‑
eral membrane (see Sect. 3.4.2).
The transport of amino acids from blood can be 
detected from the differences in their concentrations in 
the arterial and venous blood supplying and draining the 
choroid plexuses. Transport from CSF into blood can be 
detected by the appearance in venous blood of tracers 
added to CSF in the ventricles [125, 126]. Extraction of 
amino acids from blood can be substantial although just 
as for glucose the total amounts of amino acids entering 
the brain are much smaller via the choroid plexuses than 
via the blood–brain barrier.
3  Fluid secretion by the choroid plexuses
The primary function of the choroid plexuses is to pro‑
duce CSF [2–4] with the rate of fluid secretion being 
<~20% of the blood plasma flow to the plexuses in rats 
(see e.g. [134]) and perhaps a lower percentage in 
humans.4 The roles of the choroid plexuses in supplying 
micronutrients, vitamins, Ca2+ and Mg2+ and in actively 
excluding or removing other substances are also 
4 Choroid plexus secretion and blood flow Choroid plexus secretion 
rate as a percentage of blood flow to the plexuses can be calculated from 
estimates of the fraction of cerebral blood flow that goes to the plex-
uses, ~0.01 (see Sect.  2), the volume fraction of plasma in blood, ~0.5, 
the cerebral blood flow, ~800  ml  min−1, and the rate of CSF production 
~400 ml day−1 = ~0.3 ml min−1, with the result 0.3 ml min−1/(0.01 × 0.5× 
800 ml min−1) = 7.5%.
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important (for reviews see e.g. [2, 16, 21, 135–138]). Sim‑
ilarly, the plexuses play a critical role in development of 
the brain and the provision of growth factors (see [139] 
and references therein).
3.1  Composition of fluid secreted by the choroid plexuses
The composition of recently formed CSF can be deter‑
mined, at least approximately, by direct measurements 
of the fluid close to the choroid plexuses [140–142]. The 
composition of this fluid is similar but not identical (see 
Table  1) to that of CSF in the ventricles, i.e. a slightly 
hyperosmotic (perhaps by 1–5 mOsmol kg−1) solution of 
Na+, K+, Cl−, HCO3− and small amounts of many other 
solutes like Mg2+, HPO32−, glucose and amino acids (see 
Table 2.5 in [17] and [4] for further discussion).
3.2  Rate of fluid secretion across the choroid plexuses
The newly secreted CSF leaves the region of the cho‑
roid plexuses and emerges from the ventricles into the 
cisterna magna. The time averaged outflow from the 
ventricles can be measured by ventriculo‑cisternal per‑
fusion and corresponds at least approximately to the 
rate of production of fluid by the choroid plexuses, 350–
500  ml  day−1 (see section  4.2 in [15] and [2, 143]). It is 
notable that this rate also corresponds within the fairly 
wide experimental error margins of the measurements to 
the total rate of CSF production as determined by con‑
tinuous collection of the formed CSF from the lumbar 
sac (for discussion see [17] and section 3.1.3 in [15]). The 
contribution of fluid secretion by the blood–brain barrier 
to the measured rates of CSF production is considered in 
Sect. 4.1.
3.3  Mechanisms of fluid secretion by the choroid plexuses
The mechanisms of secretion by the choroid plexuses 
have been reviewed recently and comprehensively by 
Damkier et  al. [4] so evidence will be considered only 
for specific points that remain controversial or where 
the account differs from that in Damkier et al. It is now 
generally accepted that the choroid plexuses are the main 
source of CSF in the ventricles and that the process pro‑
ducing CSF is primarily secretion (i.e. driven by energy 
supplied from metabolism of the epithelial cells) rather 
than filtration (driven by energy obtained from the pres‑
sure, concentration and potential gradients imposed 
from outside the epithelial cells). Readers interested in 
the history of these issues should consult the discussions 
by Cserr [3], Davson and Segal [17], Damkier et  al. [4] 
and Spector et al. [2].
Four of the simplest arguments that CSF production 
occurs largely as a secretion by the choroid plexuses arise 
from considering (a) the composition of the CSF, (b) the 
effects of inhibitors, (c) the effects of gene silencing, and 
(d) data from in  vitro models of the epithelial layer. (a) 
The composition of CSF is not that of an ultrafiltrate. (b) 
The net production of CSF can be inhibited by drugs that 
interfere with cellular metabolism or with the coupling of 
metabolism to ion transport, e.g. mitochondrial uncou‑
plers, the Na+‑pump inhibitor ouabain [144], and the car‑
bonic anhydrase inhibitor acetazolamide [17]. (c) It has 
been shown that silencing of genes for specific transport‑
ers expressed strongly in the choroid plexuses, but weakly 
elsewhere, reduces the secretion rate [4, 145]. (d) Choroid 
plexus epithelial cells when cultured as monolayers in vitro 
have been shown to secrete fluid robustly [146, 147].
3.4  Maintenance of nearly isosmotic fluid secretion by the 
choroid plexuses
3.4.1  Comparisons with kidney proximal tubules
Parallels can be found between fluid transport by the 
choroid plexuses and that by the renal proximal tubule: 
the fluids transported are both nearly isosmotic with 
plasma and the rates of transport per gram of tissue 
appear to be comparable [148]. The principal role of each 
of these epithelia is to transport a substantial quantity 
of fluid leaving behind the “undesirables” and there are 
other parallels in their functions [21]. At a mechanis‑
tic level the Na+‑pumps in both are located on the side 
towards which there is a net fluid flow but there are sub‑
stantial differences in their handling of small ions includ‑
ing HCO3−, the transport of glucose and the role of 
paracellular transport.
It is by no means certain how water transport is linked 
to that of solutes in either the choroid plexus (see [4]) or 
the proximal tubule. However, in the latter there is clear 
experimental evidence from studies in which net fluxes of 
both NaCl and water were eliminated, that the epithe‑
lium can maintain a gradient of NaCl with the water 
coming as close as can be determined to osmotic 
Table 1 Ion concentrations and pH in choroid plexus, CSF 
and plasma of adult rats
LV lateral ventricle; 4th V 4th ventricle
Data from [171] except values marked * from [170].  Values of [HCO3
−] in 
parentheses were calculated from pH and pCO2
Ion concentrations (mmol per litre of H2O)













− (11) (11) 22–24 21
pH 7.06 7.04 7.33 7.44
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equilibrium [149, 150].5 This does not prove the absence 
of active transport of water, but it does demonstrate that 
the rate of any such active transport (including secondary 
active transport via solute transporters) is not sufficient 
compared to osmotically driven water movements to 
produce a measurable gradient of osmolality. The evi‑
dence for the choroid plexus is not so clear cut because 
all available data come from experiments in which net 
fluxes of water and solutes were not eliminated and thus 
there were complications resulting from unstirred layers. 
Such complications can give the appearance of active 
transport of water when there is none [151]. This is con‑
sidered further in footnote 5.
3.4.2  Transcellular and paracellular routes for water transfer
Osmotically driven water movement across a choroid 
plexus requires routes that have sufficiently high water 
permeability. That AQP1 water channels are important 
in the secretion process and thus that transcellular routes 
are important may be inferred from the observation 
that in AQP1 knock‑out mice the rate of choroid plexus 
secretion is 25% lower than that in normal mice, with an 
80% lower water permeability of the apical membrane in 
which most of the AQP1 is expressed [152]. However, 
5 Solute and water gradients in kidney proximal tubule and choroid plexus 
When solutes that cannot be absorbed are added to renal proximal tubular 
fluid in a segment that is blocked at both ends, the epithelial cells initially 
continue to transport NaCl and water out of the lumen to the blood. A 
steady-state with constant tubular contents is reached when passive NaCl 
leak back into the lumen balances active transport out. There is then a gra-
dient of [NaCl], higher outside than inside, but no gradient of osmolality as 
the difference in osmolality for the impermeant solute balances that of NaCl. 
There must be active transport of NaCl to generate and maintain its gradient 
but there is no evidence from these experiments for active transport of water 
[149, 150]. Similar conclusions had been reached earlier using rat ileum 
[481], but the arguments used in the experiments on proximal tubules [149, 
150] are particularly elegant in that they are based on the steady-state condi-
tion in which there are no net fluxes of solutes or water. In particular in this 
condition because there is no flow and no net transport of NaCl there are no 
gradients of concentration in any "unstirred layers" (see next paragraph).
Comparable tests assessing the steady-state gradients that can be main-
tained in the absence of flow appear never to have been carried out for the 
choroid plexus. The closest to such a test is probably the demonstration by 
Heisey et al.  [482] that the choroid plexus continues to secrete even when 
the fluid in the ventricles is diluted, a result similar to that seen in the gall 
bladder where absorption of fluid can proceed when the lumen is hyperos-
motic by as much as 80 mOsmol kg−1) [483, 484]. However, as discussed by 
Spring [151] for the gall bladder, this type of observation is not sufficient to 
prove "active transport of water" [485–487]. For the choroid plexus when 
there is net flow it may be possible to have lower osmolality in the CSF 
than the blood but at the same time higher osmolality at the apical surface 
(CSF side) than at the basolateral surface (blood side) of the epithelial cells. 
The difference is made up by the osmotic gradients across "unstirred lay-
ers", presumably primarily between the capillaries and the epithelial cells. 
Thus water could be moving down the osmotic gradient created by active 
transport of solute across the epithelial layer while being carried through 
the non-selective unstirred layers by pressure driven bulk flow of the entire 
solution. No active transport of water per se would then be required to 
account for the net secretion. With epithelia uphill water movement has 
only been seen when there are supporting structures, e.g. connective tissue, 
that create conditions in which unstirred layers are inevitable [151].
there are far fewer aquaporins present on the basolateral 
side [153] and for the transcellular route the water must 
cross this membrane as well. The sidedness of the AQP1 
distribution remains puzzling [4]. One possibility is that 
the water permeability of the basolateral membrane is 
increased by the presence of a protein or proteins other 
than AQP1. One candidate is the glucose carrier GLUT1 
(see Sect. 2.5). This particular carrier has been shown to 
produce water permeability in membranes [154–157] 
and is highly expressed in the basolateral membrane of 
the choroid plexus [127–129, 132, 158].
It has not been established that the osmotic gradients 
and water permeability are large enough to account for the 
water fluxes across the choroid plexus without some form 
of active transport of water [4]. It is very likely, almost 
inevitable, that there will be some secondary active trans‑
port of water by coupling water movements to those of 
hydrophilic solutes including ions in their respective trans‑
porters [156, 157, 159–161]. However, there remains con‑
siderable scepticism that such internal coupling can move 
as much water as required or achieve the final result of a 
nearly isosmotic secretion (see e.g. [151, 162, 163]).
As discussed by Damkier et  al. [4] water flux across the 
choroidal epithelium might also occur paracellularly pass‑
ing through tight junctions and lateral spaces between the 
cells. The permeability of tight junctions to water or solutes 
is determined by the profile of proteins that they contain, 
in particular the specific forms of claudin, a family of trans‑
membrane proteins. The claudins most highly expressed at 
the choroid plexuses are claudin‑1, ‑2 and ‑3 together with ‑9, 
‑19, and ‑20 [24]. Claudin‑2 has been especially well studied 
[164, 165] and shown to form narrow (0.65–0.75 nm), water‑
filled cation‑selective (PNa/PCl of 6–8) paracellular pores, 
selectivity being conferred by a negatively charged site within 
the pore. Claudin‑2 is a typical component of leaky epithelia 
such as proximal tubule and choroid plexus that have high 
water‑transport rates [166]. Experiments by Rosenthal et al. 
[166] have shown that the presence of claudin‑2 in the tight 
junctions of an otherwise tight epithelium is associated with 
enhanced water flux and increased paracellular Na+ flow. 
During development, the expression of claudin‑2 relative to 
other claudins increases in the choroid plexuses. As noted 
by Strazielle and coworkers [24] this parallels the increasing 
rate of CSF secretion. It is highly relevant that the profile of 
claudins expressed in the tight junctions between endothelial 
cells at the blood–brain barrier is different from that found 
between epithelial cells in the choroid plexuses and reflects 
the tighter barrier of the former [24].
3.5  Expression of ion transporters
The whole profile of transporters expressed in the cho‑
roid plexus has been the subject of major transcriptome 
studies comparing adult and embryonic tissue [25, 167].
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Studies on the expression of specific transporters at 
the RNA and protein levels in adults have been reviewed 
recently [4, 168]. It has been found in these studies that 
ion transporters are expressed in choroid plexus epithe‑
lial cells at levels sufficiently high to allow clear detailed 
cellular localization by immunohistochemistry as illus‑
trated in Fig.  5. Figure  6 indicates the transporters pre‑
sent together with the ions they transport. From the 
known properties of these transporters together with 
careful measurements of electrical potentials and cur‑
rents and from the results of techniques such as gene 
knockout, it is possible to describe the main features of 
solute transport involved in secretion as shown in the 
figure and described in Sect. 3.6. More extensive discus‑
sion and detailed referencing can be found in reviews by 
Brown et al. [169] and Damkier et al. [4].
3.6  Summary of mechanisms for the principal species 
transported
The following sections are based on the scheme shown in 
Fig. 6, which is derived from the description and figures 
presented by Damkier et  al. [4]. Damkier et  al. should 
be consulted for discussion of the supporting evidence. 
The ion concentrations in choroid plexus found by Smith 
et al. [170] and Johanson and Murphy [171] are compared 
with those in CSF and plasma in Table  1. Of particular 
note are the relatively high [Na+]CPcell and low [K+]CPcell.
3.6.1  Pathways of Na+ transport
As with other secretory epithelia, the main driving 
force for fluid movement across the choroid plexus is 
provided by the Na+, K+‑ATPase or Na+‑pump. This 
actively transports Na+ out of the epithelial cells into 
CSF [144, 172] so reducing intracellular [Na+] and pro‑
viding a gradient for Na+ influx via other transport‑
ers. Na+ entry from the blood side is thought to occur 
primarily by the Na+, HCO3− cotransporter, NBCn2/
NCBE. Some Na+ leaves the cell towards the CSF via 
NBCe2 (sodium bicarbonate electrogenic transporter 
number 2) driven outward by the coupled outward 
flux of 3 HCO3− ions. (The free energy available from 
movement of 1 Na+ down its concentration gradient 
into the cell can carry 2 HCO3− inwards whereas it 
takes movement of 3 HCO3− out of the cell to provide 
the free energy needed to shift 1 Na+ out of the cell.) 
The direction of the Na+ flux via NKCC1 is not known 
with certainty (see Sect.  3.6.4): if the concentrations 













Fig. 5 Immunofluorescence staining of ion transporters in the choroid plexus of the IVth ventricle in a mouse or b rat. The Na+, K+-ATPase (red) is 
prominent in the apical brush border of the epithelial cells facing the lumen of the ventricle. The Na+, HCO3
− cotransporter, NCBE/NBCn2 (green) 
is localized to the basolateral membranes of the epithelial cells facing the stroma (interstitium) in which are embedded the capillaries. Nuclei are 
stained with To-pro 3 DNA stain (blue). Scale bar 100 µm. Previously unpublished images provided by Dr. Jeppe Praetorius. Antibodies: Na+, K+-
ATPase α1-subunit [537]; Slc4a10/Ncbe/NBCn2 [538] and To-pro 3 DNA stain (invitrogen). For a similar fluorescence image localizing NBCe2 to the 
brush border see [539]. For images that localize Na+, K+-ATPase to the brush border, AQP1 primarily but not exclusively to the brush border, and 
Ncbe/NBCn2 and AE2 to the basolateral membrane see [540, 541]
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Na+‑linked amino acid transporters are present in the 
apical membrane they are ignored here because their 
relative contribution to Na+ transport is thought to be 
small.
Na+ can also cross the epithelial layer via the paracellu‑
lar route through tight junctions. The likely direction of 
the net flux from CSF to blood is indicated in Fig. 6. The 
claudins present in these tight junctions are expected to 
allow passive movement of small univalent cations and 
water. Thus there should be observable tracer fluxes of 
Na+ in each direction but with a net paracellular flux that 
is smaller than the transcellular movements. Paracellular 
fluxes are considered further in Sect. 3.6.4 in connection 
with K+ transport. Studies on the relative sizes of the uni‑
directional versus net fluxes across the choroid plexuses 
as a whole have produced discordant results, but it is 
likely that as in other leaky epithelia the unidirectional 
flux from blood to CSF substantially exceeds the net 
flux.6
So long as water moves easily enough to allow newly 
secreted CSF to be nearly isosmotic (slightly hyperos‑
motic with plasma, see Sect.  3.4), regulation of the rate 
6 Tracer and net fluxes of Na+ across the choroid plexuses Davson and Segal 
[173] and Davson and Welch [264] found that the tracer Na+ flux towards 
the CSF in the rabbit was just sufficient to account for the amount of Na+ 
in the secretion leaving no room for a tracer flux in the opposite direction. 
This is a very surprising result because for a leaky epithelium there should be 
tracer fluxes in both directions and this has been observed in other studies. 
For instance the tracer fluxes have been shown to be several fold larger than 
the net fluxes for proximal tubules of the kidney [488–491] and the choroid 
plexuses of bullfrogs [492, 493]. Smith and Rapoport [261] and Murphy and 
Johanson [265] reported tracer Na+ flux towards CSF in the rat of 2.3% min−1 
(relative to Na+ content of the CSF) but did not report net CSF secretion rates. 
Their values for the influx are about three times larger than needed to account 
for the secretion rates (expressed as a percentage of CSF volume) measured 
by others, using ventriculo-cisternal perfusion: 0.72 or 0.75% min−1 (values in 

































Fig. 6 Ion transporters and transport pathways involved in normal secretion by the choroid plexus based on the description in Damkier et al. [4] 
with some modifications. See also [542]. On the CSF side, Na+, K+-ATPase actively transports Na+ out of and K+ into the epithelial cell, maintaining 
the gradients that drive the other ion movements indicated. The red circle used in the symbol for this pump indicates that energy for the transport 
is input from hydrolysis of ATP. Arrows within the cell indicate transfers: in black Na+, in green K+, in red Cl−, and in blue HCO3
−. On the blood side, 
dashed arrows in the symbol for the Na+, HCO3
−-cotransporter, NCBE/NBCn2, indicate the involvement of H+ and Cl− if the transporter is NCBE, but 
not if the transporter is NBCn2. On the CSF side, transport via the Na+, K+, 2 Cl−-cotransporter, NKCC1, could be in either direction depending on the 
concentrations of Na+, K+, and Cl− on the two sides of the membrane: for the concentrations in Table 1 transport is outward as shown. The electrical 
potential inside the cells is substantially negative while the CSF is somewhat positive relative to the fluid on the blood side of the epithelium. The 
source of the current that maintains the potential in the CSF may be the blood–brain barrier (see Sects. 3.7, 6.4 with its associated footnotes)
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of net Na+ transport is almost equivalent to regulation of 
the rate of CSF fluid secretion (see discussion of electro‑
neutrality and constant osmolality in Sect. 6).
3.6.1.1 Is an amiloride‑sensitive ion channel involved 
in Na+ transport at the choroid plexus? 
Evidence for the presence of an amiloride‑sensitive 
Na+ channel at the choroid plexus is conflicting. In an 
early study Davson and Segal [173] observed that ami‑
loride could inhibit CSF production. However, this was 
seen only when it was infused at high concentration 
(~1.5  mM) directly into a carotid loop. Subsequently 
Murphy and Johanson [174] also detected inhibition with 
amiloride but noted explicitly that the concentration of 
amiloride needed (near 120 µM) was larger than required 
for specific inhibition of Na+ channels. They concluded 
that amiloride was acting by inhibiting a Na+/H+ 
exchanger rather than an epithelial Na+ channel, ENaC.
Histochemical techniques have also been used to look 
for ENaC channels in the epithelial cells. Leenen et  al. 
[175, 176] reported the presence of alpha, beta and gamma 
subunits of ENaC in choroid plexus using antibodies 
developed by Masilamani, Knepper et al. [177]. However, 
these subunits appeared to be primarily in the cytoplasm 
and the apical brush border rather than the basolateral 
membrane where they would have been expected in order 
to mediate Na+ entry. In experiments to assess channel 
function, Leenen et  al. measured 22Na+ uptake (which 
they called retention) into choroid plexus epithelial cells 
and found a decrease following application of benzamil, 
an amiloride derivative that is more selective at inhibiting 
ENaC. Based on these results they suggested that ENaC 
in the apical membrane might be involved in a regulated 
backleak of Na+ from CSF into the epithelial cells, which 
could be important in the control of secretion [178].
Others however have reported evidence against a role for 
ENaC. Millar and Brown, using the methods described in 
[179], could see no evidence of an amiloride‑sensitive cur‑
rent. Their unpublished experiments showed that amiloride 
at a relatively low concentration of 10 µM (but which is still 
50–100 fold greater than the expected IC50 for inhibition of 
ENaC) had no effect on the residual current (current in the 
absence of K+ and with reduced Cl− currents): the conduct‑
ances measured in the absence and presence of amiloride 
were 10.5 ± 1.4 pS/pF and 9.5 ± 0.9 pS/pF (n = 11) respec‑
tively, ([4] and Brown, personal communication). Further‑
more Praetorius using his own antibodies could find beta 
and gamma subunits of ENaC in the choroid plexus but he 
was unable to confirm the presence of the alpha subunits 
needed for formation of ENaC channels [4].
Regardless of the resolution of this matter, there is no evi‑
dence that ENaC provides a basolateral route of entry for Na+ 
that would contribute towards secretion of fluid. The effect of 
amiloride observed at high concentration might conceivably 
be on the permeability of the paracellular pathway as sug‑
gested by Wright [180]. This possibility is discussed in more 
detail for the blood–brain barrier in Sect. 4.3.4.
3.6.2  Pathways of HCO3
− and Cl− transport
The most important anions in CSF secretion are HCO3− and 
Cl−. HCO3− enters the choroid plexus epithelial cells via the 
transporter known as either NBCn2 or NCBE (see Fig. 6). 
If, as indicated by the solid arrows, this transporter operates 
with stoichiometry of 1 Na+ and 1 HCO3− moving inwards 
the name NBCn2 (sodium bicarbonate neutral transporter 
number 2) is appropriate. Alternatively if, as indicated by 
solid and dashed arrows, 1 Na+ and 1 HCO3− move inwards 
and 1 H+ and 1 Cl− outwards the name should be NCBE 
(sodium driven chloride bicarbonate exchanger) which effec‑
tively loads the cell with 2 HCO3− for each Na+ transported. 
As discussed in [4], the rat gene when expressed in mouse 
NIH‑3T3 fibroblasts behaves as Ncbe [181] while the human 
gene when expressed in Xenopus laevis oocytes behaves as 
NBCn2 [182]. It may be that the mode of operation is deter‑
mined by the type of cell in which the gene is expressed or by 
the species of the gene. If it is the type of cell that is impor‑
tant, then expression of the human gene in human cells may 
produce NCBE, which is favoured by the present functional 
evidence (see Sect. 3.6.3). As shown in Fig. 7 with the trans‑
porter in the NCBE mode the H+ exported can be thought 
of as originating from CO2 conversion catalysed by carbonic 
anhydrase to H2CO3, which dissociates to H+ and HCO3−. 
Outside the cell the exported H+ reacts with HCO3−, again 
catalysed by carbonic anhydrase, leading to the formation 
of CO2. The net effect of one cycle of NCBE in the direction 
shown together with movement of CO2 would be influx of 1 
Na+ and 2 HCO3− and efflux of 1 Cl−.
HCO3− leaves the epithelial cell into CSF via NBCe2 as 
indicated in Fig. 6 and possibly via anion selective chan‑
nels. The ratio of the amounts of HCO3− and Na+ in 
CSF is close to ~1:6, but that in newly secreted CSF is 
somewhat higher (see [183, 184] and for further refer‑
ences [185]). Coupling of Na+ entry via its major route to 
import of 1 or even 2 HCO3− ions per Na+ ion means that 
far more HCO3− enters the cell on the basolateral, blood 
side than appears in CSF. As indicated above the rest is 
thought to be recycled across the basolateral membrane 
via AE2, which mediates exchange of HCO3− for Cl−.
Regulation of HCO3− transport across the choroid 
plexus and its interrelations with H+, CO2 and Cl− trans‑
port are considered in Sect. 6.
The transport of Cl− is inextricably linked to that of 
HCO3− because the only known route for net entry of Cl− to 
the epithelial cells from the blood is an exchange of Cl− for 
HCO3− via AE2 (see Fig. 6). In the scheme shown, there is a 
ready supply of HCO3− for exchange as the major route for 
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Na+ entry is by cotransport with HCO3−. If the cotransporter 
is NBCn2, then a large proportion of the HCO3− that enters 
would be recycled by AE2 and thus the combined effect of 
the NBCn2 and AE2 would be entry mainly of NaCl with 
a smaller amount of NaHCO3. If alternatively the cotrans‑
porter is NCBE, then AE2 must exchange a much larger 
amount of HCO3− for Cl− as it must transport enough Cl− to 
supply both the amount secreted and the amount transferred 
out of the cells across the basolateral membrane by NCBE. 
A small amount of Cl− returns to the blood via KCC3. The 
combination of DIDS (4,4′‑diisothiocyanostilbene‑2,2′‑
disulfonic acid), which inhibits AE2, and bumetanide, which 
inhibits NKCC1, reduces 36Cl− uptake into isolated choroid 
plexus by 90% [186].
Cl− efflux from the epithelial cells appears to involve both 
transporters and channels [187]. On the apical side Cl− is 
likely to leave the epithelial cells to the CSF by cotransport 
with K+ mediated by KCC4 and via anion channels that 
have been observed functionally but whose molecular iden‑
tities are as yet unknown (see [4]). NKCC1 has been shown 
to mediate large tracer fluxes in both directions. If the ion 
concentrations in CSF and within the epithelial cells are 
those shown in Table 1, then NKCC1 must also be a route 
for net outward Cl− flux [188] (see Sect. 3.6.4).
The indirect coupling of Cl− fluxes to those of Na+ via 
the combination of NBCn2/NCBE and AE2 provides an 
explanation for the observation that net Cl− transport 
across the epithelium can be against its electrochemical 
gradient [189].
3.6.3  Role of carbonic anhydrase in HCO3
− transport
Carbonic anhydrase is important in many secretory/
absorptive epithelia both for hydration of CO2 to form 
H2CO3 and for the reverse reaction. In the choroid plexus 
the soluble CAII isoform is known to be present within the 
epithelial cells and there are also membrane bound iso‑
forms present on both basolateral and apical membranes 
[190–193]. Carbonic anhydrase is very likely to be involved 
somehow in CSF secretion because secretion is inhibited 
at least 50% by acetazolamide [16] and the only established 
action of acetazolamide is to inhibit carbonic anhydrase 
(possible effects on AQP4, but not on the AQP1 found in 
the choroid plexus, are considered in 7). How carbonic 
anhydrase is involved in CSF secretion is less clear.
From consideration of the transporters shown in Fig. 6, 
if NBCn2/NCBE imports NaHCO3 without export of HCl, 
7 Effects of acetazolamide on aquaporins There is considerable interest in 
finding alternative actions of acetazolamide as its effects in treating acute 
mountain sickness have still not been adequately explained [494]. On the bal-
ance of present evidence, acetazolamide may inhibit water fluxes via the aqua-
porin AQP4 found in astrocytes. However, AQP4 is not found in the choroid 
plexus and acetazolamide appears not to inhibit AQP1 that is present [495]. 
Even for AQP4 acetazolamide only inhibits at concentrations approaching its 
solubility limit in water, ~1.5 mM [496] (but see also references in [494]).
i.e. it operates as NBCn2, hydration/dehydration is not 
required for transport of HCO3− and there is no obvious 
role for carbonic anhydrase in this transport. However, if 
NBCn2/NCBE works both to import HCO3− and to export 
H+, i.e. it operates as NCBE, then there would be an obvi‑
ous role for carbonic anhydrase because hydration and 
dehydration are needed to supply and remove the protons 
at an adequate rate (see Fig. 7). Thus the available functional 
evidence favours operation as NCBE rather than NBCn2. A 
controversial alternative possibility is that carbonic anhy‑
drase is present at the membranes of the epithelial cells as 
part of transport metabolons (complexes of two or more 
proteins at least one of which is a transporter) [194, 195]. 
If so, and carbonic anhydrase binding to the transporter 
modifies the transport function, then acetazolamide might 
by binding to the carbonic anhydrase inhibit the function of 
the transporter, accounting for the reduction in secretion.
3.6.4  Pathways for K+ transport
The activity of the Na+‑pump loads K+ into the epithe‑
lial cells from the CSF. All other routes for K+ transport 
mediate net K+ efflux or in the case of NKCC1 the direc‑
tion of transport is finely balanced (see below and [4] for 
references and discussion). Almost but not quite all of the 
K+ that enters the epithelial cells from the CSF is recy‑
cled to the CSF via some combination of KCC4, K+ chan‑
nels and NKCC1 (see below), all of which are known to 
be present in the apical membrane (see Fig. 6).
The only known route of transfer of K+ across the baso‑
lateral membrane is KCC3 which mediates a net efflux of 
K+ from epithelial cells towards blood, i.e. [K+]in[Cl−]in/
([K+]out[Cl−]out) > 1. This indicates outward transport since 
ratios > 1 indicate a net outward driving force while those 
<1 indicate inward. Net efflux across the basolateral mem‑
brane implies that the net flux across the epithelium by the 
transcellular route must be towards blood. This being so, 





basolateral membrane blood cell 
H2CO3 H2CO3
c.a. c.a. 
H+ 2 HCO32 HCO3
Fig. 7 Net transport by the Cl−-dependent Na+, HCO3
−-
cotransporter, NCBE, in the basolateral membrane of the choroid 
plexus epithelial cells would be equivalent to the transport of 1 Na+ 
and 2 HCO3
− into the cell and 1 Cl− out. Carbonic anhydrase cata-
lyzes the steps indicated by c.a.
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into CSF across the choroid plexus by another route. This 
is presumed to be the paracellular pathway with K+ pass‑
ing through the tight junctions and lateral spaces between 
the epithelial cells. The conditions to allow this are met 
because the tight junctions in the choroid plexus are leaky 
to monovalent cations and the electrochemical gradient 
for K+ will drive K+ in the direction of the CSF.
NKCC1 in the apical membrane has been shown to 
mediate large tracer fluxes of Rb+ [188]. However, while 
studies in isolated choroid plexus have found that it medi‑
ates net efflux [188], other studies focussed on epithelial 
cell volume strongly imply that NKCC1 mediates net 
influx [196, 197]. The results may all correctly reflect the 
circumstances in which they have been measured because 
the net driving force, derived from the concentrations of 
Na+, K+ and Cl−, is finely balanced and NKCC1 could be 
transporting in either direction [4, 188]. For the concen‑







 is 2.6, 
which indicates outward transport.
It has been suggested [198, 199] that the presence of 
both the Na+‑pump and NKCC1 in the apical mem‑
brane [188] allows an uncoupling of Na+ and K+ fluxes. 
Thus increased [K+]CSF could stimulate flux of K+ from 
CSF into the choroid plexus cells (or inhibit that in the 
opposite direction) by both of these transporters while 
increasing Na+ efflux from the cells via the pump but 
favouring Na+ influx via NKCC1. This would allow K+ 
transport to be changed without disturbing the net 
transport of Na+. It is, however, unlikely that this is the 
complete story because raised CSF K+ concentration is 
also likely to change the net flux of K+ through KCC4 
and K+ channels in the apical membrane (see Fig. 6).
The [K+] of newly formed CSF is remarkably stable in 
the face of changes in plasma [K+] with the CSF concentra‑
tion remaining at ~3.5 mmol kg−1 as plasma concentration 
increases from 4 to 9 mmol kg−1 [141, 200]. As discussed 
in Sect. 5 how this is achieved is only partially understood.
3.7  Electrical current and potential difference across the 
choroid plexus
Ion transfer via each of the known transporters in the baso‑
lateral membrane is electrically neutral and no ion channels 
have been localized to this membrane [4]. If this is correct 
and no charge carrying mechanisms have been missed, 
there can be no net transcellular current and the conduct‑
ance of the epithelium is determined by the permeability of 
the paracellular pathway through the tight junctions (see 
Sect. 6.4 and associated footnote for further discussion).
Ion transfer across the apical membrane via many of the 
transporters and channels is associated with net movement 
of charge. Thus the rates of transfer across this membrane 
should be sensitive to the apical membrane potential and 
the value of the potential difference across this membrane 
should be the value that preserves electroneutrality of the 
cells. Electroneutrality is discussed in Sect. 6.
4  Ion and fluid transport at the blood–brain 
barrier
The primary functions of the blood–brain barrier are to 
allow ready access to the brain parenchyma of O2 and 
nutrients such as glucose and essential amino acids and 
ready removal from the brain of waste products like CO2, 
while at the same time providing a barrier to the move‑
ment of substances that should not be allowed to enter 
or leave the brain. The blood–brain barrier also plays the 
principal role in long‑term regulation of the ionic com‑
position of ISF. Although astrocytes are very important 
in short‑term control of ISF ionic composition, a process 
sometimes called physiological buffering, they cannot set 
or determine the long‑term composition (see e.g. Sect. 5).
Unfortunately, it has not been possible to determine the 
composition of the fluid, if any, secreted by the blood–brain 
barrier by direct sampling (compare Sect. 3.1). However, if 
the fluid secretion rate were known, one could infer the 
composition because the net fluxes of solutes and water 
across the blood–brain barrier plus the water produced by 
brain cell metabolism must replace the fluid that is lost by 
net outflow from the parenchyma after allowance for meta‑
bolic changes (see sections 1.4 and 4 in [15]). The fluid lost 
is a nearly isosmotic solution with composition very close 
to that of CSF. Thus the net fluid transferred across the 
blood–brain barrier into the brain must be either a hyper‑
osmotic secretion or a hypoosmotic absorbate to make the 
net product, including the ~60 ml day−1 of metabolic water, 
nearly isosmotic (see Sect. 4.7 and 8).
8 Osmolality of fluid transferred across the blood–brain barrier: effect of meta‑
bolic water production Metabolic water production, ~3.3 mol day−1 (see Sect. 2.2) 
expressed in terms of volume is 3.3 mol day−1 × 18 ml mol−1 = 60 ml day−1. This 
is very small compared to the large amounts of water entering and leaving the 
brain but it is not small compared to the possible net water flow across the blood–
brain barrier. As a consequence the osmolality of the secretion across the barrier, 
defined as amount of solutes secreted divided by amount of water secreted, may 
be surprisingly large. If the net rate of production of fluid by the combination of 
the blood–brain barrier and metabolic production of water were 200 ml day−1 
and the metabolic production of water 60 ml day−1, then for each 140 ml of water 
transferred across the blood–brain barrier into ISF, 30  mmol of NaCl would 
have to be transferred for the final [NaCl] of ISF to be 150 mM. Thus the ratio 
of the net amount of NaCl transported across the blood–brain barrier to the 
net amount of water crossing the barrier would be 30 mmol/140 ml = 214 mM 
which is much greater than the concentration in either the endothelial cells or the 
ISF. The osmolality of the fluid within the basement membrane separating the 
endothelial cells from the astrocyte endfeet is considered in Sect. 4.7.
The calculation above assumes that the osmolality of the net outflow of ISF 
from the parenchyma is determined almost entirely by [NaCl] as would be cor-
rect if the composition of ISF were the same as that of CSF (see e.g. Table 2.5 
in [17]). However, metabolic wastes may be at higher concentrations in ISF 
than in CSF. It should be noted that the principal metabolites, e.g. CO2, amino 
acids etc., need not be considered as they are at low concentrations as a result 
of transport across the blood–brain barrier (see e.g. Sect. 2). Similarly as noted 
in Sect. 6.3, [lactate−]ISF is normally only of the order of 1–2 mM. More gen-
erally for this example calculation to be valid, the rate of production of those 
osmotically active metabolic wastes that are removed from the parenchyma by 
outflow of ISF must be substantially less than 18 mOsmol day−1.
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4.1  Evidence for and against fluid secretion by the blood–
brain barrier
The most widely quoted value for blood–brain barrier secre‑
tion rate, 10–20% of that by the choroid plexuses, was based 
on washout of markers from the brain parenchyma with half‑
times of 6–12  h (see e.g. [201, 202] and discussion in sec‑
tions 3.2 and 4.1.1 of [15]). However, this estimate has been 
called into question on two grounds. Firstly, the experiments 
were conducted under barbiturate anaesthesia, which has 
subsequently been shown to reduce the washout rate [203] 
(discussed in section 4.1.1 in [15]). This inhibition by barbi‑
turate would have led towards underestimates of the wash‑
out rate by as much as sixfold, and thus, based on washout 
evidence alone, the blood–brain secretion rate could even 
be as large as the rate of production of CSF by the choroid 
plexuses. Secondly, the washout of marker might be caused 
by fluid arising from a source other than the blood–brain 
barrier. It has been suggested that such a source may be peri‑
arterial influx of CSF into the parenchyma (reviewed in [204] 
and [15]). This periarterial influx combined with perivenous 
efflux of fluid was originally proposed to explain data for the 
distribution of horseradish peroxidase [205]. Recently it has 
been championed, based on evidence obtained using in vivo 
imaging of the movements of fluorescent tracers, and has 
been termed the glymphatic circulation [206]. As discussed 
at length in [15] the glymphatic hypothesis is intriguing, 
raises important issues and explains key qualitative features 
of movements of substances into and out of the parenchyma. 
However, it is still lacking in both quantitative detail and 
explanations for some aspects of the data. (For example, 
what induces NaCl to move from the periarterial spaces, into 
the interstitium and then into perivenular spaces?) It is pre‑
mature to describe “the glymphatic circulation” as a proven 
fact (see [21, 207–211] for critical views).
The effect of ignoring net periarterial influx of CSF, if it 
exists, would be to make too large the estimates based on 
washout data of the secretion rate at the blood–brain bar‑
rier (see sections 4.3 and 5 in [15]). No estimates are availa‑
ble for the magnitude of net flows by any perivascular route 
and thus such flows might account for all or none of the 
washout of markers. As a consequence of the uncertainties 
related to the use of barbiturate anaesthesia and to the mag‑
nitude of the flow of CSF into the brain parenchyma, other 
sources of evidence are needed to provide an estimate of the 
rate of secretion of fluid across the blood–brain barrier.
There are six types of evidence that can be used in 
arguments for or against blood–brain barrier secretion of 
fluid. The various structures and flows discussed are indi‑
cated schematically in Fig. 8.
1. Observation: if fluid is perfused through the cerebral 
aqueduct more comes out than goes in [212, 213]. 
Interpretation: the extra fluid that crosses the epend-
yma lining the aqueduct must have originated some-
where and the obvious suggestion is the blood–brain 
barrier in the surrounding parenchyma. However, con-
sideration needs to be given to the possibility that it 
might be recirculation of CSF entering the parenchyma 
from the subarachnoid spaces via periarterial pathways.
2. Observation: 3–9  months after destruction of 
80–90% of the choroid plexuses in rhesus monkeys 
CSF production, measured by ventriculo-cisternal 
perfusion, is as much as 60% of the normal rate [214] 
(see also [215, 216] and sections 3.1.1 and 3.2 in [15]). 
These results have never been convincingly explained 
on any basis other than extrachoroidal secretion of 
fluid. This evidence coincides with the general clini-
cal experience that it is difficult to alleviate hydro-
cephalus using choroidectomy alone which partially 
explains the ascendancy of shunt placement as a treat-
ment [215, 217–219] but see [2]. Interpretation: there 
is a source of CSF in addition to the choroid plexuses.
3. A third type of evidence has arisen from studies of the 
distribution and flow of CSF in hydrocephalus. These 
studies have used measurements of ventricular vol-
umes, perfusion techniques to measure production and 
absorption of CSF and more recently phase contrast 
magnetic resonance imaging (PC-MRI) to monitor CSF 
flow. In the interpretation of these it is necessary to con-
sider the sites of CSF outflow as well as those of CSF 
production. The arguments are summarized in the fol-
lowing paragraphs. For elaboration see Fig. 8, 9 and pre-
vious discussion in sections 4.2.1.1–4.2.2.2 of [15].
9 Evidence obtained in studies on hydrocephalus concerning fluid secretion 
by the blood–brain barrier (Item 3 in Sect. 4.1 is amplified in the following)
1.  When the cerebral aqueduct is blocked CSF production within the lat-
eral and third ventricles continues but the ventricles do not continue to 
swell at a rate that would accommodate the CSF added, i.e. there must 
then be a route of escape from the lateral or third ventricles. This route 
has been called "ventricular absorption" [220, 221]. The evidence estab-
lishing ventricular absorption in non-communicating hydrocephalus 
still stands. It is important to note that this does not require absorption 
across the blood–brain barrier as the fluid may pass through the perive-
ntricular parenchyma, which is oedematous, to other sites of absorp-
tion (see section 4.2.4 in [15]). There is even evidence that some such 
absorption may occur normally for sucrose [222].
2.  Injection of kaolin into the cisterna magna of cats or dogs produces a long-
lasting block of CSF flow from the cisterna magna to the cranial and spi-
nal subarachnoid spaces, an acute elevation of intraventricular pressure, 
and a sustained ventricular swelling. CSF production within the ventricles 
is maintained, but over days and weeks the ventricles do not continue to 
swell to accommodate the added CSF. Thus chronically the CSF must 
escape. It was assumed by those who developed this model that the route 
was by ventricular absorption [220, 497, 498] and it was used in attempts 
to investigate this process. However, it has now been shown convinc-
ingly, at least in cats, that in chronic kaolin induced hydrocephalus there 
is almost no ventricular absorption [223]. Instead (see Fig.  5) CSF flows 
into the swollen central canal of the spinal cord [499], then across swol-
len or damaged spinal tissue to the spinal subarachnoid space and finally 
flows out via spinal nerve roots [223, 224]. Demonstration that ventricular 
absorption did not account for CSF outflow in this model appears to have 
discredited the possibility of such absorption despite the compelling evi-
dence for it in non-communicating hydrocephalus described above.
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i. Observation: when the cerebral aqueduct is 
blocked, indicated at (i) in Fig.  8, CSF escapes 
from the lateral and third ventricles. Interpreta-
tion: to do this it must pass by some means other 
than the cerebral aqueduct to a site for outflow 
[220, 221]. There is independent evidence that 
such routes exist, at least for sucrose [222].
ii. Observation: when the cisterna magna and connec-
tions from the IVth ventricle to the subarachnoid 
space are blocked following to kaolin injection, there 
is diversion of CSF from the IVth ventricle into the 
central canal of the spinal cord leading to alternative 
sites of outflow [223, 224]. Interpretation: because in 
kaolin hydrocephalus the outflow originates from 
the IVth ventricle, this model cannot be used to 
describe the swelling of the lateral and IIIrd ventri-
cles in non-communicating hydrocephalus in which 
the aqueduct is blocked (see Fig. 8).
iii. Observation: in communicating hydrocephalus 
there are indications from movements of imper-
meant markers [225–227] and from flow meas-
urements by PC-MRI [228–230] (but see [231]) 
that there is reversed net flow of CSF through the 
cerebral aqueduct (see Fig.  9). Interpretation: if 
this is correct, there must be a source of the fluid 
that flows from the IVth to the IIIrd ventricle. That 
from the choroid plexus in the IVth ventricle is 
not enough (see also footnote 9) and the plausible 
source of the extra fluid is the blood–brain bar-
rier. In addition as in non-communicating hydro-
cephalus, there must be a route from the lateral or 
IIIrd ventricles to a site of outflow from the brain. 
The PC-MRI experiments on net flow in com-
municating hydrocephalus remain controversial 
and should be revisited (see section 4.2.2.2 in [15], 
[231] and see also footnote 9).
4. Observation: spinal perfusion studies and compari-
sons of ventriculo-lumbar and cisternal-lumbar per-
fusions (see Fig. 8) have been used to estimate spinal 
formation and absorption of CSF. Estimates of spinal 
CSF formation are in effect based on the dilution of an 
impermeant marker as the fluid travels the length of 
the cord while those for absorption are based on the 
difference between the amounts of marker infused and 
recovered. In cats, dogs and rhesus monkeys [232–
236] fluid absorption was easily demonstrated but 
these studies failed to detect spinal CSF formation.
 Interpretation: these studies put an upper limit on 
the rate of ~1 µl min−1 which has led to the general 
view that there is little or no secretion of fluid in the 
spinal cord. To put these studies into perspective it is 
necessary to have an estimate of how large the rate of 
secretion into the spinal cord would be if there were 
a functionally important secretion across the blood–
brain barrier: 200  ml  day−1 or 0.1  µl  g−1  min−1 is 
a high estimate of the secretion rate in humans 
with a 1400  g brain. The mass of the spinal cord of 
a human is only 35 g, which leads to an estimate of 
3.5  µl  min−1 for secretion into the spinal cord. The 
dogs, cats and rhesus monkeys used in the perfu-
sion studies are about 10× smaller than humans 
which suggests that the secretion rates into the spinal 
cord would also be much smaller. None of the exist-
ing studies looking for secretion of fluid into the spi-
nal cord have been sufficiently accurate to detect the 
secretion that might be expected.
5. Observation: the tracer influx of Na+ over the entire 
blood–brain barrier is as large as that across the cho-
roid plexus in rats and rabbits (see Sect. 4.3.2) and is 
substantially larger than the net flux required for even 
the largest estimates of blood-barrier fluid secre-
tion rate (see below and Sect.  4.3.5). Tracer efflux 
has also been measured (see Sect.  4.3.2 and associ-
ated footnote) and is similar in size to the influx. 
Interpretation: the difference between influx and 
efflux is so inaccurate that it cannot be used in any 
argument for or against the existence of a net influx 
Footnote 9 continued
3.  When markers are injected into the cisterna magna of normal subjects 
or experimental animals they distribute rapidly into the cranial suba-
rachnoid space and less rapidly into the spinal subarachnoid space but 
not to any observable extent into the lateral and third ventricles. By 
contrast in communicating hydrocephalus, i.e. hydrocephalus in which 
the pathways connecting the ventricles and cisterna magna are func-
tional, the markers penetrate and accumulate in the ventricles and to 
some extent in periventricular parenchyma (see e.g. chapter 4 in [225] 
and [226, 227]). It is, as if there is a reversed flow of CSF carrying the 
markers through the cerebral aqueduct in hydrocephalus, but not nor-
mally. The reversed net flow implies an important source of CSF other 
than the choroid plexuses in the lateral and IIIrd ventricles. If the rate 
of secretion by the choroid plexuses is proportional to choroid plexus 
mass that from the choroid plexus in the IVth ventricle is not sufficient 
and there must be a non-choroidal source.
 PC-MRI studies in normal subjects and patients with communicating 
hydrocephalus have revealed that the flow of CSF through the cerebral aque-
duct varies with time with a flow that is directed from the IIIrd to the IVth 
ventricle in systole and from IVth to IIIrd in diastole. If this accounts for the 
non-random variation in the CSF flow, the net, average flow over time can 
be calculated by taking an average over a cardiac cycle. The “noise” and vari-
ations from one recording to the next have usually been reduced by calculat-
ing an average over a number of recordings synchronized (i.e. with recording 
gated) to the cardiac cycle. However, this second stage of averaging will atten-
uate any and every component of flow changes that is not synchronous with 
the cardiac cycle, not just random fluctuations. Dreha-Kulaczewski et al. [500] 
have reported that the major variations in CSF flow through the aqueduct fol-
low the respiratory rather than the cardiac cycle and it is indeed plausible as 
they state that these variations in CSF flow would not have been seen in the 
cardiac-gating studies. Whether changes in CSF flow through the aqueduct 
in the respiratory cycle distort the calculation of the net flow in the cardiac 
gating studies depends on whether or not the signal recorded in the individual 
traces varied linearly with flow over the entire range of flows occurring and 
whether enough cycles were averaged. If both criteria were met the net flow 
would still be correct and the inference of reversed net flow, fourth to third 
ventricle, from the data in these studies would still stand.
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of Na+ (and hence fluid secretion). However, because 
efflux is not clearly smaller than influx, and the Na+ 
influx is not much greater across the blood–brain 
barrier than across the choroid plexuses, the net Na+ 
flux across the blood–brain barrier is likely to be less 
than the net Na+ flux across the choroid plexus and 
the same will apply to the rates of fluid secretion. 
More accurate data are required before this argument 
can be made quantitative (see Sects. 4.3.2 and 4.3.5).
6. Observation: inhibitors of ion transporters found at 
the blood–brain barrier reduce the rate of develop-
ment of focal oedema [19, 237–240] as if they are 
inhibiting fluid secretion into the region. Interpretation: 
it should be borne in mind that these same ion trans-
porters are also found at other sites within the brain 
and thus the inhibitor effects on fluid accumulation 
might be indirect [241]. Nevertheless at present it 
appears that these effects are evidence that there can 
be secretion across the blood–brain barrier.10
10 Rate of fluid secretion by the blood–brain barrier. Does ISF need to mix 
with CSF to reach lymph or blood? The available evidence does not exclude 
a fluid secretion rate across the blood–brain barrier as large as that for the 
choroid plexuses. However, if the secretion rate were larger than say 50% 
of choroid plexus secretion rate and outflow of ISF from the parenchyma 
were to CSF, then the estimates of the rate of CSF production rate would 
be markedly different if based on ventriculo-cisternal perfusion experiments 
on the one hand and e.g. collection of CSF from the lumbar sac on the other 
(see Sect. 3.2). The difference would have been larger than those seen [17]. 
Thus if the secretion rate is so large, much of the ISF must leave the brain 
without mixing with CSF that can be obtained from the lumbar sac. Lack 
of mixing was proposed by Cserr, Bradbury and colleagues [202, 501, 502] 
based on the relatively small proportion of markers injected into the paren-
chyma that could be recovered from CSF drawn from the cisterna magna. 
More recent work has emphasized routes that do not entail mixing of the 
outflow from the parenchyma with CSF even in the subarachnoid space 































Fig. 8 Schematic diagram of brain structures, CSF flows and perfusion pipette positions related to the perfusion studies and other investigations 
discussed in this section. Most of the CSF is produced by the choroid plexuses located in the lateral (L), IIIrd and IVth ventricles. Net CSF flow then 
normally proceeds through the cisterna magna (CM) to the subarachnoid spaces (SA), which for this purpose include the basal cisterns. Outflow 
from the brain occurs via a number of routes including perineural routes through the cribriform plate (cp), the arachnoid villi (av), perineural 
pathways at roots of nerves (nr) including those in the spinal cord, and, in addition, perivascular routes and dural lymphatics that are not shown 
[543, 544]. Any fluid secreted by the blood–brain barrier within the parenchyma can flow into CSF in the subarachnoid spaces or leave the brain by 
perivascular and perhaps perineural pathways without first mixing with the CSF that is sampled at the cisterna magna. Flows are investigated using 
a number of perfusion techniques. In ventriculo-cisternal perfusion, fluid is injected via a pipette or cannula at (a) and withdrawn at (b). For ventric-
ulo-lumbar perfusion the withdrawal is at (c) while for ventriculo-subarachnoid perfusion at d. For spinal perfusion fluid is injected at (b) or (e) and 
withdrawn at (c). In non-communicating hydrocephalus as discussed in this review, the aqueduct connecting the IIIrd and IVth ventricles is blocked 
as indicated at (i). In hydrocephalus induced by injection of kaolin into the cisterna magna the block is at the cisterna magna and at its connec-
tions to the IVth ventricle and the subarachnoid spaces as indicated at (ii). The causative pathology in communicating hydrocephalus is unknown 
but outflow of CSF is somehow hindered (see Fig. 9). In kaolin induced hydrocephalus the major escape route for CSF is now thought to be along 
the spinal canal, through spinal parenchyma to the subarachnoid space and out via the nerve roots. In non-communicating hydrocephalus (point 
3i) and possibly in communicating hydrocephalus (points 3iii) there is a route of escape of CSF from the lateral and IIIrd ventricles, indicated in the 
diagram as being from the IIIrd ventricle
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From the in  vivo evidence and the arguments consid‑
ered above, there is a strong but still far from conclu‑
sive case that the blood–brain barrier normally secretes 
fluid. While the amounts secreted across the blood–
brain barrier and choroid plexus may be of the same 
order, the blood flows from which they are derived dif‑
fer by almost 100‑fold. It is thus not at all surprising 
that arterio‑venous concentration differences for imper‑
meant substances can be measured for the choroid plex‑
uses [148, 242] but not for the blood–brain barrier.
4.1.1  Net fluxes of inorganic ions across the blood–brain 
barrier
The net transfers of inorganic ions across the blood–
brain barrier are small. These long‑term average net 
fluxes can be calculated if the net rate of fluid loss 
from the parenchyma is known. Taking for example 
200 ml day−1 (towards the upper end of currently plau‑
sible guesses) it is possible to calculate the size of the 
ion transfers that would be entailed. The fluids leaving 
the parenchyma are thought to have the concentrations 
of Na+, K+, Cl− and HCO3− and total osmolality similar 
to those in CSF. On this basis the net transfer of Na+ 
across the blood–brain barrier is only 0.15 mol l−1 × 0 .2  
l day1 = 30 mmol day−1. This is substantially less than 
the Na+ movement into the endothelial cells associ‑
ated with amino acid reabsorption, 145  mmol  day−1 
(see Sect.  2.4.2). Therefore the endothelial cells of the 
blood–brain barrier are certainly capable of active 
transport of sufficient Na+ to support secretion at this 
rate. Furthermore the small size of the net ion transport 
entailed in fluid secretion explains the “heroic efforts” 
[21] needed to detect the ion fluxes and the expression 
of the transporters that mediate them.
As will be described in the following sections, all the 
molecular components needed for secretion of ions and 
fluid are present at the blood–brain barrier. In addition 
there is an energy source which could drive secretion 
as the number of mitochondria in the endothelial cells 
of the blood–brain barrier is relatively high, sufficient 
to occupy 5–10% of the cell volume [1, 243]. What is 
lacking is conclusive evidence that the transporters are 
appropriately organized and function together so as to 
achieve a net secretion of fluid. For a recent, emphatic 
statement of the view that the blood–brain barrier 
secretes very little, if any, fluid see [2, 21] but see also 
Sect. 4.3.3 for a critique of part of the basis of that view.
Caveat: while most of this section is written as if net 
secretion does take place across the blood–brain barrier, it 
must be kept in mind that this has not been proven.
4.2  Hydrostatic pressure gradients cannot be responsible 
for significant fluid movement across the blood–brain 
barrier
Hydrostatic pressure differences could, at least in princi‑
ple, drive fluid movements between blood in the 
microvessels and ISF as indeed they do between blood 
and peripheral tissues. Such a mechanism has been pro‑
posed variously to explain movements of fluid either into 
or out of the brain (for references see [15]). However, 
Fig. 9 A schematic diagram of one interpretation of the differences 
in CSF flow in normal subjects and those with communicating 
hydrocephalus. In normal subjects, CSF is secreted by the choroid 
plexuses into the lateral (L), IIIrd and IVth ventricles. Some fluid is also 
secreted into the parenchyma, presumably by the blood–brain bar-
rier. The magnitude of the net flow through the cerebral aqueduct is 
close to the sum of the secretions into the lateral and IIIrd ventricles. 
Fluid passes through the IVth ventricle and cisterna magna (CM) 
on its way to routes of outflow from the brain, i.e. via arachnoid villi, 
nerve tracts through the cribriform plate, and both perivascular and 
perineural pathways. At least some of these routes allow exit of fluid 
from the parenchyma without it ever mixing with CSF in the large 
cavities. In communicating hydrocephalus there is some deficit in the 
normal route of outflow indicated by the red X. The observation of 
reversed net flow through the cerebral aqueduct implies that another 
source of fluid enters CSF at some point, shown in the diagram as 
the cisterna magna, and, when combined with the secretion from 
the choroid plexus in the IVth ventricle, it equals the flow through 
the aqueduct. Some other pathway allowing fluid to escape from 
the ventricles must exist perhaps emerging from the IIIrd ventricle as 
shown. One possibility is flow through swollen periventricular paren-
chyma eventually reaching an exit route, perhaps either perivascular 
or perineural. Fluid exit via absorption across the blood–brain barrier 
is unlikely because this would require substantial alteration of barrier 
properties (see Sect. 5.1 with the caveats in sections 3.2 and 2.7 in 
[15]
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there is a large difference between microvessels in the 
brain and those in the periphery in that the former have 
much lower permeability to Na+ and Cl− (see Sect. 4.3.2). 
Thus any pressure forcing water across the blood–brain 
barrier would leave solute behind and wash solute away 
on the brain side. The developing solute concentration 
difference would produce an osmotic pressure sufficient 
to stop water flow long before the concentration differ‑
ence would become sufficient to drive the solute across 
the barrier. This is in complete contrast to the situation 
for capillaries and venules in peripheral tissues. The per‑
meabilities to Na+ and Cl− are there so large and the 
resulting differences in [Na+] and [Cl−] so small that the 
osmotic pressure differences resulting from them are 
much smaller than the hydrostatic and colloid osmotic 
pressure differences. Net fluid movements across periph‑
eral microvessel walls are well described by the Starling 
mechanism in which transfers of water and small solutes 
are driven by differences in the hydrostatic and colloid 
osmotic pressures. At the blood–brain barrier there must 
be transport of solutes with water following either by 
simple diffusion through the lipid bilayers of the endothe‑
lial cell membranes or via specific proteins, perhaps 
GLUT1 (see Sect. 4.3.6,11 and section 2.7 of [15]).
4.3  Functional evidence for ion transport at the blood–
brain barrier from in vivo (and ex vivo) studies
In vivo techniques have been used to measure tracer 
influxes of ions into the brain and sometimes with more 
difficulty tracer effluxes. However, it has not been pos‑
sible to measure net fluxes. That the transfers are tak‑
ing place across the blood–brain barrier has had to be 
inferred from measurements of changes in the content of 
parenchyma, extracellular plus intracellular, and allow‑
ance for exchanges between the ISF and CSF. Discus‑
sion of in  vivo results for K+ and Na+ are given below. 
Evidence for movements of HCO3− is inextricably linked 
11 Hydrostatic pressure gradient needed to drive fluid movement across the 
blood–brain barrier If we take a volume transfer of 200 ml day−1 containing 
0.15 M NaCl into a 1400 g brain, the required flux, Jreq, is 21 µmol g−1 day−1 
or 0.25 nmol g−1 s−1. Based on influx of radiolabelled Na+ from the blood, 
the permeability of the blood–brain barrier to Na+ times the surface area 
of the barrier per gram of brain, is PS = 1 to 3 × 10−5 cm3 g−1 s−1 [16, 261] 
and the value for Cl− is similar. Using the midpoint of this range, the con-
centration difference required is then Δc = Jreq/PS = 12.5 mM for each of 
Na+ and Cl−. As a driving force for water movement a concentration differ-




with RT =  19  mmHg  mM−1 and thus the concentration gradient needed 
to drive the flux of NaCl corresponds to an osmotic pressure difference of 
500 mmHg, more than ten times larger than any possible hydrostatic pres-
sure difference across the barrier (this point has been made repeatedly 
before, see e.g. [507] and for further discussion [15] section  2.7). Put the 
other way round active transport of solute across the barrier can easily pro-
duce solute gradients that would produce osmotic pressure differences far 
more important than any possible hydrostatic pressure differences.
to consideration of pH and discussion is postponed until 
Sect. 6.
4.3.1  Results mainly concerned with K+ movement
It was established in early studies that [K+]CSF is less than 
would be the case if it were at equilibrium with [K+]plasma 
and the potential difference between plasma and CSF. 
Thus for [K+]plasma = 4.6 mM [17] and a potential differ‑
ence of 4 mV CSF positive (see Sect. 6.4 and its footnotes), 
the equilibrium value of [K+]CSF would be 3.9 mM (calcu‑
lated using the Nernst equation) while the measured value 
in the cisterna magna is less than 3  mM [17]. Because 
[K+]ISF is closely similar to or less than [K+]CSF [244–247] 
there must be an active process maintaining lower con‑
centrations of K+ in CSF and ISF than in plasma [17, 244]. 
Bito et  al. took these results to imply that K+ must be 
actively transported from ISF to blood across the blood–
brain barrier [244]. However, while such active transport 
may be the correct explanation, the lack of equilibrium is 
not enough to imply the existence of a net, active flux of 
K+ from ISF to plasma. If there is a sufficient net secre‑
tion of fluid, including K+, across the blood–brain barrier, 
then [K+]ISF will be the same as the concentration in the 
secreted fluid (after dilution with metabolic water), which 
could easily be lower than in plasma [241, 248].
The earliest tracer studies on K+ movement established 
that 42K+ added to blood appears rapidly in CSF [249] but 
slowly in the brain parenchyma [250]. The long half‑time 
for penetration into brain (10–20  h) results because the 
K+ content of the brain is very large and the permeability 
of the blood–brain barrier to K+ is much lower than that 
of peripheral capillaries. K+ in the blood can enter the 
parenchyma either across the blood–brain barrier or indi‑
rectly by CSF secretion across the choroid plexus followed 
by diffusion into the parenchyma. A substantial amount 
may enter via the latter route. In the ventriculo‑cisternal 
perfusion experiments of Cserr it was observed that more 
42K+ left the ventricles by diffusion into the parenchyma 
than by the outflow of CSF [251]. But, nevertheless Katz‑
man [252] calculated from the penetration rates into the 
parenchyma from CSF and from blood that approximately 
4/5ths of K+ entry to the brain was actually across the 
blood–brain barrier rather than via the choroid plexuses.
Control of [K+]ISF in the face of long‑term changes in 
[K+]plasma was investigated by Bradbury and Kleeman [253] 
who found that the rate of [K+] influx (measured with 42K+) 
increased with [K+]plasma as if there were two components 
of influx, one at a rate independent of [K+]plasma the other 
proportional to [K+]plasma. At normal [K+]plasma, 3.5–4 mM, 
the two components were almost equal. Despite the 
increase in influx, the amount of K+ in the brain showed no 
variation with [K+]plasma (see Sect. 5). They concluded that 
“the larger volume of brain tissue relative to that of CSF, 
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and the remoteness of parts of the brain from ventricular 
or subarachnoid CSF make it extremely unlikely that the 
control of the [K+]ISF of the brain is secondary to control of 
the CSF by the choroid plexuses”. Furthermore they noted 
that maintenance of nearly constant [K+]ISF requires some 
mechanism for increasing efflux from ISF to blood when 
[K+]plasma is increased.
The principal proposal for how efflux of K+ is increased 
is still that presented by Bradbury and Stulcova [254]. Using 
ventriculo‑cisternal perfusion they calculated 42K+ flux 
from brain to blood from the loss of 42K+ from perfusates 
with different [K+]. They found that the loss had two com‑
ponents. At low [K+], almost all of the loss was accounted 
for by uptake into the cells of the parenchyma with little 
efflux to blood, but as [K+] was increased the calculated rate 
of K+ efflux increased as a sigmoidal function of [K+]. Oua‑
bain added to the perfusate at 10 µM inhibited the K+ efflux 
and lower [Na+]CSF increased it. All of these findings are 
consistent with efflux of K+ from brain to blood being via 
the Na+‑pump, and are reminiscent of the situation in red 
blood cells where the pumping rate is a sigmoid function of 
external [K+] [255] and is inhibited by ouabain and exter‑
nal [Na+] [256, 257]. Activation of the Na+‑pump by exter‑
nal K+ in isolated cerebral microvessels has been shown to 
occur over the range of [K+] encountered in ISF [258].
Bradbury, Segal and Wilson [259] found that reducing 
[K+]ISF by perfusing the subarachnoid space with K+ free 
solution, produced a 50% increase in the amount of 42K+ 
from plasma that accumulated in the parenchyma over a 
2 h period. They suggested that over 2 h [42K+]ISF may have 
increased sufficiently for there to be a substantial efflux of 
42K+ from the brain which would be mediated by the Na+‑
pump. Because the relation between pump rate at the 
blood–brain barrier and [K+]ISF is sigmoidal in the rele‑
vant range of concentrations, decreasing [K+]ISF would 
decrease the pump rate for 42K+ which would increase the 
accumulation of 42K+ in the brain. Difficulties with this 
explanation and other possibilities are considered in 12.
12 Effect of reducing [K+] on influx of ISF42K+ Bradbury, Segal and Wilson [259] 
found that reducing [K+]ISF produced a 50% increase in the amount of 42K+ 
from plasma that accumulated in the parenchyma over a 2-h period. They 
suggested two possible explanations: entry of K+ occurs by a mechanism 
that displays a long-pore effect; and sufficient 42K+ accumulates within 2 h 
for efflux to substantially reduce the net accumulation. Decreasing [K+]ISF 
would then by decreasing the rate of efflux decrease this effect, leading to an 
increase in the net amount accumulated.
A long-pore effect occurs when permeation is via a long, multiply-occupied, 
single-file pore. Well known examples include pores formed by gramicidin 
A [508, 509] and the delayed rectifier K+ channels found in nerve and mus-
cle [510]. In essence the long-pore effect can greatly reduce the unidirec-
tional flux of ions through the pore in the direction counter to the net flow. 
This explanation is difficult to sustain for 42K+ influx across the blood–brain 
barrier because transport of K+ into the endothelial cells across the luminal 
membrane is thought to be mediated by NKCC1 while transport out of the 
cells in the abluminal membrane is in the direction of the net flow through 
the channels (see Sect. 4.5.3).
Footnote 12 continued
Explanation in terms of enhanced efflux of 42K+ also encounters difficul-
ties. The half-time for accumulation of K+ in the brain parenchyma is of 
the order of 19 h [250] and thus even over a time as long as 2 h, the small 
increase in [42K+]ISF will not lead to sufficient efflux to reduce the net rate 
of accumulation to an extent that changes in this efflux would matter. Per-
haps, a closely related, potentially larger effect might be sufficient. To enter 
the brain 42K+ must cross the endothelial cell into the basement membrane 
on the abluminal side and then move onwards either through or around 
the astrocyte endfeet (see Sect. 5). [42K+] in the basement membrane may 
increase more rapidly and to a greater extent than in the parenchyma as a 
whole. (A similar effect is considered for amino acids in footnote 3.) How-
ever, even this is not a convincing explanation because the astrocyte endfeet 
contain high densities of K+ channels, which would minimize this effect.
As the simple explanations have proved wanting, it would appear to be nec-
essary to consider some form of regulation of the number or activity of K+ 
transporters.
From the data from many sources tabulated by Brad‑
bury (Table  8.1 in [16]) the values for K+ permeability 
were generally about 0.5–0.7  ml  h−1  g−1. (The data are 
expressed as the PS product, i.e. the product of permea‑
bility and area of barrier, usually per gram of tissue.) Keep 
et  al. noted that K+ permeability in the adult rat would 
be inadequate to support a net influx of K+ in the foetus 
sufficient for brain growth. They found that the blood–
brain barrier K+ permeability in rat foetus was much 
larger (2.5 ml h−1 g−1) [260]. Smith and Rapoport [261] 
measured entry of tracer K+ into regions of parenchyma 
far from the ventricles and hence not initially affected by 
entry via the choroid plexuses and CSF. They found per‑
meabilities similar to the earlier values. They also com‑
pared influx into parenchyma and into CSF from which 
it can be concluded that for K+ the blood–brain barrier 
route is the dominant route of entry into brain [261] (see 
discussion for Na+ in the next section).
In a meeting abstract Ennis et  al. [262] reported that 
1 mM ouabain reduced 86Rb+ influx into in situ perfused 
rat brains by about 50%. If as expected [263] ouabain 
could only reach the luminal side of the blood–brain bar‑
rier from the perfusate this result argues that Na+‑pump 
activity is present in the luminal membrane. Furthermore 
this route accounts for roughly half of the entry of K+ on 
this side of the endothelial cells (see Sect. 4.4.1 for further 
discussion of luminal Na+‑pumps). This result contrasts 
with the premise that most of the K+ entry across the 
luminal membrane occurs via NKCC1 (see Sect.  4.5.1). 
NKCC1 has been localized to the luminal surface both 
in endothelial monolayers and in  vivo (see Sect.  4.4.2). 
It would be very interesting to know the effect of the 
NKCC1 inhibitor bumetanide on K+ influx in the in situ 
perfused brain.
Further results comparing influx of K+ into CSF 
and the parenchyma and the changes in influx when 
[K+]plasma is changed acutely or chronically are discussed 
in Sects. 5.1 and 5.2.
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4.3.2  Results mainly concerned with Na+ movement
Davson and Segal [173] measured tracer flux into the 
brain parenchyma when 22Na+ was added to blood and 
found that this was not affected by ouabain, acetazola‑
mide, or amiloride all of which had been shown to 
affect CSF secretion. From this they concluded that 
entry must be across the blood–brain barrier but that 
this measured 22Na+ influx did not represent a net flux. 
The tracer influx calculated from these and additional 
studies the following year by Davson and Welch [264] is 
indeed larger than any estimates of net flux that have 
been made (see Sect.  4.3.6). Unfortunately, they went 
on to conclude that there is no secretion (or absorp‑
tion). This conclusion does not follow from their data. 
To reach any conclusion about the net flux of Na+ and 
fluid secretion requires measurements of both tracer 
influx and efflux, these measurements being sufficiently 
accurate to determine the difference between them. To 
date this has not been possible.13
Data from many sources for values for Na+ and Cl− 
permeabilities, 0.08–0.19 ml h−1 g−1, were tabulated by 
Bradbury (Table 8.1 in [16]). Smith and Rapoport [261] 
found similar values and noted that following intra‑
venous injection of tracers, the Na+ and Cl− perme‑
abilities of the blood–brain barrier were comparable to 
those of cell membranes, i.e. much greater than those 
of lipid bilayers but much smaller than those of leaky 
epithelia and peripheral capillary walls. The permeabili‑
ties to Na+ and Cl− were similar to each other and to 
that of mannitol.
From their data obtained with rats, Smith and Rapo‑
port [261] calculated the transfer constants for Na+ 
across the blood–brain barrier into samples of brain 
parenchyma, kBBB = 2 × 10−5 s−1, and across the choroid 
plexus into CSF, kCSF  =  3.8  ×  10−4  s−1. (The transfer 
constant for a solute is the ratio of the rate of transfer 
into unit volume of destination to the concentration at 
13 Na+ tracer influx and efflux data at the blood–brain barrier Davson and 
Welch [264] measured changes in concentration of tracers in CSF and the 
parenchyma when 22Na+ was infused intravenously and interpreted these 
using a model for exchanges between blood and CSF, CSF and brain paren-
chyma, and blood and brain parenchyma. The net flux across the blood–
brain barrier was modelled as permeability multiplied by the concentration 
difference across the barrier. From their data they calculated a PS product 
(the product of the permeability and the area of barrier, usually per gram 
of tissue) of 0.074 cm3 h−1 g−1 for Na+ influx and a slightly higher value for 
Cl− influx. Cserr et al. [511] measured the rate of Na+ efflux after injecting 
22Na+ into the parenchyma of rats, and found a rate constant of 0.43 h−1. 
For a passive permeability this can be converted to a PS product by multi-
plying by the extracellular volume per unit weight of tissue, which in effect 
they took to be c. 0.16 cm3 g−1. Because the resulting estimate of PS based 
on tracer efflux, 0.43 h−1 × 0.16 cm3 g−1 = 0.069 cm3 h−1 g−1, is within the 
range of the estimates based on tracer influx, their results confirm that the 
net flux is too small to measure by these techniques, but the range of pos-
sible values is also too large to allow these measurements to be used as an 
argument against secretion of Na+ and fluid by the blood–brain barrier.
the source, which is calculated from experimental data 
for transfers into the brain or CSF as
where T is the time allowed for influx.) The substan‑
tially larger value of the transfer constant for choroid 
plexus compared to that for the blood–brain barrier 
calculated by Smith and Rapoport has been cited as 
evidence of a “great difference in plasma ion penetra‑
tion at the two barriers” (see p. 81 in [2]). However, this 
comparison is misleading. The transfer constants are 
rate constants for transfers into unit volumes of paren‑
chyma or CSF. The comparison that is more revealing is 
between the rate for Na+ transfer into the whole paren‑
chyma and rate for transfer into the entire volume of 
CSF. To obtain the rates for the total transfers it is nec‑
essary to multiply the transfer constants by the volumes 
of the respective destinations, ~1.7  cm3 for the brain 
and ~0.1  cm3 for CSF and by [Na+]plasma. This gives 
transfer rates of 3.4 × 10−5 cm3 s−1 [Na+]plasma for the 
blood–brain barrier and 3.8 × 10−5 cm3 s−1 × [Na+]plas
ma for the choroid plexuses.
The conclusion from these calculations for rats is that 
neither the choroid plexuses nor the blood–brain barrier 
can be ignored when considering influx of Na+ into the 
brain. Davson and Welch [264] found in rabbits that the 
time courses for tracer concentrations in brain water and 
CSF were similar. This implies that in rabbits substan‑
tially more Na+ enters the brain via the blood–brain bar‑
rier than via the choroid plexuses.
4.3.3  Results from further in vivo studies using inhibitors
The mechanisms that allow influx of Na+ into the brain 
across the blood–brain barrier have been investigated 
using inhibitors. Using such an approach Murphy and 
Johanson [265] confirmed that in vivo the carbonic anhy‑
drase inhibitor acetazolamide inhibits secretion of Na+ at 
the choroid plexus but does not inhibit 22Na+ influx into 
brain across the blood–brain barrier. They also showed in 
contrast to Davson and Segal’s earlier observations [173] 
that amiloride, which inhibits Na+ transport in many epi‑
thelia, did produce a 22% inhibition of Na+ influx at the 
blood–brain barrier but at a relatively high dose, i.e. that 
calculated to produce a plasma concentration of 0.12 mM 
[174].
Betz [266], using an intracarotid bolus injection tech‑
nique, compared Na+ uptakes over a range of [Na+] in 
the presence and absence of inhibitors. The uptake at a 
low [Na+], 1.4 mM, was found to have both saturable and 
unsaturable components. The saturable component was 
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which inhibit different Na+ transport mechanisms. These 
results suggested the presence of two distinct satura‑
ble transport systems. The amiloride‑sensitive compo‑
nent was thought from its apparent KD (no inhibition at 
0.1 µM and maximal at 1 µM) to be an ion channel. The 
furosemide‑sensitive component was thought to be a 
Na+, Cl− cotransporter. The saturable components could 
be detected at low [Na+], but they could not be seen in 
tracer influx measurements conducted with more physi‑
ological [Na+], e.g. 140 mM.
Ennis, Ren and Betz [267] sought to improve the char‑
acterization of Na+ influx using an in situ perfused brain 
preparation that allowed uptake to continue for 10  min 
from solutions containing 140  mM Na+. Despite the 
previous results described above showing domination of 
the unsaturable component at 140  mM Na+, using this 
later technique they found about 25% of the uptake was 
via a saturable mechanism that could be inhibited com‑
pletely by 25 µM dimethylamiloride, an amiloride deriva‑
tive selective for Na+/H+ exchangers such as NHE1 or 
NHE2. These NHEs are now known to be expressed in 
brain endothelial cells (see Sect.  4.4.2). Why this com‑
ponent could be seen in these experiments but not the 
earlier experiments may be explained by the possibility 
that the perfused brains were acidotic. It is known from 
in  vitro experiments with brain endothelial cells [268] 
(see Sect. 4.5.2) that NHE activity is strongly activated at 
low intracellular pH. Ennis et al. [267] found that neither 
bumetanide, an inhibitor of Na+, K+, Cl− cotransporters, 
at the high concentration of 250 µM nor hydrochlorothi‑
azide, an inhibitor of Na+, Cl− cotransporters, at the high 
concentration of 1.5  mM had any effect on tracer Na+ 
influx into the brain. This bumetanide result is consistent 
with an earlier result from Smith and Rapoport [269] that 
the rate of 22Na+ tracer entry into the brain across the 
blood–brain barrier was the same at 25 and 95 mM Cl−.
4.3.4  Transcellular versus paracellular routes for Na+ and Cl−
It has been possible to inhibit K+ tracer fluxes but not 
those for Na+ across the blood–brain barrier in  vivo 
using ouabain. Why? A possible explanation is sug‑
gested by the properties of the tracer influx of Na+ at 
normal concentrations: (i) it is not blocked by inhibi‑
tors of the Na+ transporters known to be present and 
is not affected by [Cl−]plasma (see Sect.  4.3.3); (ii) it is 
unsaturable and (iii) it is much larger than any possi‑
ble net flux of Na+ across the barrier (see Sect. 4.3.5). 
These are the properties expected for transport by a 
paracellular route. Such transport: (i) would be inde‑
pendent of any of the transporters involved in the 
transcellular route and thus not subject to their inhibi‑
tion, (ii) would be similar to electrodiffusion (diffusion 
of ions when there are both concentration and electri‑
cal potential gradients) which is unsaturable, and (iii) 
would have a net flux much smaller than influx or efflux 
because [Na+] is almost the same on both sides of the 
barrier and the potential difference across it is small, 
e.g. 4 mV, ISF relative to plasma (see Sect. 6.4 and asso‑
ciated footnotes). For further arguments in favour of a 
paracellular route for transport see [270].
Electrodiffusion by a paracellular route would of 
course imply that there is a paracellular conductance. 
The conductance of this proposed pathway must not 
be greater than the total measured conductance of the 
barrier. Smith and Rapoport [261] calculated that the 
Na+ and Cl− permeabilities they measured, if occur‑
ring by electrodiffusion, would together correspond to 
an electrical conductance of about 1.6 ×  10−4  s  cm−2 
(or resistance of 8000   cm2). This is less than the 
best available measurements of barrier conductance, 
5–7 × 10−4 S cm−2 [271, 272].
The tight junctions at the blood–brain barrier are 
among the tightest in the body. This probably reflects 
the high abundance of claudin‑5, which is known to 
reduce the conductance of tight junctions to low levels. 
However, apparently there are no estimates, other than 
from the transendothelial resistance estimates above, of 
just how low the conductance becomes. For reviews of 
the properties of the tight junctions see [273–276].
There are two further observations in the literature that 
argue against all of the observed tracer fluxes of Na+ and 
Cl− across the blood–brain barrier being via a paracel‑
lular route. The first concerns fluxes of Na+. In the per‑
fused brain experiments discussed in Sect.  4.3.3 about 
a third of the unsaturable Na+ influx was inhibited by 
phenamil, an amiloride derivative [267] thought to be 
selective for inhibition of epithelial Na+ channels, which 
may mean that less than half of the Na+ tracer influx is 
paracellular. However because in these experiments 
the inhibitor was used at a much higher concentration, 
25  µM, than the sub‑micromolar concentrations found 
to block Na+ channels in epithelia [277, 278], it is con‑
ceivable that its effect was not on a channel in the plasma 
membrane but on some other target. One possibility is 
that it was acting less specifically to reduce the conduct‑
ance of the tight junctions and thus affect movement via 
a paracellular route. Amiloride itself, at concentrations 
higher than those used to block Na+ selective channels, 
is known to reduce fluxes through tight junctions (albeit 
those with much higher conductances) [180, 279–281] 
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lending support to the idea that phenamil might be doing 
something similar (compare the discussion of the effects 
of amiloride in choroid plexus in Sect. 3.6.1.1). Further‑
more such inhibition may not be a total block of the per‑
meation pathways, but may instead be a modification of 
the permeation pathway, for instance by changing surface 
charge [282–284]. That type of action may explain why 
the reported inhibition has been only partial. In sum‑
mary, this evidence may be consistent with anything up 
to almost all of the Na+ tracer influx being paracellular.
The second of the observations that can be used to 
argue against a paracellular route concerns fluxes of Cl−. 
Tracer influx of Cl− was observed to occur at a rate com‑
parable to that for Na+ [261] but, in contrast to Na+ 
transport, that for Cl− was reported to be entirely satura‑
ble as if it were occurring via transporters and hence 
transcellular (see Fig. 12). However in interpreting their 
results, Smith and Rapoport [269] assumed that all of the 
transport occurred by a single mechanism, either satura‑
ble or unsaturable. If it is assumed instead that transport 
has two components, one saturable and the other unsatu‑
rable, the improvement in the fit to their data is statisti‑
cally significant (see Fig.  10 and 14) and most of the 
transport is found to be unsaturable. Thus their data are 
consistent with a large proportion of the tracer flux of 
Cl− occurring via an unsaturable and hence possibly par‑
acellular route.
In conclusion, evidence that the tracer flux of Na+ 
occurs by a route that does not involve either the Na+‑
pump or NKCC1 is very strong but the suggestion that 
this separate route is paracellular still needs more direct 
confirmation.
14 Curve fitting of data for influx of 36Cl− into brain cortex Smith and Rapo-
port [269] measured the uptake of 36Cl− into a volume of brain parietal cor-
tex over a period, T, and divided the average uptake rate (units mmol l−1 s−1 
or mM  s−1) by the integral of [36Cl−] over the same period to obtain a 
transfer constant (see Eq. 1). This is then multiplied by [Cl−]plasma to obtain 
the unidirectional Cl− influx over the same period, with results shown in 
Fig. 10 (Fig. 3b in [269]). These data have been fitted here by non-linear least 














The short dashed curve is the fit reported by Smith and Rapoport with 
P = 0, Vmax = 250 ×−5 mM s−1, Km = 43 mM, and, as calculated here, a 
residual sum of squares of 5555  ×  10−10 (mM  s−1)2. The solid curve is 
the best fit with P  =  0.88  ×  10−5  s−1, Vmax  =  103  ×  10−5  mM  s−1, and 
Km =  14  mM and a residual sum of squares of 4341 ×  10−10  (mM  s−1)2. 
For an F test on the improvement in fit provided by allowing P to vary (see 
[512]), p  <  0.03. The long-dashed straight line is for P  =  1.2  ×  10−5  s−1, 
Vmax  =  56  ×−5  mM  s−1, Km  =  0, and a residual sum of squares of 
4918 × 10−10 (mM s−1)2. The proportions of the influx for [Cl−]plasma = 118 
mM by the unsaturable component are 0, 53 and 72% respectively in the 
three fits. Two conclusions follow from comparisons of these fits. Firstly the 
data suggest that more than half of the influx (blood to brain) occurs by an 
unsaturable mechanism and secondly the data do not determine an accurate 
value for the Km of the saturable component. To reach firmer conclusions 
either more accurate data must be obtained or the data must extend over a 
larger range of [Cl−]plasma, which might be possible at the lower end of the 
range.
To return to the initial question, there is a simple rea‑
son that may explain why it has been possible to dem‑
onstrate inhibition of K+ fluxes but not Na+ fluxes using 
ouabain. The principal mechanisms that load K+ into the 
endothelial cells, the Na+‑pump and NKCC1, have ratios 
for Na+ and K+ transport of 3/2 and 1/1 (see Sects. 4.6.1 
and 4.6.4). By contrast the ratio for a paracellular, unsatu‑
rable, electrodiffusion‑like route would be expected to 
be roughly the same as the ratio of the Na+ and K+ con‑
centrations, i.e. approximately 150/4 = ~37. Thus on this 
basis alone it is plausible that transcellular transport will 
be a much larger fraction of the total transport of K+ 
than it is of Na+.
4.3.5  Comparison of Na+ tracer flux, net Na+ flux inferred 
from tracer data and the net Na+ flux needed 
to support any significant fluid secretion
It is instructive to compare measured Na+ tracer fluxes 
[16, 261] (see Sect.  4.3.2) with the net Na+ flux that 
would occur if tracer flux represented paracellular elec‑
trodiffusion and with the net Na+ flux that would occur 
as part of fluid secretion, e.g. for purposes of illustration 
at 200  ml  day−1 for an adult human. Calculation of net 
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Fig. 10 Unidirectional Cl− influx into parietal cortex as a function of 
[Cl−]plasma. The Cl
− influx has been calculated as the transfer constant, 
k, taken from Fig. 3a in [269] times [Cl−]plasma. The short-dashed 
curve is plotted using the expression for transport by a saturable 
transporter with k = Vmax/(Km + [Cl−]plasma), maximum transport 
rate, Vmax = 250 mM s−1, and Michaelis constant, Km = 43 mM as 
described by Smith and Rapoport [269]. The solid curve is the best fit 
for a model with a single saturable component plus an unsaturable 
component. 53% of the influx is unsaturable at [Cl−]plasma = 118 mM. 
As shown by the long-dashed line, it is even possible to fit the data 
more closely than by Smith and Rapoport’s expression by assuming 
a high affinity, saturable component and an unsaturable compo-
nent with 72% of the uptake unsaturable at 118 mM. The fitting is 
described in more detail in footnote 14
Page 26 of 69Hladky and Barrand  Fluids Barriers CNS   (2016) 13:19 
of 4  mV is explained in.15 The net flux as part of fluid 
secretion is calculated as the secretion rate multiplied by 
the concentration of Na+ in the secretion. These values 
are compared in Table 2.
The values in the table illustrate two points. The first 
and most important point is that tracer influx is much 
larger than all credible net fluxes calculated from the 
possible rates of fluid secretion. As noted by Davson 
and Segal [173] because tracer influx is so much larger 
than any conceivable net flux, it must to a large extent 
be balanced by a tracer efflux. The second point is that, 
if tracer flux occurs by electrodiffusion, then even quite 
small potential differences across the barrier between 
ISF and plasma will produce net fluxes comparable in 
size to those that might support secretion. As discussed 
in Sect.  6.4 and associated footnote, it is likely that 
there is a potential, of the order of 3 or 4 mV [285], ISF 
positive, across the blood–brain barrier. The Na+ flux 
driven by this small potential would be in the opposite 
direction to that required for secretion, but Cl− flux 
would be in the same direction as the secretion. This 
could have important implications as the potential dif‑
ference may become more positive in acidosis. How‑
ever, there does not appear to have been any study on 
the consequences of changes in this potential for net 
transport of Na+, Cl− and fluid across the blood–brain 
barrier (but see [286]).
To restate the main conclusion from these compari‑
sons, net flux by a mechanism involving active transport 
and hence presumably transcellular can make a major 
contribution to total net flux across the blood–brain bar‑
rier but at the same time be much smaller than tracer 
influx (or efflux) measured across the barrier. Inhibition 
of transport via an active, hence transcellular mechanism 
may thus not be detectable by measuring tracer influx 
because the latter occurs primarily by a separate, passive 
15 Calculated net flux if the mechanism of tracer influx is electrodiffusion 
For electrodiffusion of ions across a barrier the unidirectional fluxes, −→J  and 
←−
J  and net flux, Jnet can be written terms of rate constants for transfers in 



























where, because these equations must reduce to the Nernst equation at equi-






F is the Faraday, R the gas constant, T the absolute temperature and, 
V = Vi − Vp is the potential in ISF minus that in plasma. When the Na+ 





































mechanism, presumably paracellular (see Sect. 4.3.4 but 
also the discussion of results for dimethylamiloride [267] 
in Sect. 4.3.3).
4.3.6  Results concerned with water transfer
As can be judged from the magnitude of unidirectional 
fluxes of water noted earlier (see Sect. 2.1), water mole‑
cules can easily cross the blood–brain barrier. However, 
because permeability = flux/concentration and the con‑
centration of water is so high (55  M), permeability to 
water could still be relatively small despite these large 
observed unidirectional fluxes. It is thus necessary to ask 
if the barrier is sufficiently permeable to water that the 
water component of fluid secretion could be driven by 
the small osmotic gradients that can exist. Osmotic water 
permeability (or in different units the filtration constant) 
has been measured for the blood–brain barrier in rabbits 
[287, 288] and humans [289] and in both is close to 
1.1 × 10−3 cm s−1 (or 1.2 × 10−6 ml min−1 cm−2 mM−1). 
(See 16 for definitions of some of the constants used to 
state the permeabilities and their units and for the 
16 Water permeabilities It should be noted that the constants considered 
here describe permeation of just water. They can not be used to describe 
flow of the entire fluid crossing the blood–brain barrier including solutes in 
response to a hydrostatic gradient.
The hydraulic permeability of a barrier to water, Lp, is defined as the 
ratio of the volume flow of water per unit area, JV, to the net pressure 
difference, hydrostatic plus osmotic, ΔPtotal. Fenstermacher and John-
son [287] measured and reported a filtration constant defined as JV/
Δc where Δc is the concentration difference of impermeant solutes 
(which for this purpose includes Na+ and Cl−). The filtration con-
stant equals LpRT where R is the gas constant, 8.3  J  mol−1  K−1 and 
T is the absolute temperature. At 37  °C, T  =  310  K and RT 
=  2576  J  mol−1  =  2576  N  m−2  mM−1  =  19.4  mmHg  mM−1. 
For calculation of the filtration constant they assumed that the surface area 
of capillaries per gram of parenchyma was 52 cm2 g−1. Fenstermacher [288] 
recalculated the value assuming 100 cm2 g−1 with the result LpRT = 1.2 × 1
0−6 ml min−1 cm−2 mM−1. To facilitate comparison with the tracer perme-
ability of water, Pd = (flux of tracer per unit area)/(difference in tracer con-




v¯w where v¯w is the partial molar volume of water. Fenstermacher 
and Johnson’s value becomes Pf  =  1.1  ×  10−3  cm  s−1 which as stated in 
Sect. 4.3.6 is well within the range of values found for lipid bilayers.
From the filtration constant and an estimate of the area of membrane per 
gram of parenchyma, and the expression relating net water flow and con-
centration difference of impermeant
JV = LpRTc
it is possible to calculate the concentration difference of NaCl that would 
be needed to drive a net flow of 0.1 µl g−1 min−1 (corresponding to 200 
ml day−1 in a human). Using 100 cm2 g−1 (the value used in [288]), and 





= �c/2 = JV /(2LpRT )
=
0.1µ l g−1 min−1 × 10−3 mlµl−1
2× 1.2× 10−6 ml min−1mM−1cm−2 × 100 cm2 g−1
= 0.4 mM
Table 2 Comparison of observed Na+ tracer influx, cal-
culated net Na+ flux driven by 4 mV if by electrodiffusion 
and Na+ flux needed for secretion of 200 ml day−1 at the 
blood–brain barrier
Quantity and formulae Value 
(mmol kg−1 h−1)




= 70 cm3 kg−1h−1 × 0.15mmol cm−3
10.5
If�V = 4mV, net flux
= tracer influx×�V × (F/RT )
= 10.5mmol kg−1h−1 × 4mV/27mV
1.55
Net flux of Na+
needed for secretion of 200ml day−1in a 1.4 kg brain
= 0.2 l day−1 × 150mmol l−1/(24 h day−1 × 1.4 kg)
0.9
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mechanism, presumably paracellular (see Sect. 4.3.4 but 
also the discussion of results for dimethylamiloride [267] 
in Sect. 4.3.3).
4.3.6  Results concerned with water transfer
As can be judged from the magnitude of unidirectional 
fluxes of water noted earlier (see Sect. 2.1), water mole‑
cules can easily cross the blood–brain barrier. However, 
because permeability = flux/concentration and the con‑
centration of water is so high (55  M), permeability to 
water could still be relatively small despite these large 
observed unidirectional fluxes. It is thus necessary to ask 
if the barrier is sufficiently permeable to water that the 
water component of fluid secretion could be driven by 
the small osmotic gradients that can exist. Osmotic water 
permeability (or in different units the filtration constant) 
has been measured for the blood–brain barrier in rabbits 
[287, 288] and humans [289] and in both is close to 
1.1 × 10−3 cm s−1 (or 1.2 × 10−6 ml min−1 cm−2 mM−1). 
(See 16 for definitions of some of the constants used to 
state the permeabilities and their units and for the 
16 Water permeabilities It should be noted that the constants considered 
here describe permeation of just water. They can not be used to describe 
flow of the entire fluid crossing the blood–brain barrier including solutes in 
response to a hydrostatic gradient.
The hydraulic permeability of a barrier to water, Lp, is defined as the 
ratio of the volume flow of water per unit area, JV, to the net pressure 
difference, hydrostatic plus osmotic, ΔPtotal. Fenstermacher and John-
son [287] measured and reported a filtration constant defined as JV/
Δc where Δc is the concentration difference of impermeant solutes 
(which for this purpose includes Na+ and Cl−). The filtration con-
stant equals LpRT where R is the gas constant, 8.3  J  mol−1  K−1 and 
T is the absolute temperature. At 37  °C, T  =  310  K and RT 
=  2576  J  mol−1  =  2576  N  m−2  mM−1  =  19.4  mmHg  mM−1. 
For calculation of the filtration constant they assumed that the surface area 
of capillaries per gram of parenchyma was 52 cm2 g−1. Fenstermacher [288] 
recalculated the value assuming 100 cm2 g−1 with the result LpRT = 1.2 × 1
0−6 ml min−1 cm−2 mM−1. To facilitate comparison with the tracer perme-
ability of water, Pd = (flux of tracer per unit area)/(difference in tracer con-




v¯w where v¯w is the partial molar volume of water. Fenstermacher 
and Johnson’s value becomes Pf  =  1.1  ×  10−3  cm  s−1 which as stated in 
Sect. 4.3.6 is well within the range of values found for lipid bilayers.
From the filtration constant and an estimate of the area of membrane per 
gram of parenchyma, and the expression relating net water flow and con-
centration difference of impermeant
JV = LpRTc
it is possible to calculate the concentration difference of NaCl that would 
be needed to drive a net flow of 0.1 µl g−1 min−1 (corresponding to 200 
ml day−1 in a human). Using 100 cm2 g−1 (the value used in [288]), and 





= �c/2 = JV /(2LpRT )
=
0.1µ l g−1 min−1 × 10−3 mlµl−1
2× 1.2× 10−6 ml min−1mM−1cm−2 × 100 cm2 g−1
= 0.4 mM
calculations that are the basis of the comparisons made 
here). This value, which is consistent with there being 
large unidirectional fluxes, can be used to calculate the 
osmotic gradient that would be needed for fluid secretion 
of 0.1 µl g−1 min−1 (corresponding to 200 ml day−1 in a 
human). This water flow could be driven by as little as 
0.4 mM NaCl concentration difference. As this value is so 
small, there is no need to propose anything beyond 
osmotically driven water flux to explain the net flux of 
water across the blood–brain barrier.
The measured water permeability is well within the 
possible range of water permeabilities for protein‑free 
lipid bilayers [290]. Thus it is not surprising that no 
aquaporins have been detected in brain endothelial cells 
in vivo [13] and their appearance in these cells in culture 
is thought to be a result of dedifferentiation [291] and not 
an indication of the normal situation within the brain.
Even though the permeability of the lipid bilayers may 
be adequate, that of the endothelial cell membranes may 
be increased further by the presence of transporters and 
other proteins. In particular GLUT1 is known to be 
highly expressed in the brain endothelium (see 
Sect. 2.4.1) and it is known to increase the osmotic water 
permeability of membranes in other cell types 
[154–157].17
17 Water cotransport  The movement of water by cotransport with ions or 
other solutes either by direct coupling or by local osmotic effects within a 
transporter vestibule [160] may be large enough to contribute to the net 
water flux across the blood–brain barrier. If so, the osmotically driven flow 
might be decreased or even changed in direction so that the final result is 
still a fluid close to osmotic equilibrium. Coupled transport of 40 water 
molecules with each glucose molecule has been proposed for GLUT1 
in another context [157]. (This is in addition to the water permeability 
induced by GLUT1.) At the blood–brain barrier with a net glucose transfer 
of 0.6 mol day−1 this would mean addition of 24 mol day−1 (440 ml day−1) 
of water to the brain without accompanying osmotically active solutes (the 
glucose is consumed). This combined with metabolically produced water 
would mean that the osmotically driven water flow across the blood–brain 
barrier would be out of the brain.
4.4  Evidence for the presence of ion transporters able 
to move osmotically important solutes across the 
blood–brain barrier
Identification and localization of the transporters 
involved in the transport of Na+, K+, Cl− and HCO3− 
across the endothelial cells of the blood–brain barrier is 
challenging and has not reached the same level of cer‑
tainty as at the choroid plexus. This is partly because 
brain endothelial cells are very different in shape from 
choroidal epithelial cells (see Fig.  11). Each choroid 
plexus epithelial cell has an apical membrane that is 
tightly folded into a brush border and a basolateral mem‑
brane that is less tightly but still extensively folded. Fur‑
thermore the apical and basolateral regions of the cells 
are sufficiently far apart to be distinguishable by light 
microscopy (see Fig. 5). So, when a choroid plexus cell is 
viewed in section, transporters can be clearly detected at 
the cell borders both because there is a lot of membrane 
folded into the border and because there is a high density 
of transporters in the membranes.
By contrast it is difficult to detect transporters that may 
be present on endothelial cells of the blood–brain bar‑
rier. This is because there are few foldings to increase the 
amount of membrane at the two surfaces of the cells and 
the numbers of ion transporters per unit area of mem‑
brane may be relatively small (as judged by measured ion 
fluxes). Furthermore, because the endothelial cells are 
so thin, under the light microscope it is not possible to 
distinguish between luminal and abluminal membranes. 
Despite these difficulties, as discussed in Sects. 4.4.1 
and 4.4.2, four ion transporters have been identified and 
localized primarily to one membrane or the other. These 
are the Na+, K+‑ATPase, a.k.a. the Na+‑pump, NKCC1, 













apical brush border 
folded basolateral membrane 
Fig. 11 Schematic diagram emphasizing differences between 
choroid plexus epithelial and blood–brain barrier endothelial cells 
relevant to the detection of transporters. Note the difference in scale 
bars
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evidence for the presence and activity of AE2, NBCn1 
and NBCe1. A large number of proteins including trans‑
porters have also been identified in brain endothelial cells 
at the transcript level [292, 293].
4.4.1  Expression and localization of Na+, K+‑ATPase
The key transporter that couples metabolic energy to ion 
transport at the blood–brain barrier is the Na+‑pump 
otherwise called Na+, K+‑ATPase. The presence of this 
pump in the membranes of blood–brain barrier endothe‑
lial cells has been firmly established by evidence from a 
number of different studies. These studies have been vari‑
ously based on: ouabain‑sensitive release of phosphate 
from ATP by the Na+, K+‑ATPase in isolated microves‑
sels [294] and their isolated membranes [295, 296], 
inhibition by ouabain of K+ or Rb+ uptake into isolated 
microvessels [294, 297, 298] and cultured brain endothe‑
lial cells [299], ouabain binding [294, 300, 301] and the 
presence of ouabain‑inhibited, K+‑dependent p‑nitro‑
phenylphosphatase (K‑NPPase) activity [302–304] in 
the abluminal membranes of the endothelial cells in vivo 
[295, 305–312].
Preferential localization of the Na+‑pump to the abluminal 
rather than luminal membrane remains likely but controver‑
sial. Most but not all electron microscopy studies using the 
K‑NPPase cytochemical assay have found primarily ablumi‑
nal localization. This assay, however, has to be carefully con‑
trolled because it is clear that it can detect other ATPase 
activities including that of alkaline phosphatase, which is pre‑
sent in both membranes of the endothelial cells. In all studies 
using this assay where the necessary control criteria were 
met, i.e. activity not blocked by alkaline phosphatase inhibi‑
tors and either dependent on K+ or inhibited by ouabain, 
predominantly abluminal localization was observed [295, 
305–309, 312] (see below). However, even in these studies, 
because the assays were conducted after tissue fixation there 
is the ever present risk that Na+‑pumps were inactivated 
prior to the assay [304, 313, 314]. Furthermore, it is conceiva‑
ble that fixation might have affected the pumps in one mem‑
brane more than the other [311]. It should be noted that, 
using the K‑NPPase cytochemical assay, differences in locali‑
zation of the Na+‑pumps were observed in the choroid 
plexus that have never been adequately explained [315]. (For 
further discussion see 18).
An alternative method for determining the sidedness 
of pump activity is based on separation of luminal and 
abluminal membranes by density gradient centrifuga‑
tion. Betz et al. [295] and Sanchez del Pino et al. [296] 
detected pump activity in separated membrane frac‑
tions using release of phosphate from ATP. Betz et  al. 
found that ouabain‑sensitive, Na+‑ and K+‑dependent 
release by Na+, K+‑ATPase was at much higher levels 
in that fraction identified as being primarily ablumi‑
nal. Sanchez del Pino et  al. using markers for luminal 
and abluminal membranes found that 75% of Na+, 
K+‑ATPase activity was abluminal and 25% luminal. 
Furthermore they found that the concentrations of oua‑
bain required for inhibition of activities in the lumi‑
nal and abluminal membranes differed suggesting that 
there may be different isoforms expressed on the two 
surfaces. Three different α subunits and two β subu‑
nits of the Na+, K+‑ATPase have been reported to be 
expressed at the blood–brain barrier allowing for the 
possibility of six different pumps ([316], but see [317]).
18 The pNPP‑ATPase assay for localization of the Na+, K+ ‑ATPase Ernst 
[302, 303] introduced a procedure for localizing the pNPP-ATPase activity 
of the Na+-pumps based on the hydrolysis of pNPP (p-nitrophenylphos-
phate) in a K+ dependent step, capture of the phosphate using strontium, 
and subsequent conversion to a stable lead precipitate which can be seen 
in the electron microscope, the so-called two-step or indirect procedure. 
Mayahara et  al. [304] introduced a substantial simplification of the pro-
cedure to allow omission of the strontium step, the so-called one-step or 
direct procedure. In both methods the tissue is fixed prior to the enzyme 
assay step using formaldehyde with or without glutaraldehyde. Prior fixation 
entails the risk that the ATPase will be inactivated. Mayahara reported that 
2% formaldehyde +0.5% glutaraldehyde was the best compromise between 
adequate fixation and loss of enzyme activity.
The pNPP-ATPase assay is not selective for Na+-pumps. It also detects alka-
line phosphatase, which can be eliminated from the results by inclusion of a 
suitable inhibitor, e.g. levamisole. However, even so it is necessary to dem-
onstrate that the activity detected requires the presence of K+ and is inhib-
ited by ouabain, usually at 1 mM.
Manoonkitiwongsa et al. [311] investigated the effects of a range of concen-
trations of formaldehyde and glutaraldehyde. They found that fixation with 
2% formaldehyde yielded 1.5 as the ratio of the luminal to abluminal prod-
uct densities but with 2% formaldehyde plus glutaraldehyde at 0.1, 0.25 or 
0.5% the ratio decreased to 0.7, 0.5 or 0.4 [311]. They concluded that glu-
taraldehyde had an effect to selectively decrease luminal activity. Arguing 
against this, previous studies that had found strong abluminal predomi-
nance include those with (e.g. [295, 305]) and without [308] glutaraldehyde. 
It may be significant that Manoonkitiwongsa et al. reported that some activ-
ity (always in the presence of levamisole to inhibit alkaline phosphatase) 
persisted in the absence of K+ or in the presence of ouabain, but even 
though the measured hydrolysis thus had to represent more than one type 
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Na+
Fig. 12 Transporters localized to membranes of the endothelial cells 
of the blood–brain barrier. The Na+, K+-ATPase and the Na+/H+-
exchangers, NHE1 and NHE2, are also present on the opposite sides 
of the cell but at lower densities
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It is interesting to note that in a more recent study of 
fractionated membranes prepared from porcine brain 
capillaries and analysed for Na+, K+‑ATPase not by its 
activity but on the basis of its protein sequence (selected/
multiple reaction monitoring experiments, SRM/MRM, 
see e.g. [318]), it was far from clear that Na+, K+‑ATPase 
expression was predominantly at the abluminal surface 
[98]. Given these conflicting results the exact sidedness 
of the Na+‑pump remains an unresolved issue. At pre‑
sent the balance of evidence supports a predominant 
localization of the Na+‑pumps (at least functionally) in 
the abluminal membrane (see Sect. 4.3.1 for further dis‑
cussion). It is important that the distribution of activity 
be determined in future work since it provides clues as 
to the direction of movement of Na+ at the blood–brain 
barrier.
4.4.2  Evidence for expression of other ion transporters at the 
blood–brain barrier
NKCC1 has been localized primarily to the luminal mem‑
brane by O’Donnell and coworkers using bumetanide 
binding assays with cultured endothelial cells [319] and 
immuno‑electron microscopy with brain slices [237, 
320]. They also used immuno‑electron microscopy to 
localize NHE1 and NHE2 [321] primarily but not exclu‑
sively on the luminal membrane. NHE1 and NHE2 have 
been detected by western blot analysis in cultured rat 
cerebral microvascular endothelial cells [322], cultured 
bovine microvascular endothelial cells [321] and freshly 
isolated rat cerebral microvessels [321]. Other results 
regarding NKCC1, NHE1 and NHE2 expression have 
been reviewed by O’Donnell [19].
HCO3− transporters have been detected at the mRNA 
level in brain endothelial cells (see Fig. 13) and at the pro‑
tein level by fluorescence microscopy on microvessels in 
brain slices. The relative levels of mRNA compared with 
the ubiquitous exchanger NHE1 have been measured in 
brain endothelial cells and compared with those in iso‑
lated choroid plexus and renal cortex. Prominent expres‑
sion of mRNA for the Cl−/HCO3− exchanger AE2 and 
the Na+, HCO3− cotransporters NBCe1 and NBCn1 
were detected in brain endothelial cells with lower lev‑
els for AE3, NCBE/NBCn2 and NDCBE. NBCn1 was 
detected in membranes isolated from cultured rat brain 
endothelial cells by western blot analysis [322]. Immuno‑
histochemistry on relatively thick frozen rat cortical brain 
slices has shown clear selective labelling of microves‑
sels for AE2 and labelling for NBCe1 and NBCn1 [241]. 
A preliminary report indicates that the same transport‑
ers are present in both bovine cerebral microvascular 
endothelial cells (CMEC) and freshly isolated rat brain 
microvessels [323, and M.E. O’Donnell personal commu‑
nication]. So far localization of these HCO3− transporters 
to one or the other of the brain endothelial cell surfaces 
has not been achieved.
Detection and location of K+ channels that may be 
important in blood–brain barrier function is considered 
in Sect.  4.5.3 alongside the functional evidence for the 
currents they mediate.
4.5  Functional evidence of ion transport at the blood–
brain barrier from in vitro studies with brain 
endothelial cells
The in  vivo tracer studies described above demonstrate 
that small monovalent ions can cross the blood–brain 
barrier. However, a major hindrance to in  vivo studies 
has been the lack of methods for direct measurements of 
net fluxes across the barrier and tracer fluxes into or out 
of the endothelial cells. In vitro systems, i.e. isolated brain 
microvessels and primary cultures of brain microvascu‑
lar endothelial cells, allow for better access to the brain 
endothelial cells under conditions that can be more closely 
controlled. It is thus possible to measure fluxes into and 
out of the endothelial cells. Unfortunately at present there 
is no in vitro preparation that allows determination of net 
fluxes of Na+, K+, Cl− or HCO3− across the cells [10].
4.5.1  Evidence concerning Na+, K+ and Cl− transport
Evidence obtained from early studies on the presence 
and functions of the Na+‑pump in brain endothelial cells 


































































rat brain endothelial cells 
choroid plexus 
kidney  
Fig. 13 mRNA expression relative to that of the Na+/H+-exchanger, 
NHE1, in rat brain endothelial cells, choroid plexus and kidney cortex. 
At the blood–brain barrier expression of mRNAs for anion exchangers 
2 and 3, AE2 and AE3, the Na+/H+-exchanger, NHE1, the charge-
transporting Na+, HCO3
−-cotransporter, NBCe1 and the neutral Na+, 
HCO3
−-cotransporter, NBCn1, are prominent. Those for the Cl−-
dependent Na+, HCO3
−-cotransporters, NCBE/NBCn2, and NDCBE are 
clearly detected. Redrawn from data in [336]
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Evidence of other transporters for Na+ has also been 
obtained. Betz used both isolated microvessels and cul‑
tured endothelial cells [324] to demonstrate the pres‑
ence of amiloride‑sensitive, saturable processes for 
22Na+ entry into the cells. This entry was stimulated by 
increasing internal Na+ (preincubation in the presence 
of ouabain) or by increased internal H+. It was inhibited 
by extracellular Na+, H+, Li+ and NH4+ strongly sug‑
gesting the presence of a Na+/H+ exchanger presumably 
located in the abluminal membrane, this being the side 
of the endothelial cells exposed to the bathing solution. 
However, they could not detect any process that could 
be inhibited by furosemide which impairs Na+, Cl− 
cotransport including that by NKCC1 (discussed below). 
In hindsight this is surprising as other groups have seen 
activity of NKCC1. An unfortunate choice of experi‑
mental conditions may have hidden the function of this 
transporter. In the study by Betz, uptakes were usually 
determined using buffer with very low Na+, K+ and Cl− 
concentrations and it is not clear that the effects of furo‑
semide were ever investigated in the presence of ouabain 
(to inhibit the large K+ influx and Na+ efflux via the Na+‑
pump) with simultaneously sufficient Na+, K+ and Cl− to 
produce influx of Na+ and K+ by NKCC1. Nor were the 
effects of furosemide investigated in the presence of both 
ouabain and amiloride.
The presence of Na+, K+, Cl−‑cotransport in isolated 
rat brain microvessels was subsequently suggested by 
the finding of an ouabain‑insensitive, Na+‑ and Cl−‑
dependent component of Rb+ influx [325]. The cotrans‑
port was also seen in cultured bovine brain microvascular 
endothelial cells by O’Donnell’s group in 1993 [326] and 
the presence of this activity was soon confirmed by the 
results of others [327, 328]. It was shown that ouabain, 
blocking Na+, K+‑ATPase, and bumetanide, blocking 
Na+, K+, 2Cl−‑cotransport, inhibited K+ influx into the 
cultured cells to roughly equal extents and the combina‑
tion inhibited entry by about 90% [299, 329]. The oua‑
bain‑insensitive transport was inhibited almost equally 
by bumetanide or by omission of either Cl− or Na+ from 
the bathing solution [329]. With application on just one 
side of endothelial cells grown on permeable supports, 
the inhibition of K+ influx into the cells was much greater 
when bumetanide was applied on the luminal rather 
than abluminal side. From their observations, Sun et  al. 
inferred that about 90% of the cotransporter responsi‑
ble was present on the luminal side [319]. The molecular 
identity of the cotransporter as NKCC1 was established 
soon after [330]. These results in combination with the 
immunohistochemistry in brain slices localizing NKCC1 
to the luminal membrane of the endothelial cells strongly 
suggest that NKCC1 plays an important role at the 
blood–brain barrier.
Unfortunately O’Donnell and colleagues [319, 329] did 
not test the sidedness of inhibition by ouabain. It would 
be very interesting to know the proportions of K+ entry 
inhibited on each side of the cells given that evidence 
from both expression studies (Sect.  4.4.1) and in  situ 
brain perfusion (Sect.  4.3.1) now suggests that Na+‑
pumps are present in both membranes.
Though there is substantial information available 
about transport of Na+ and K+, much less is available 
about Cl−. It is very likely that in addition to NKCC1 
there are channels conducting Cl− that are important 
for the functions of the blood–brain barrier. It is clear 
from patch‑clamp studies that anion conductances 
exist (see e.g. [331, 332] which will mediate efflux of 
Cl− from the cells, but no channels have been identified 
at the molecular level. Cl− is also inextricably involved 
in the transport of HCO3− by AE2.
4.5.2  Evidence concerning HCO3
−, Cl− and H+ transport
It is very difficult to study the transport of HCO3− 
across the blood–brain barrier either in vivo or in vitro 
using radiotracers because there is interconversion 
between HCO3− and CO2 (see Sects. 6.1 and 6.4.2). 
However, transport of H+ and HCO3− into and out of 
brain endothelial cells can be studied in vitro by moni‑
toring the effects that movements of these ions have on 
intracellular pH (pHi). This has been done with brain 
endothelial cells grown in culture using the fluorescent 
indicator BCECF. In the steady‑state in vivo, the rate of 
transport of HCO3− out of cells plus the rate of trans‑
port of H+ into cells, together called acid loading, must 
be almost the same as acid extrusion because otherwise 
pHi could not be stable given that H+ and HCO3− are 
the major ions affecting intracellular pH.19 The types of 
transport thought to be important in movements of H+ 
and HCO3− and their classification into acid extruders 
and loaders and the dependence of the various trans‑
porters on presence of HCO3− are indicated in Fig. 14.
The transporters indicated below the horizontal line in 
Fig. 14 are functional whether or not HCO3− is present. 
The first, i.e. the “leak” is detectable in the presence or 
absence of HCO3− and is seen as a slow acidification of 
the cells in the absence of HCO3− or presence of DIDS, 
which blocks many forms of HCO3− transport, combined 
19 Net rate of acid extrusion At steady-state [HCO3−] and [H+] are con-
stant inside the cells and there is no net accumulation of acid within the 
cells. Thus the net rate of acid extrusion from the cells must be balanced by 
the net rate of acid production within them as part of metabolism. Most of 
the acid production is in the form of CO2 that is extruded from the cells as 
such. The next most important source is production of lactic acid, but this 
is extruded as such by MCT1 (see Sect. 6.3). Other contributions can arise 
from metabolism of fats and protein, but these are at such low rates that 
they do not affect the conclusions in this section. Thus the net rate of acid 
extrusion, other than as CO2 and lactic acid, must be close to zero.
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with the absence of Na+ (replacement with NMDG+) or 
presence of EIPA, which blocks NHEs. This acidification 
is not blocked by replacement of Cl− by gluconate−. It is, 
however, apparently reversed by replacement of exter‑
nal Na+ by K+, which is expected to strongly depolarize 
the cells [268]. This suggests that the “leak” is sensitive 
to membrane potential and independent of HCO3− and 
thus plausibly a channel‑like permeability to H+. The 
“leak” acts as an acid loader but at a much smaller rate 
than the acid loading described below in the presence of 
HCO3− and Cl−.
The other type of HCO3−‑independent transporter 
shown in Fig.  14 is NHE. Na+/H+ exchange has been 
found in many studies looking at recovery of cells from 
markedly reduced pHi after additions of acid to the 
cell interior [268, 324, 333–336]. However, if rat brain 
endothelial cells sit in nominally HCO3−‑free Hepes buff‑
ered solution, remarkably little happens to their pHi when 
Na+/H+ exchange is inhibited either by exposure to EIPA, 
an inhibitor of Na+/H+ exchangers, or even more telling 
by replacement of all external Na+ with the membrane 
impermeant cation NMDG+ [336]. This suggests that 
under these resting conditions Na+/H+ exchange occurs 
at only a very slow rate, comparable to the “leak”, because 
if it were rapid, pHi would decrease after the exchanger 
was either silenced by EIPA or reversed by removal of 
external Na+. This conclusion has been confirmed by 
studying the rate of Na+/H+ exchange as a function of 
pHi, which reveals that exchange is markedly activated by 
low pHi but is almost quiescent at resting pHi [268].
The transporters indicated above the horizontal line 
in Fig. 14 are expected to be active whenever HCO3− is 
present. Their activities have been revealed primarily 
by looking at the effects of ion substitutions and trans‑
port inhibitors on the rate of change of pHi. With cells 
initially in a solution containing Na+, Cl− and HCO3−, 
Na+ removal from the external solution led to a marked 
increase in the rate of pHi decrease, i.e. it led to a marked 
acidification, see Fig.  15a. This effect together with the 
rate of pH increase produced by removing Cl− (shown in 
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Fig. 14 Types of transporters that load or extrude acid from brain 
endothelial cells. In the presence of CO2/HCO3
− acid is added (i.e. 
HCO3
− is removed) primarily by either Cl−/HCO3
− exchange (AE: AE2 
and possibly AE3) or a Na+, HCO3
− cotransporter operating in a 3:1 
mode (NBC: probably NBCe1). Acid is extruded by Na+ driven trans-
port by several Na+, HCO3
− cotransporters either Cl−-independent 
(NBC: e.g. NBCn1 (n = 1) and NBCe1 in a 2:1 mode (n = 2) or Cl−-
dependent (NDCBE-like). In the absence of CO2/HCO3
− the principal 
loader is here called the “leak” and the principal extruder is a Na+/
H+-exchanger (NHE). The classification into loaders and extruders 
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Fig. 15 Effects of Na+ or Cl− removal on pHi in the presence of CO2/
HCO3
−. a When NaCl is replaced by n-methyl-d-glucosamine chloride, 
NMDG Cl, there is a progressive acidification of cells that is initially 
somewhat faster. Replacement of the Na+ allows pHi to recover. The 
dashed line indicates the drift in pHi observed when no substitu-
tion is made. It is attributed to the “leak” described in the text. This 
trace is the mean of four experiments. b When NaCl is replaced by 
Na gluconate there is a transient rapid alkalinization of the cells. This 
trace is from a single experiment. Both a and b are replotted from 
data sets used in [336]. Both effects are statistically significant, see 
Table 3 in [336]
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preincubation with DIDS can be interpreted as existence 
for two types of activity: Na+‑driven, HCO3−‑dependent 
acid extrusion and Na+‑independent, Cl−‑ and HCO3−‑
dependent acid loading (see Fig.  16). In this scheme, 
acid loading (i.e. HCO3− extrusion) and acid extru‑
sion (HCO3− loading) are both occurring when the cells 
are unchallenged but are in approximate balance (see 
Fig. 16a). Replacing external Na+ with membrane imper‑
meant NMDG+ reverses the direction of the Na+, HCO3− 
cotransport so that it contributes to loss of HCO3− from 
the cells until they are depleted of Na+ (Fig.  16b). Thus 
initially the rate of acidification is changed from that cor‑
responding to approximate balance of loading and extru‑
sion, to that seen when the major type of extruder is 
converted into a loader [336].
The Cl− dependence of Na+, HCO3− cotransport can 
be investigated by replacing Cl− with membrane imper‑
meant gluconate−, allowing time for intracellular Cl− to 
be depleted and then replacing Na+ with NMDG+. In 
experiments where this was done, the change observed 
in acidification rate induced by removal of external Na+ 
appeared to be less after depleting Cl−, but the effect 
did not reach statistical significance [336]. Na+, HCO3− 
cotransport also contributes to recovery of pHi when 
a cell is acidified from pHi  =  7.1–6.5 using the NH4+‑
pulse technique. When the effect of Cl− was tested in this 
type of experiment the HCO3−‑dependent recovery was 
approximately twice as fast in the presence of Cl− than 
when Cl− had been replaced by gluconate−. This finding 
suggests that part of the Na+, HCO3−‑cotransport is 
Cl−‑dependent, i.e. occurring by a NDCBE‑like cotrans‑
porter [268]. There appear to be three Na+, HCO3−‑
cotransporters involved in HCO3− transport in brain 
endothelial cells, NBCe1 and NBCn1, which are Cl−‑
independent and the NDCBE‑like transporter, which is 
Cl−‑dependent.
The functional data from cultured cells have revealed 
the existence of a net inward Na+‑dependent flux of 
HCO3− but not the size of the contribution to this flux 
made by each of the individual cotransporters. The 
measured net flux will be the sum of fluxes occurring 
by NBCn1 and by NDCBE‑like transporter, but whether 
the flux via NBCe1 adds to or subtracts from this sum 
depends on its mode of operation. If NBCe1 transports 
2 HCO3− per Na+, the transport will be into the cell and 
it will add to the sum. However, if NBCe1 transports 3 
HCO3− per Na+, it will transport out of the cell and it 
will subtract from the sum.
Evidence for the functional presence of a Cl−/HCO3− 
exchanger was obtained from observing the initial effect 
of removing external Cl−. Replacing external Cl− with 
membrane‑impermeant gluconate− reverses the direc‑
tion of Cl−/HCO3− exchange so that it contributes to 
entry of HCO3− into the cells until they become depleted 
of Cl−. Thus initially acidification rate is changed from 
that corresponding to approximate balance of loading 
and extrusion (Fig. 16a), to that seen when the major acid 
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Fig. 16 Simplified scheme for explaining the initial results of ion substitutions and inhibition by 4,4′-diisothiocyano-2,2′-stilbenedisulfonic acid 
(DIDS). In a the rates of acid loading by Cl−/HCO3
− exchange and acid extrusion by Na+, HCO3
−-cotransport are nearly in balance and the pH is 
stable. In b removal of external Na+ reverses the direction of the Na+ gradient and Na+, HCO3
−-cotransport is acid loading until the internal Na+ is 
depleted. While both types of transport are acid loading, pHi falls, i.e. there is cellular acidification. In c removal of external Cl
− reverses the direction 
of the Cl− gradient and Cl−/HCO3
− exchange is acid extruding until the internal Cl− is depleted. While both types of transport are acid extruding, 
pHi increases, i.e. there is cellular alkalinization. In d DIDS blocks both types of transport and there is little acid loading or extrusion and only slow if 
any change in pHi
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The Na+ dependence of Cl−, HCO3− exchange can be 
investigated by replacing Na+ with membrane‑imper‑
meant NMDG +, allowing time for intracellular Na+ 
to become depleted and then replacing Cl− with glu‑
conate−. The change in alkalinization rate induced by 
removal of external Cl− was observed to be almost the 
same before and after depleting brain endothelial cells 
of Na+ [336]. Thus the Cl−, HCO3− exchanger appears 
to be Na+‑independent, a property of the AE family of 
exchangers. The most prominently expressed member 
of this family in these cells is AE2.
The initial effects of ion substitutions on pHi are ade‑
quately described by the scheme shown in Fig. 16. In the 
longer term, the effects of substitutions are likely to be 
more complex, e.g. after external Cl− removal the cells 
should shrink markedly and there will also be changes in 
membrane potential and in concentrations of ions other 
than Cl−, HCO3− and H+.
As stated above preincubation of brain endothelial cells 
with DIDS prevents changes in acidification and alkalini‑
zation produced by removal of external Na+ or Cl−. Yet 
acutely in the presence of Na+, Cl−, and HCO3− adding 
DIDS produces no observable effect on pHi. This suggests 
that DIDS is blocking both the loaders and extruders as 
indicated in Fig. 16d [336].
It is possible to produce a rapid alkalinization of cells in 
CO2/HCO3−‑containing solution either by removing CO2/
HCO3− (see above) or by adding a weak base such as tri‑
methylamine. Trimethylamine diffuses into cells and com‑
bines with H+ forming trimethylammonium+. This weak 
base procedure has the advantage of allowing investiga‑
tion of recovery of pHi towards normal in the presence or 
absence of HCO3− and Cl−. Using this method, it was 
observed that recovery, which is acid loading, was 3 times 
faster when HCO3− was present than when it was absent 
but only if Cl− was also present. This suggests that acid load‑
ing occurs primarily by Cl−‑dependent extrusion of HCO3−. 
The increase in recovery rate was blocked by DIDS, which 
together with the dependence on Cl− adds to the evidence 
favouring the presence of an AE‑like transporter.
Evidence that any particular transporter expressed 
accounts for an activity observed can in principle be 
obtained using specific inhibitors, by genetic knockouts or 
by transient knock‑down of expression. EIPA is selective 
for NHE transporters but does not distinguish between 
the isoforms while DIDS inhibits many transporters and 
thus can not be used for precise molecular identifica‑
tion. siRNA has been used successfully to reduce levels 
of NHE1 and of AE2 in a cell line derived from rat brain 
microvascular endothelial cells. As expected lower expres‑
sion of NHE1 reduced pHi recovery rate following addition 
of acid to the cells while lower expression of AE2 reduced 
the alkalinization rate when Cl− was removed [241].
4.5.3  Evidence concerning K+ transport
In vitro evidence for influx of K+ into brain endothe‑
lial cells across the luminal side via NKCC1 was dis‑
cussed in Sect. 4.5.1. While evidence was obtained that 
the ouabain‑sensitive Na+‑pump mediates K+ influx 
in  vitro, no evidence was obtained showing that this 
entry was abluminal (see Sect. 4.5.1). However, there is 
in vivo evidence showing that K+ influx from brain into 
the cells across the abluminal membrane is via the pump 
(see Sect.  4.3.1). On each side of the endothelial cells 
the influx exceeds the possible net flux across the cells, 
and thus at each membrane there must be a mechanism 
allowing efflux of most of the K+ that enters [332, 337]. 
There are no reports of K+, Cl− cotransporters being 
present or active at the blood–brain barrier but also no 
reports of a careful search. By contrast many K+ chan‑
nels have been characterized in cultured brain micro‑
vascular endothelial cells using patch clamp experiments 
[240, 332, 338–348]. In acutely dissociated rat brain 
endothelial cells mRNA is present and there are func‑
tional signatures for channels containing Kv1.3, Kir2.1 
and Kir2.2 [332]. There is also western blot, immunocy‑
tochemical and patch clamp evidence for the presence of 
KCa3.1 in bovine brain endothelial cells [240, 347, 349]. 
Studies of the role of this channel should be aided by the 
recent development of a selective blocker, TRAM‑34 
[240, 347, 348]. However, while it seems from the evi‑
dence that there are several types of K+ channels that 
may play important roles in K+ transport at the blood–
brain barrier, many details are missing including the 
localization of the ion channels to one membrane or the 
other of the endothelium. A plausible suggestion [332, 
350] is that different channels are expressed on the two 
sides as this arrangement would allow separate regula‑
tion of K+ efflux across each membrane to achieve the 
proper balance with influx mechanisms. The role of the 
blood–brain barrier in regulation of [K+] in ISF and CSF 
is considered in Sect. 5.
4.6  Mechanisms for ion and water movements across the 
endothelial layer of the blood–brain barrier: a current 
description
A number of possible schemes for transport across 
the blood–brain barrier based on both the in  vivo and 
in vitro results above can be envisaged of which two are 
shown in Figs. 17 and 18. The two schemes differ in the 
suggested locations of AE2 and NBCe1. Experimen‑
tal localization has not yet been reported. It should be 
noted that these are in some sense extremes of a range. 
Both or either of AE2 and NBCe1 may be present in 
both membranes.
Based on the schemes in the figure the net transport of 
ions appears to be as described in the following sections.
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4.6.1  Na+ transport
The Na+, K+‑ATPase or Na+‑pump actively transports 
Na+ out of the cells into the ISF and to some extent to 
plasma. This reduces the intracellular [Na+] which pro‑
vides the gradient for Na+ influx via other transporters. 
Na+ entry from the blood is thought to occur primarily 
by the Na+, K+, Cl− cotransporter, NKCC1, though some 
must also occur by cotransport with HCO3−, probably 
via NBCn1 and possibly, if it is expressed in the luminal 
membrane, by NBCe1 working in the 1 Na+, 2 HCO3− 
mode. If NBCe1 is instead in the abluminal membrane 
it would be sensible for it to be operating in the 1 Na+, 
3 HCO3− mode, which would mediate efflux of Na+ and 
HCO3− from the cells to the ISF. From the concentrations 
in ISF, overall approximately 126/150ths of the net flux 






















































 Cl NDCBE - like 
NHE(1,2) NHE(1,2) 
Fig. 17 One possible scheme for ion transport by the blood–brain barrier. The Na+-pump is shown with more on the abluminal than luminal side 
of the endothelial cells. Transporters shown with solid circles have been identified in the membrane indicated; those with dashed circles have been 
identified at a molecular level but not localized; while those with dotted circles or rectangles have been identified only functionally. The red circle 
used in the symbol for the Na+, K+-ATPase indicates that energy for the transport is input from hydrolysis of ATP. Arrows within the cell indicate 
transfers: in black Na+, in green K+, in red Cl−, and in blue HCO3
−. The electrical potential and ion concentrations inside the cells in vivo are not 
known. In primary cell culture the potential is about −40 mV [see e.g. 332]. Note that, in contrast to the choroid plexuses, at the blood–brain barrier 
there are likely to be conductances in both the luminal and abluminal membranes. NHE(1,2) is shown separately from the rest as it is unlikely to be 
active when pHi is in the normal range. However, it is strongly activated by low pHi as may occur in hypoxia/ischemia
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by Cl− (126  mM NaCl) while most of the remaining 
24/150ths by HCO3− (24 mM NaHCO3).
The principal routes for Na+ entry across the abluminal 
membrane are likely to be the Na+‑linked transporters of 
organic solutes including prominently those for amino 
acids (see Sect. 2.4.2). If as appears likely, the preponder‑
ance of the linked transporters are in the abluminal mem‑
brane [120] and if in addition the Na+ flux via these is the 
largest component of Na+ entry to the cells (see Sect. 4.1.1 
for comparison of the coupled Na+ fluxes and those 
needed for any realistic rate of secretion) then if the Na+‑
pumps were evenly distributed or primarily in the luminal 
membrane there would be an associated net active flux of 
Na+ towards plasma, i.e. a net reabsorption of fluid. At 
present the balance of evidence supports secretion under 
normal conditions (see Sect. 4.1). Obviously, it would be 
very interesting indeed if it were found that the distribu‑
tion of Na+‑pump activity could be altered.
4.6.2  HCO3
− and Cl− transport
HCO3− will enter the cells from the blood via NBCn1, 
which is known to transport 1 Na+ for 1 HCO3−, and 
possibly via NBCe1 transporting 1 Na+ and 2 HCO3−. 
HCO3− will leave the cells via AE2 in the first scheme 
shown in Fig. 17 or via NBCe1 transporting 1 Na+ and 3 

























































Fig. 18 A second possible scheme for ion transport by the blood–brain barrier. This differs from the first, shown in Fig. 17, by swapping the posi-
tions of NBCe1 and AE2. For the key to lines and colours see the legend to Fig. 17. The consequences of the swap are considered in Sects. 4.6.1, 4.6.2
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and the NDCBE‑like transporters must mediate influx, 
and thus are predicted to be present in the luminal 
(blood facing) membrane. In the first scheme, suggested 
by Taylor et al. [336], NBCe1 would also be located in the 
luminal membrane mediating influx while AE2 would be 
located in the abluminal membrane mediating HCO3− 
efflux in exchange for Cl−. Thus all the HCO3− transport‑
ers would be moving HCO3− in the direction required 
for secretion, but there would be no obvious reason 
why three NBC‑like transporters are required. The sec‑
ond scheme incorporates the suggestion by O’Donnell 
[19] that AE2 is located in the luminal membrane. The 
HCO3− efflux route from the cell would then be provided 
by NBCe1. This scheme places the HCO3− transport‑
ers in positions analogous to those seen in the choroid 
plexuses but AE2 is now redundant to the extent that 
no matter how much it transports changes in the other 
HCO3− transporters can compensate. Both schemes are 
plausible. Further experimental results are required. It 
should be noted that in our present state of ignorance 
(see especially Sect. 4.4.1) other schemes are conceivable 
in which the HCO3− transporters in schemes 1 or 2 are 
placed in the opposite membranes. These schemes would 
produce secondary active transport of HCO3− from ISF 
to blood as envisaged many years ago by Pappenheimer, 
Fencl and colleagues  [351, 352].
NKCC1 brings in Cl− across the luminal membrane 
and AE2 will also transport Cl− inward across the mem‑
brane in which it is located. Thus there must be an addi‑
tional Cl− transporter in the abluminal membrane to 
move Cl− from the cells to the brain as part of any secre‑
tion. Furthermore because NKCC1 brings in two Cl− for 
each Na+, if this mechanism accounts for a large pro‑
portion of the luminal Na+ entry, more Cl− will enter 
than can be part of any possible transcellular net flux. 
An additional Cl− transporter is required in the luminal 
membrane to recycle the excess Cl−.
Regulation of HCO3− transport and its interrelations 
with H+, Cl− and CO2 transport are considered in Sect. 6.
4.6.3  Role of carbonic anhydrase in HCO3
− transport
Carbonic anhydrase is present both inside [336] (iso‑
form not yet identified) and, on at least one surface, 
(CAIV [353, 354]) of brain endothelial cells (at least in 
rat). Neither scheme  1 nor 2 provides an explanation 
for why carbonic anhydrase might be required for nor‑
mal secretion as there is no need for the hydration‑dehy‑
dration reactions between CO2 and H2CO3. The in vivo 
experiments showed no effect of carbonic anhydrase 
inhibitors on tracer fluxes, however, these results do not 
reveal whether or not there is an effect on net fluxes (see 
Sect. 4.3.5). Further experiments are required.
4.6.4  K+ transport
K+ is loaded into the cells from both sides: from the 
blood by NKCC1 and to some extent by the Na+‑pump 
(see Sect. 4.4.1) and from the ISF by the Na+‑pump. On 
each side the influx exceeds the net flux across the cells, 
and thus at each membrane there must be pathways for 
efflux of most of the K+ that enters. These are thought to 
be K+ channels (see Sect. 4.5.3). K+ transport is consid‑
ered further in Sect. 5.
4.7  A description of Na+, Cl− and water transport 
across the blood–brain barrier
So far transport across only the endothelial layer of the 
blood–brain barrier has been discussed. To cross into 
the brain parenchyma solutes and water must cross 
not only the endothelial cells but also the surrounding 
basement membrane and the layer of astrocyte endfeet. 
There is little reported data about channels or trans‑
porters for Na+ or Cl− or the presence and activity of 
the Na+‑pump in the astrocyte endfeet. In the absence 
of any such evidence it would appear that the fluxes of 
these ions between blood and brain parenchyma pass 
through the clefts between the endfeet. This is scheme 
(1) in Fig. 4.
The importance of water fluxes via aquaporin 4 (AQP4) 
in the endfoot membrane under normal circumstances 
has not been established. In mice in which AQP4 has 
been knocked out in astrocytes the endfeet are swollen. 
This observation led Amiry–Moghaddam et  al. to sug‑
gest that AQP4 is needed to allow efflux of metabolically 
produced water [355]. Regardless of whether or not this 
swelling is due to accumulation of metabolic water, the 
idea that AQP4 might be mediating an efflux of water 
from the astrocytes under normal conditions deserves 
further consideration.
It was argued in Sect. 4.1 that there is a strong circum‑
stantial case that there is a net secretion of fluid from 
blood to brain across the blood–brain barrier. It was 
argued at the start of Sect. 4 that the ratio of the amount 
of NaCl transported to the amount of water transported 
must be higher, possibly much higher (see also footnote 
8), than in an isosmotic solution because when the secre‑
tion is diluted with metabolically produced water the 
net product is nearly isosmotic. If, as is very likely, the 
interior of the astrocytes is nearly isosmotic, secretion 
of hyperosmotic fluid into the basement membrane by 
the endothelial cells would imply that the osmotic gradi‑
ent across the AQP4‑containing membranes is directed 
from endfoot towards the basement membrane—i.e. 
AQP4 would be mediating a net flux of water into the 
basement membrane. This water when combined with 
the hyperosmotic endothelial cell secretion would 
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produce a product that is not so strongly hyperosmotic, 
which would then emerge into the interstitial spaces of 
the brain by way of the clefts. This is scenario 3 in Fig. 4. 
If the net movement of fluid across the blood–brain bar‑
rier is a hypoosmotic absorption rather than a hyperos‑
motic secretion, then the source of the excess water is 
likely to be efflux from astrocyte endfeet much of which 
would be via AQP4.
The function of AQP4 is to increase water permeabil‑
ity. High functional expression of AQP4 would allow a 
given osmotic gradient to drive a larger flux of water or 
a given flux of water to be driven by a smaller osmotic 
gradient. The osmotic gradient across the endfoot mem‑
brane is likely to be small because the parenchyma as a 
whole is known to be nearly isosmotic with blood and the 
water permeability of the endothelium is sufficiently high 
(see Sect. 4.3.6) that the osmolality within the basement 
membrane will also be close to that of plasma. As men‑
tioned above, it is known that in the absence of AQP4 
the endfeet swell [355], as if an efflux of water has been 
blocked. Thus it appears that AQP4 is needed for the sec‑
ond reason: to allow a small gradient to drive a net water 
efflux from the endfeet.
Both AQP4 and the potassium channel subunit Kir4.1 
are highly expressed in the astrocyte endfeet [356–358]. 
The possible implications of this are discussed further in 
Sect. 5.3.
5  Role of the brain interfaces in regulation of K+ 
in the brain
K+ levels in the brain are remarkably stable with [K+]ISF 
less than [K+]plasma [16, 246–248, 253, 359–361]. By tak‑
ing up K+ from ISF, astrocytes can limit increases in 
[K+]ISF resulting from nervous activity inside the brain, 
but such uptake or release cannot protect the brain as a 
whole from long‑term changes in [K+]plasma. For instance 
if the rate of entry is increased due to an increase in 
[K+]plasma, the astrocytes and neurons could initially take 
up K+ so reducing the increase in [K+]ISF, but such a pro‑
cess has a finite capacity and eventually net uptake into 
the brain cells must cease.
There are only two ways to reach a new steady‑state in 
the brain in the face of a sustained increase in [K+]plasma: 
either decrease the rate of entry from the blood or 
increase the rate of exit from the brain. In other words 
the long‑term steady‑state for K+ in the brain is depend‑
ent on transport processes at the blood–brain interfaces 
together with K+ loss as part of fluid outflow from the 
brain. Of these routes, transfers across the blood–brain 
barrier, (a) and (b) in Fig.  19, are thought to be most 
important because measurements show that far more K+ 
enters and leaves the parenchyma across the blood–brain 
barrier than enters CSF across the choroid plexuses [16, 
250, 253, 261] (see Sect. 4.3.1) or leaves in the fluid out‑
flow. In addition it has been shown in the rat that reg‑
ulation of [K+]ISF develops at an earlier age than that of 
[K+]CSF [247]. Nevertheless it is clear that the rate of K+ 
secretion by the choroid plexuses is also regulated.
5.1  K+ transport across the choroid plexuses
In studies on the composition of choroid plexus secre‑
tion, [K+] (~3.5 mmol kg−1) in the secretion was remark‑
ably stable in the face of acute changes in either [K+]plasma 
and/or CSF secretion rate [141, 200, 247, 362]. Current 
knowledge of the transporters present in the choroid 
plexuses is consistent with this observation but can 
hardly be held to predict it.
Sampling choroid plexus secretion directly is difficult 
though not impossible and there have been two such 
studies [200, 362] (see Sect.  6.4.1). Useful information 
can be obtained more readily by sampling CSF from the 
ventricles and cisternae. Using this method, Stummer 
et  al. [361] measured the flux of 86Rb+ from blood to 
CSF at low, normal and high [K+]plasma. They collected a 
large fraction of the total CSF from rats (100 µl samples) 
10  min after introduction of the tracer into the blood. 
This time interval they argued was insufficient for there 
to be appreciable entry of tracer into the CSF via the 
blood–brain barrier and parenchyma. The results they 
obtained demonstrate a clear difference in 86Rb+ accu‑
mulation between acute (minutes) and chronic (days) 
variations in [K+]plasma [361]. With acute variations the 
K+ influx, calculated from 86Rb+ accumulation, increased 
with [K+]plasma. By contrast, after [K+]plasma had been 
maintained at different levels for more than a week, the 
K+ influx was independent of [K+]plasma.
The observation that acutely K+ influx increases with 
[K+]plasma is expected since much of the influx is thought 
to be paracellular (see Sect. 3.6.4). The observation that 
K+ influx does change while the [K+] in the secretion 
does not implies that there is an increased efflux of K+ 
from the secretion back to blood. The most likely mech‑
anism for this is that K+ entering via the paracellular 
route produces an increase in [K+] within the secretion, 
too small or too local to be measured, and this increase 
somehow produces a disproportionately large increase 
in transfer of K+ from the secretion back into the epi‑
thelial cells, probably via the Na+‑pump (compare with 
Sect. 4.3.1), and hence to the blood.
How the transcellular and paracellular routes of 
transfer (see Sect.  3.6.4) are regulated to achieve an 
unchanged influx from blood to CSF in the face of a 
long‑term change in [K+]plasma is unclear. The suggestion 
made by Stummer et al. [361] that there was downregula‑
tion of a transporter that mediates K+ transfer into the 
secreted fluid presumed that the influx was transcellular 
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while the available evidence implicates a large paracel‑
lular component. Klarr et al. [363] found that in choroid 
plexuses isolated from hypo‑, normo‑ or hyper‑kalemic 
rats both expression of the α1 and β1 subunits of the 
Na+, K+‑ ATPase and ouabain sensitive K+ uptake into 
the epithelial cells increased with [K+]plasma and pointed 
out that similar change in transfer of K+ from nascent 
CSF to blood by the Na+‑pumps in vivo would be in the 
correct direction to help stabilize [K+] in the secretion. 
This could appear as a reduction in influx, if K+ emerg‑
ing from either the transcellular or paracellular routes 
were transported back into the epithelial cells so effi‑
ciently, that a significant portion would not be able to 
diffuse away into CSF and hence be counted as part of 
the influx. Changes in the paracellular route, i.e. in the 
tight junctions, have yet to be considered as part of the 
explanation.
5.2  K+ transport across the blood–brain barrier
In vivo studies on K+ transport across the blood–brain 
barrier and regulation of [K+]ISF were considered in 
Sects. 4.3.1 and 4.3.4 and evidence from in vitro studies 
and the mechanisms for transport across the endothe‑
lial cells were discussed in Sects. 4.5.1, 4.5.3 and 4.6.4. It 
should be noted that because the in vivo flux experiments 
all used measurements of the K+ content of the paren‑
chyma their results do not distinguish between transfers 
between blood and astrocyte endfeet, (a) in Fig.  19, on 
the one hand and between blood and ISF, (b) in Fig. 19, 
on the other.
Alongside their experiments on influx into CSF, Stum‑
mer et  al. [361] compared influx of K+ into the brain 
parenchyma for acute (minutes) and chronic (days) varia‑
tions in [K+]plasma (see Fig. 20). With acute variations the 
rate of accumulation (calculated from 86Rb+ uptake) 
increased with [K+]plasma while with chronic changes any 
variation with [K+]plasma was much smaller. Stummer 
et al. suggest that the difference between the responses to 
acute and chronic changes indicates that chronically 
there is regulation of the number of transporters mediat‑
ing influx, with the number decreasing as [K+]plasma 
increases. The obvious candidate at the blood–brain bar‑
rier is NKCC1 but that would also affect transport of Na+ 
and Cl−. Another possible explanation is considered in 
footnote.20 Unfortunately there is no other evidence to 
suggest which transporter is regulated, let alone how. 
There is evidence for down regulation of the α3 subunit of 
the Na+, K+‑ATPase in hyperkalemia [364], but no obvi‑
ous way that this result can be used to explain the data 
for 86Rb+ influx.
In theory the arrangement of transporters at the 
blood–brain barrier shown in Figs.  17 or 18 could pro‑
duce a net transport of K+ in either direction depending 
on the K+ concentrations, the potential difference across 
the barrier and the relative activities of the different 
transporters and channels present. Because the net flux 
across each membrane is the small difference between 
relatively large influx and efflux, subtle changes in any 
20 Possible effect of upregulation of luminal membrane K+ channels 
Another possibility is suggested by the schemes shown in Figs. 17 and 18. 
Instead of downregulation of NKCC1 that mediates a net flux into the cells, 
there might be upregulation of K+ channels in the luminal membrane that 
mediate a net flux out of the cells. Tracer that enters via NKCC1 can either 
return to plasma or continue onwards towards ISF. Increasing the rate of 
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Fig. 20 Tracer influx of K+ into brain parenchyma with acute (X) or 
chronic (+) variations in plasma [K+] as calculated by Stummer et al. 
















Fig. 19 Schematic diagram of K+ exchanges that are thought to 
be most important in regulation of [K+]ISF and brain K
+ content: a 
between plasma and astrocytes via the endothelial cells, the base-
ment membrane surrounding them and K+ channels in astrocyte 
endfoot membranes; b between plasma and ISF via the endothelial 
cells, the basement membrane and clefts between the endfeet; c 
between astrocytes and ISF; and d between ISF in the extracellular 
space and brain cells
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factors affecting these fluxes could produce large changes 
in the net flux across the cells. For instance the variation 
of Na+‑pump rate with [K+] in the basement membrane 
may have a large effect on the net flux of K+ (see Sects. 
4.3.1 and 5.3).
In summary: on a time scale of seconds, astrocytes 
buffer [K+]ISF; on a time scale of minutes to hours, [K+]ISF 
is protected against changes in [K+]plasma by marked 
increases in K+ efflux for small changes in [K+]ISF; and on 
a time scale of days, the regulation is improved further by 
changes in the processes that allow K+ to enter across the 
blood–brain barrier when [K+]plasma is increased.
5.3  The role of K+ channels in glial endfeet
K+ channels containing Kir4.1 subunits are prominently 
expressed in the endfoot membrane facing the endothe‑
lial cells [365, 366]. Furthermore there is evidence from 
studies on neurovascular coupling (see end of Sect. 2.3) 
suggesting that release of K+ from endfeet does occur 
following neuronal activity and thus that the channels 
are functionally active. How and why are K+ channels 
localised especially (though not exclusively) in these 
endfeet?
AQP4 (see Sect. 4.7) and Kir4.1 colocalize to the end‑
foot membrane facing the basement membrane (or basal 
lamina) by binding to different components of the dys‑
trophin‑associated protein complex, which also binds 
to laminin in the basement membrane [356–358]. How‑
ever, the presence or absence of AQP4 does not appear 
to affect the properties of the Kir4.1 channels [367, 368], 
though there may be functional interaction in the paren‑
chyma because water fluxes may change the time course 
of changes in [K+] [369]. However, there is no evidence 
that this happens in the basement membrane of the 
blood–brain barrier.
One of the established functions of the selective K+ 
conductance of astrocyte membranes is the so‑called 
‘spatial buffering’ mechanism that can redistribute 
extracellular K+ [370–373]. K+ released from active 
neurons causes local elevation of [K+]ISF and conse‑
quent entry of K+ into astrocytes, leading to depolari‑
sation and inward current that spreads to other regions 
of the astrocyte syncytium. The current carried by K+ 
leaves the astrocytes where [K+]ISF is less elevated. 
In effect, excess K+ is spread out by a passive mecha‑
nism over a larger volume, thus reducing the change 
in [K+]ISF locally. Such redistribution (and subsequent 
return by the same mechanism) would tend to happen 
anyway by extracellular diffusion, but can be enhanced 
fivefold over large distances as seen in rabbit cortex 
[372]. For some disturbances (see Fig. 5 in [374]) spatial 
redistribution can be the dominant buffering mecha‑
nism for [K+]ISF close to active neurons.
A special form of spatial buffering, shown to occur in 
retinal glial (Müller) cells is K+ ‘siphoning’ [373, 375–
377]. K+ channels in Müller cells are particularly concen‑
trated at the inner and outer retinal surfaces where the 
large fluid volumes appear to act as sinks to buffer con‑
centration changes within the densely packed neural lay‑
ers of the retina. Since glial K+ channels in both retina 
and mammalian brain are also concentrated in the end‑
feet surrounding blood vessels, it is natural to suggest 
that these may serve the function of siphoning excess K+ 
to or from capillaries where they may be exchanged with 
blood or via perivascular routes to CSF (see discussion in 
[378]). However, significant K+ efflux across the blood–
brain barrier is not easily detected during even extreme 
nervous activity [379] and at this site such mechanisms 
may be too slow to play a significant part in the dynamics 
of K+ buffering over periods of seconds or even minutes 
(see [372], section 5.3.1 in [16], and section III in [380]).
With such small blood–brain barrier fluxes, Gard‑
ner–Medwin (personal communication) has argued that 
concentrating K+ channels close to capillaries would 
have little or no benefit in [K+]ISF buffering compared 
with uniform distribution of the channels over the entire 
astrocyte membrane and reliance on simple diffusion of 
K+ to capillaries. Instead he suggests that the reason why 
localization of Kir4.1 matters is that this combined with 
the almost complete coverage of the endothelial tube by 
endfeet may be important for the longer term homeo‑
static regulation of blood–brain barrier K+ transport. In 
this view the concentration (strictly the electrochemi‑
cal potential) of K+ in the endfeet is taken to be a more 
reliable measure of the long‑term K+ status of the brain 
than the fluctuating and unrepresentative [K+]ISF in the 
nearby extracellular space. Keeping K+ in the basement 
membrane close to equilibrium with K+ in the astro‑
cytes rather than with K+ in the extracellular spaces (see 
Fig. 19) ensures that the transport across the blood–brain 
barrier reflects the concentrations and amounts of K+ 
over a wide region of parenchyma. If this is correct, the 
reason why a high density of channels and hence high 
K+ conductance is required in the endfoot membrane is 
not so much to allow a large K+ flux but rather to reduce 
to nearly negligible levels the electrochemical gradient 
required to drive the small net K+ flux that occurs (com‑
pare with the discussion of the role of AQP4 in Sect. 4.7).
6  pH and concentration of HCO3
− in the 
extracellular fluids of the brain: importance 
of HCO3
− transport at the blood–brain barrier 
and choroid plexuses
This section considers the extent to which the blood–
brain interfaces are involved in determining the pH of the 
extracellular fluids of the brain.
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The concentration of H+ in extracellular fluid in gen‑
eral is small compared to those of any other ions consid‑
ered in this review. Nevertheless even these small 
concentrations are important because H+ can bind 
reversibly to many body constituents altering their net 
charges with resultant effects on their function. To pro‑
vide a stable environment in which cells can control their 
intracellular pH, extracellular pH is regulated to fall 
within a relatively narrow range, 7.35–7.45 (see e.g. pp. 
224 and 225 in [381]) corresponding to [H+] 45 and 
35 nmol kg−1 respectively. This is done by controlling the 
concentrations of CO2 and HCO3− (see Sect.  6.1.1). In 
most tissues of the body, CO2 and HCO3− exchange 
freely across capillary walls and thus regulation of plasma 
pH controls extracellular pH. The brain is different: CO2 
still moves freely between plasma and ISF, but move‑
ments of HCO3− are governed by the function of specific 
transporters at the blood–brain interfaces. Under many 
circumstances this reduces variation of pH within the 
extracellular fluids of the brain (see Fig. 21 and 21) allows 
closer regulation (see e.g. [382–385]) although Siesjö 
[382] discusses the important point that control of 
plasma pH still accounts for a large part of the control of 
CSF and ISF pH.
Regulation of pH and [HCO3−] in ISF and CSF has 
been the subject of many reviews including [16, 59, 382, 
386–390]. Two major conferences highlighted the con‑
troversies in the early work [391, 392]. Kazemi and John‑
son [393] and Fencl [185] gave comprehensive cover 
of work up to 1986 and Davson [17] and Nattie [394] 
gave accounts as of the late 1990s. The effects of many 
21 Compensation and relative changes in pHarterial and pHCSF In metabolic 
acidosis decreased [HCO3−]arterial and pHarterial increase ventilation rate 
over time and decrease pCO2 which reduces the size of the decrease in 
[HCO3−]arterial/pCO2,arterial and hence (see Sect. 6.1.1) reduces the decrease 
in pHarterial. This reduction in the size of the change in pHarterial is called res-
piratory compensation. Respiratory compensation also reduces the size of 
the increase in pHarterial in metabolic alkalosis by increasing pCO2. Tighter 
regulation of pHCSF than of pHarterial is achieved because while the changes 
in pCO2 are similar in CSF and arterial plasma, the change in [HCO3−]CSF is 
less than that of [HCO3−]arterial as shown in Fig. 21c, d. There would be per-
fect regulation of pHCSF if the fold change in [HCO3−]CSF were equal to the 
fold change in pCO2,CSF, i.e. if the new values of [HCO3−]CSF and pCO2,CSF 
were the same factor times their old values.
In respiratory acidosis increased pCO2 and decreased pHarterial increase 
metabolic production of HCO3− which increases [HCO3−]arterial and in turn 
reduces the size of the decrease in [HCO3−]arterial/pCO2,arterial and hence 
the decrease in pHarterial. This reduction in the size of the change in pH is 
called metabolic compensation. Note that pHarterial is still decreased because 
in compensated respiratory disturbances the fold change in [HCO3−]arterial 
is still smaller than the fold change in pCO2. For there to be tighter regu-
lation of pHCSF than of pHarterial in respiratory acidosis it would be neces-
sary for the fold change in [HCO3−]CSF to be closer to the fold change in 
pCO2, i.e. the fold change in [HCO3−]CSF would have to exceed the fold 
change in [HCO3−]arterial. This is not the case in the data for human respira-
tory acidosis shown in Fig. 21b nor for more recent data (see [185]) where 
the fold changes in [HCO3−]CSF are similar to or smaller than those in 
[HCO3−]arterial.
transport inhibitors are discussed in [393]. The subject 
has been surveyed more recently by Nattie [395]. It is 
remarkable that other reviews, those that refer to “brain 
pH” rather than intracellular and extracellular pH (see 
e.g. [385, 396]), largely ignore regulation of extracellular 
pH even though this must affect the regulation of intra‑
cellular pH.
Control of ISF pH is more important than that of 
CSF pH (see e.g. [382, 386, 392, 397]. This is primarily 
because it is the ISF that comes into direct contact with 
cells within the brain parenchyma. However, because 
it is much easier to measure the composition of CSF, 
many of the available results relate to this. Fortunately 
it is generally accepted that in the steady‑state, the ionic 
compositions of CSF and ISF are closely similar but with 
somewhat higher pCO2, lower pO2 and lower glucose 
concentration in ISF than in CSF [351, 352].
In ISF pCO2 is determined by the rate of production 
of CO2 by brain cells and the net rate at which CO2 is 
removed in the blood (see Sect. 2.2). In CSF pCO2 is typi‑
cally 7–9 mmHg higher than in arterial blood [386] and 
presumably slightly higher still within the parenchyma 
where the CO2 is produced. These differences will vary 
with blood flow [386]. However the available evidence 
indicates that the change in the difference between pCO2 
in ISF and blood is of relatively minor importance in 
understanding the changes in pH within the brain when 
the composition of arterial blood is altered [185, 386, 
393]. In the following discussion it will be assumed that 
changes in pCO2 in arterial blood will quickly produce 
similar changes in pCO2 throughout the brain.
CO2 is able to cross membranes either by diffusion as 
molecular CO2 (scheme a, Fig. 22a) or by a more com‑
plicated sequence of steps (scheme b, Fig. 22b) in which 
the CO2 first hydrates to form H2CO3, the H2CO3 dis‑
sociates to form H+ and HCO3−, and then each of these 
species crosses the membrane, and the H+ and HCO3− 
recombine following which the H2CO3 dehydrates. The 
water can diffuse back across the membrane leaving the 
same overall result in both cases: the transfer of a single 
molecule of CO2. The large amounts of CO2 formed in 
the brain, ca. 3.3  mol  day−1 (see Sect.  2.2), arise from 
the oxidation of a neutral substrate, glucose. Neither the 
glucose nor the O2 brings net charge into the reaction, 
so the end product CO2 must be disposed of also with‑
out altering charge (see Sect.  6.1.2 for further discus‑
sion). This condition is satisfied by either scheme a or b. 
However, because the small, neutral molecule, CO2, can 
cross membranes rapidly (see Sect. 2.2) while transport 
of the ions, HCO3− and H+, is relatively slow and usually 
in opposite directions, scheme a is the dominant pro‑
cess and CO2 transport can be discussed without refer‑
ence to any HCO3− or H+ fluxes across the membrane.
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Fig. 21 Classic studies on the regulation of CSF pH. pH (a, b) and [HCO3
−] (c, d) in CSF are plotted against values of the same parameters in arterial 
blood plasma. a, c are for humans with acid–base disorders as indicated (taken from the compilation in Table 2 of [52] with all of the data shown). 
b, d are for goats exposed to different [HCO3
−]arterial over a week by systemic administration of NH4Cl or NaHCO3 (data extracted from Fig. 2 of [352] 
with pHarterial calculated as in their Fig. 3). pH is regulated by controlling the ratio [HCO3
−]/pCO2 (see Sect. 6.1.1). A metabolic disturbance of pH is 
one in which the causal event is a change in [HCO3
−] while a respiratory disturbance of pH is one in which the causal event is a change in pCO2. All 
of the data reported for goats are for metabolic disturbances. As can be seen in both humans and goats, in metabolic acidosis and alkalosis (dashed 
lines) pHCSF changes by much less than pHarterial, i.e. there is tighter regulation of pHCSF. By contrast in humans in respiratory acidosis (dotted line) the 
variation in pHCSF is as large or larger than the change in pHarterial. In metabolic acidosis and alkalosis the tighter control of pHCSF is a consequence 
of the smaller variation in CSF of [HCO3
−] (see c, d) and hence of the [HCO3
−]/pCO2 ratio than in arterial plasma. More recent data confirm the varia-
tions shown for metabolic disturbances and the general features of the responses to respiratory disturbances [185]). The relations between changes 
in [HCO3
−] and changes in pH are considered further in footnote 21
The net amount of HCO3− transferred into the brain 
across the blood–brain interfaces is only of the order of 
11  mmol  day−1 as estimated from an average value of 
[HCO3−] in the secretions, ~22 mM, and a total secre‑
tion rate by whatever routes of ~500 ml day−1. This is 
very much less than the amount of CO2 transferred. 
HCO3−can cross membranes either via transporters 
with which it interacts directly (scheme c, Fig.  22c) 
or via a more complicated sequence of steps (scheme 
d, Fig. 22d) in which the HCO3− first combines with a 
H+, the resultant H2CO3 dehydrates forming CO2 and 
H2O, and each then diffuses across the membrane. 
On the other side the CO2 recombines with H2O after 
which the resultant H2CO3 dissociates to form H+ 
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and HCO3−. If the overall result is to be transport of 
HCO3−, the H+ must be transported back across the 
membrane. In both schemes c and d there is a net trans‑
fer of one negative charge as part of the HCO3− trans‑
port. It is this transport of charge that differentiates the 
net transport of HCO3− or of H+ in the opposite direc‑
tion from net transport of CO2 and requires HCO3− and 
H+ transport to be considered separately from CO2 
transport (as in Sect. 6.1.2).
Both of the schemes in Fig.  22c, d are important. In 
physiological solutions at near neutral pH, [HCO3−] is 
20–25  mM and [H+] is ~0.1  µM. Thus the amount of 
net charge transferred by transport of either HCO3− or 
H+ across the choroid plexuses or the blood–brain bar‑
rier will correspond primarily to changes on either side 
of the barrier in [HCO3−]. For this reason it is often con‑
venient to talk of a flux of HCO3− in one direction even 
when the underlying mechanism may include a flux of 
H+ in the opposite direction as in Fig. 22d. Furthermore, 
as indicated in Sects. 3 and 4, the available evidence now 
strongly favours transport of HCO3− itself across the 
membranes of the choroid plexuses and the blood–brain 
barrier (and in many other epithelial processes, see e.g. 
[398, 399]). However, it is important to note that under 
conditions where intracellular pH is reduced, H+ trans‑
port, primarily via Na+/H+ exchange, can be much faster 
than HCO3− transport across one or both of the mem‑
branes of the endothelial cells of the blood–brain barrier 
[268].
HCO3− ions can be introduced into or removed from 
ISF and CSF in a number of ways, five of which are 
quantitatively prominent:
  • buffering of ISF by brain cells most of which entails 
interconversion of CO2 and HCO3− within the cells 
and exchange of HCO3− and Cl− across their mem-
branes (see Sect. 6.2);
  • production of lactic acid within brain cells and its 
transfer to the extracellular fluids where the H+ is 
buffered by the CO2/HCO3− system (see Sect. 6.3);
  • removal of lactate− together with H+ by MCT1 
(equivalent to addition of a HCO3−) (see Sect. 6.3);
  • transport of HCO3− (or equivalently of H+ in the 
opposite direction) across the choroid plexuses or 
the blood–brain barrier (see Sect. 6.4);
  • ISF and CSF can themselves be removed by fluid out-
flow from the brain (see Fig. 8 and [15]).
The first four of these routes are important in transient 
changes in [HCO3−], but it is argued in the following sec‑
tions (and previously by many others) that the fourth 
and fifth are most important on time scales of hours or 
longer.
Under normal resting conditions, [HCO3−] in 
brain extracellular fluids is less than would occur if 
it were at equilibrium with [HCO3−] in plasma. For 
[HCO3−]CSF = 22 mM and [HCO3−]plasma = 24 mM the 
value of the potential at equilibrium (calculated from the 
Nernst equation) would be −1 mV, yet the measured PD 
is between 2 and 7  mV positive [185, 286]. This is even 
the wrong sign for there to be an equilibrium. There are 
species variations in [HCO3−] in CSF and plasma but 
always it seems with [HCO3−]CSF too small for there to be 
an equilibrium [17, 400].
Two possible explanations have been offered for 
how the lower [HCO3−] in ISF and CSF is maintained 
[185, 382]: acid (primarily lactic acid) is continually 
being added to ISF and CSF converting HCO3− to CO2 
(Sect. 6.3) or there are active transport processes at one 
or both of the barriers separating CSF and ISF from 
blood plasma (Sect. 6.4).
6.1  Consideration of the physiological principles 
important for understanding pH regulation
Before discussing the transport of CO2 and HCO3− in 
and out of the brain across the interfaces (Sect.  6.4), 
it is necessary to consider the interconversion of CO2, 
HCO3− and H+ and the constraints imposed by the 
Principle of Electroneutrality and the maintenance of 
osmotic equilibrium between the brain and blood.
a
dc
b plasma ISF 





















Fig. 22 Transport schemes for CO2 (a) and (b), and for HCO3
− (c) and 
(d). Transport of CO2 and HCO3
− can be distinguished since the latter 
but not the former entails the transport of net charge. By contrast 
transport of HCO3
− in one direction and transport of H+ in the other 
can produce the same net result. See text for further explanation. The 
proportion of CO2 transport that occurs by the mechanism in (b) is 
negligible
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6.1.1  The interrelationship of CO2, HCO3
− and H+
HCO3− and H+ ions differ from fixed ions such as Cl− 
and Na+ in that they can be formed in solution from 
neutral precursors CO2 and H2O,
In physiological solutions these reactions are suffi‑
ciently fast and can be regarded as reaching equilibrium 
(i.e. wherever required carbonic anhydrase is present),
where K′ combines the equilibrium constants for the two 
reactions shown above. It has no units. Because [CO2] is 
proportional to pCO2 and the concentration of water is a 
constant (55.5 mol kg−1), Eq. 3 can be rewritten as
where K is the composite constant.
If the units of [H+] and [HCO3−] are mol kg−1 and 
pCO2 is in mmHg, then the units of K are mol2 kg−2 
mmHg−1. Equation 4 is one form of the Henderson–Has‑
selbalch equation, which is more commonly encountered 
in a logarithmic form,
where
and
In Eqs. 6–8 the various symbols stand for the numerical 
values of the quantities in Eq. 4 when they are expressed 
in the units indicated above. Numerical values must be 
used because taking logarithms of units is not defined.
As a consequence of the reactions described by Eq.  4, 
once any two of [H+], [HCO3−] and pCO2 are known the 
third can be calculated (at least in principle: the value of K 
must be known for the conditions of the solutions in ques‑
tion). Similarly anything that could be achieved by a flux of 
one of H+, HCO3− and CO2 could be achieved equally by 
some combination of fluxes of the other two (see Fig. 22). 
For brief consideration of OH− and CO32− see 22.





























(8)pK = − log (K )
22 H+- and CO2-related species that can carry charge across membranes 
H+ and  HCO3− are not the only related species that can carry charge 
across a membrane. Very rarely in studies of epithelial transport it has 
been found necessary to consider fluxes of OH− (see e.g. [513]). However, 
the properties of a transporter that would allow selective, rapidly revers-
ible binding of OH− have not yet been described. Because evidence for 
OH− transport has not been reported in studies of the choroid plexuses and 
blood–brain barrier, it has not been considered in this review. Another pos-
sible species that may be transported is CO32−. For instance it is very dif-
ficult experimentally to distinguish coupled transport of one Na+ and one 
CO32− from coupled transport of one Na+ and two HCO3−. Both transfer 
one negative charge and both require the presence of CO2 [195, 398].
HCO3− transport cannot be followed using radi‑
otracers, e.g. H14CO3−, because interconversion of 
HCO3− and CO2 and movement of CO2 across mem‑
branes (see Fig.  22) are much more rapid than transfer 
of HCO3− itself (for a possible exception see Sect. 6.4.2). 
If H14CO3− (or H11CO3−) is added to blood, the 14C (or 
11C) quickly distributes itself over all of the HCO3− and 
CO2 present. This can occur with or without net trans‑
fer of either total CO2 (labelled plus unlabelled) or total 
HCO3− [51, 184].
6.1.2  Constraints imposed by the principle 
of electroneutrality and constancy of osmolality
The first constraint is imposed by the need for electro‑
neutrality. It is not possible to add more than a negligible 
amount of HCO3− or any other charged species to a cell 
without adding or removing something else. The reason 
is that addition of very few ions produces a large enough 
electrical potential difference between the cell and its 
surroundings to prevent further addition or force a com‑
pensating movement of something else. The Principle of 
Electroneutrality is the general statement of this property 
of charges and potentials. It asserts that the net charge 
within any region, e.g. a cell or a portion of extracellular 
fluid, will always be so small that it cannot be determined 
by any means other than measuring the potential differ‑
ence between that region and its surroundings, i.e. to the 
accuracy it can be measured by all other means the net 
charge is zero.
It is important to realize that the Principle of Elec‑
troneutrality applied to any region is an approxima‑
tion. The net charge within a cell can be exactly zero 
only if there is no potential difference between it and 
its surroundings. What the Principle of Electroneutral‑
ity states is that the net charge is very small compared 
to either the total charge on the cations or the total 
charge on the anions. When the imprecisely‑known 
total charge on the anions is subtracted from the 
imprecisely‑known total charge on the cations, the dif‑
ference is smaller than the errors. Within experimental 
accuracy it is possible to say that the sum of charges on 
the cations must be equal to the sum of charges on the 
anions.
The accuracy of the electroneutrality approximation 
applied to a region increases with the total concen‑
trations of the ions present and the size of the region. 
Because the numbers of ions present scale with vol‑
ume while the potential difference produced by the net 
charge scales with the surface area (and capacitance), 
the electroneutrality assumption becomes less secure 
as the size of the region becomes smaller. Electroneu‑
trality is exactly true only when there are no electri‑
cal potential differences, but it is true to an excellent 
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approximation whenever the volume of the region is 
sufficiently large. In practical terms with physiologi‑
cal solutions electroneutrality fails when the size of the 
region becomes very small, roughly the size of a mito‑
chondrion. However, the assumption is secure (and can 
be called a “Principle”) for regions as large as a mam‑
malian cell.
For the extracellular fluids of the brain electroneutrality 
implies that
This must also be true in both the fluids lost from the 
brain and the fluids secreted into it. [lactate−] is included 
in this expression because in hypocapnia/hypoxia it can 
increase to significant levels (see Sect.  6.3). This state‑
ment is an approximation both because electroneutral‑
ity is itself an approximation but much more importantly 
because ionic species present at low concentrations, e.g. 
Mg2+, Ca2+ and various phosphate compounds, have 
been ignored. This can be justified for the present pur‑
pose, the illustration of principles, because variations in 
the concentrations of the ignored species are small com‑
pared to variations in [HCO3−]. The net charge on pro‑
teins can be ignored for extracellular fluids in the brain 
but not for plasma or intracellular fluids.
The second constraint involves the constancy of osmo‑
lality resulting from the relatively free movement of 
water. Water moves more easily than osmotically active 
solutes across the choroid plexuses and the blood–brain 
barrier. Thus to a good approximation water moves until 
the osmolality of ISF and CSF are the same as that of 
plasma, Cosmolality. Approximately this means


































































As a consequence of this relation if there is any change 
in [HCO3−] in CSF or ISF there will also be an equal but 
opposite change in [Cl−]  +  [lactate−]. For examples of 
experimental data for which [HCO3−] + [Cl−] is constant 
(see Fig.  23) below, discussion by Fencl following [401] 
and [402–404]. For [HCO3−] +  [Cl−] +  [lactate−] con‑
stant see [405]. For evidence that things may not be quite 
so simple, e.g. that osmolality may not remain constant 
in acute changes and/or that [Na+] may change, see [403, 
406].
Electroneutrality, constancy of osmolality and the reac‑
tions relating H+ and HCO3− to CO2 and H2O mean that 
neither the concentrations of H+, HCO3− and Cl− nor 
their net fluxes can be manipulated independently. A 
particular, restrictive description of this interdependence 
was developed by Stewart [407, 408] in the 1980s and 























Fig. 23 The relation between [HCO3
−]CSF and [Cl
−]CSF in chronic 
experimental metabolic acidosis and alkalosis in goats. The sum 
of [HCO3
−] and [Cl−] is very nearly constant. Redrawn from data 
abstracted by V. Fencl (see [401]) from [351, 352]
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extracellular pH regulation in the brain [185, 393]. For 
the reasons discussed in 23 Stewart’s description is not 
used here.
In summary any imbalance in charge due to an influx 
of either HCO3− or Cl−will produce an electrical poten‑
tial difference that will decrease influxes of anions and 
23 Stewart’s approach to the interdependence of ion concentrations and 
fluxes in acid‑base balance and a better but more difficult alternative The 
interdependence of ion concentrations and fluxes relevant to the control 
of pH was emphasized in an approach to the subject presented by Stew-
art [407, 408, 514]. In this approach, the independent variables that can be 
altered or controlled are taken to be pCO2, the strong ion difference (i.e. the 
sum of charges on ions like Na+ and Cl−) and the concentration of a sin-
gle "representative" buffer standing for all buffers present other than CO2 / 
HCO3−. All other variables like pH and [HCO3−] are regarded as depend-
ent and not subject to separate control. A major advantage of Stewart’s 
approach is that it allows many acid-base calculations, even involving trans-
fers across membranes, to be completed without any consideration of mem-
brane potential.
A major disadvantage of Stewart’s approach is that it becomes tempting to 
make statements like: "Hydrogen ion movements between solutions can not 
affect hydrogen ion concentration; only changes in independent variables 
can." [514] or "Furthermore there are objections, based on physicochemical 
principles, to the assumption that HCO3− (or H+) is primarily and directly 
handled by active-transport mechanisms" (pg 127 in [185]). The latter state-
ment is just wrong. It would have been much better had Stewart said "The 
observation of changes in hydrogen ion concentration implies that there 
are also changes in pCO2, the strong ion difference or the concentrations or 
properties of the buffers." Stewart’s proposals were useful in that they stim-
ulated consideration of the consequences for acid-base balance of fluxes of 
those ions that determine the strong ion difference [185, 389, 393]. However, 
despite statements to the contrary (see e.g. pp. 120–121 in [185]), Stewart’s 
choice of which variables to consider as independent is only a matter of con-
venience not one of necessity (compare [383, 390, 515]). Thus if all that is 
known is that there have been changes in [HCO3−] and [Cl−] it is not possi-
ble to say whether either change caused the other. Stewart’s approach is of no 
help in considering the role of changes in membrane potential.
Rather than defining some variables as always independent and some as 
always dependent as Stewart did, it is much better not to prejudge which 
concentrations and fluxes can be varied by external processes (e.g. trans-
port into or out of a region) and instead use the explicit constraints on the 
concentrations and fluxes described in Sect. 6.1. Indeed, now that computer 
simulations can keep track of concentrations to the accuracy needed for 
calculation of the net charge within a region as big as a cell, it is possible 
to do even better and take a more rigorous approach avoiding the need to 
assume electroneutrality (a necessary part of Stewart’s approach). The anal-
ysis should employ a model that considers the electrical potentials produced 
by the actual net charge within cells, the effects of these potentials and the 
ion concentrations on transport of ions, and the changes in intracellular net 
charge and ion concentrations produced by such ion transport. Electroneu-
trality is not imposed, but if the results of the analysis do not obey approxi-
mate electroneutrality (i.e. the membrane potentials fail to take on realistic 
values) either the model is describing a condition which would destroy the 
cell or something is wrong with either the model or the computer code used 
to implement it. Students of electrophysiology will recognize that important 
elements of this approach, avoiding the need to assume electroneutrality, 
were used in the classical description of the mechanism for propagation of 
the action potential along a nerve axon [516]. Changes in charge and poten-
tial could be calculated in that study without needing to know the concen-
trations to great accuracy because the potentials and the current across the 
membrane were measured directly.
There are, however, challenging aspects to extending this more rigorous 
approach to the choroid plexuses and blood–brain barrier: it requires detailed 
description of the actual transport processes occurring including their depend-
ence on membrane potential and it requires sufficiently accurate bookkeeping 
of ion fluxes to calculate the changes in net charge within the cell.
increase those of cations sufficiently to ensure the main‑
tenance of electroneutrality. Any imbalance of osmolality 
will lead to a water flux to restore balance.
6.2  Contribution of physiological buffering by brain cells 
to regulation of ISF pH
If pCO2 in arterial blood is increased, CO2 rapidly pen‑
etrates the brain and enters the astrocytes and neurons 
where CO2  and  H2O are converted to H+ and HCO3−. 
Most of the H+ is buffered, mainly by intracellular pro‑
teins and phosphate compounds. Some of the HCO3− 
leaves the cells in loosely‑coupled (e.g. connected by 
electrical potential changes) or tightly‑coupled (e.g. 
via AE2) exchange for Cl−. The change in [HCO3−]ISF 
reduces the change in pHISF associated with the increased 
pCO2. The whole process is closely analogous to the buff‑
ering of blood plasma by red blood cells [409, 410].
This physiological buffering of ISF by brain cells is 
important in the initial changes in [HCO3−]ISF and pHISF 
following changes in arterial pCO2 [185, 393, 394, 411–
415] (but see [395]). However, in the face of movements 
of HCO3− across the blood–brain interfaces, this process 
can only produce a transient change in [HCO3−]ISF (see 
e.g. [185, 388]) because the cells cannot continue to take 
up or release HCO3−. Two examples [415, 416] of studies 
in which physiological buffering appears to be prominent 
are considered in 24.
24 Physiological buffering of pHISF Ahmad et al.   [415] used surface pH and 
Cl− electrodes applied to exposed cortex and reported very rapid, equal but 
opposite changes in ISF [Cl−] and [HCO3−] following elevation of pCO2. 
For a pCO2 increase from ~28 to 55 mmHg, [Cl−] decreased and [HCO3−] 
increased by 4 mM with half-times of 30–40 s, much as expected for buff-
ering within the cells and exchange of intracellular HCO3− for extracellu-
lar Cl−. Similarly fast changes in ISF pH following changes in pCO2 have 
been seen using microelectrodes inserted into the parenchyma [456, 517] 
and similarly fast surface pH electrode responses have been correlated 
with phrenic nerve activity indicating activation of medullary chemorecep-
tors [517, 518]. See footnote 30 for caveats concerning results obtained in a 
related study by Ahmad et al.  [442] that may complicate interpretation of 
the results discussed here.
Physiological buffering of ISF is likely to be a major part of the explana-
tion of results for ISF pH obtained using 31P NMR by Portman et al.  [416]. 
Goats were ventilated with 0.5–1% halothane in oxygen at rates between 2 
and 21 l min−1, which produced values of arterial pH between 7.1 and 7.65. 
ISF pH and intracellular pH were recorded 10 min after each change in ven-
tilation rate. As percentages of the changes in arterial blood, the changes 
in ISF and intracellular fluid pH were 56 and 23%. These and other results 
obtained using 31P NMR [519, 520] imply that the intracellular fluid is 
strongly buffered against changes in pH as expected since this fluid is rich 
in proteins and phosphate compounds. Because the change in ISF pH was 
intermediate between those in plasma and intracellular fluid, both of which 
are regarded as strongly buffered solutions, the results also imply that ISF 
was strongly buffered even though ISF does not obviously contain sufficient 
buffers. Physiological buffering provides a plausible explanation. When 
pCO2 is increased, intracellular [HCO3−] is increased and thus [HCO3−]ISF 
can be increased by efflux of HCO3− from cells. There could also be trans-
port of HCO3− into ISF from plasma. The increase in [HCO3−]ISF then 
reduces the change in pH to the level observed.
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6.3  Impact of lactic acid production and removal on ISF pH
Lactic acid production in brain cells and its export to ISF 
has been considered as an explanation for the normal 
non‑equilibrium distribution of HCO3− between ISF and 
plasma [185, 382, 417–419]. From current evidence, it 
is likely to contribute to the setting of ISF and CSF pH 
when arterial pCO2 is greatly reduced and/or in hypoxia. 
(It should be noted that almost all of the generation of 
acid by metabolism occurs as production of CO2, which 
is eliminated as such.)
In all of the following lactate means the total amount 
of lactate present whether as undissociated lactic acid 
or lactate−, i.e. [lactate]  =  [lactic acid]  +  [lactate−]. In 
solution most of the lactic acid dissociates and [lac‑
tate−] ≫ [lactic acid].
Lactic acid production has been calculated from the 
arteriovenous difference in [lactate] and cerebral plasma 
flow but sufficiently accurate data have been difficult to 
obtain and the sampling sites chosen for the venous 
measurements will usually have ignored outflow other 
than via venous blood (see below and 25). Under normal 
conditions the balance of such evidence suggests that 
25  Arterio‑venous differences in concentrations for substrates and metab‑
olites The amount of substance taken up by or removed from a region is 
often estimated from the differences in the concentrations in the arterial 
inflow and venous outflow from the region and the blood–flow,
uptake or release = (Carterial − Cvenous) × blood flow.
For substrates for which most movement is uptake, e.g. glucose and O2, the 
uptake is reasonably estimated by this calculation. It is, of course, neces-
sary to arrange to take the venous sample from a location exposed to the 
venous outflow from the region and to none other. However, for metabo-
lites the assumption that removal from the region occurs only by release 
into the venous blood emerging from that region is incorrect if some can be 
removed to lymph. This may be important when trying to estimate the rate 
of production of lactic acid as it is clear that some of the lactate is removed 
via perivascular routes to lymph which bypasses the sites at which the 
venous blood is sampled [57, 434, 521].
lactic acid production rate is 20–40 µmol min−1 (see e.g. 
[48, 420]), which is 5–10% of the rate of glucose con‑
sumption (see  Sect. 2.4.1) [48]. The conclusion that there 
is lactic acid production is supported by other types of 
data including comparison of the rates of utilization of 
glucose and O2 (for references see [48, 421]). Lactic acid 
production rate might thus normally be as much as three 
to sixfold greater than the rate, at which HCO3− is 
secreted into the brain (the latter calculated as 22 mM × 
500 ml day−1 = 11 mmol day−1 = 5.9 µmol min−1).
Lactic acid production increases in conditions of low 
pCO2 [185, 382, 393, 405, 417–419]. When pCO2 is 
reduced from 37 to 18  mmHg, [lactate−]CSF increases 
from about 1.6–3.2  mM [422]. At these concentra‑
tions the rate at which lactate is removed by MCT1 (see 
below) will be roughly in proportion to the concentra‑
tion difference between ISF and plasma (see below). As 
[lactate−]plasma is about 1  mM, this suggests a three to 
fourfold increase in the rate of lactic acid production 
(compare the discussion following [401]).
If [lactate−] increases, electroneutrality and constant 
osmolality require that [HCO3−] + [Cl−] must decrease by a 
similar amount (see Eq. 11 and following). It has sometimes 
been argued that increased [lactate−] causes a decrease in 
[HCO3−] [185, 393] (see also footnote 23) but that argument 
does not take into account possible changes in [Cl−] and 
does not provide any basis for considering the mechanisms 
that bring about changes in [HCO3−]. Such mechanisms 
and the fact that the changes in [HCO3−] resulting from lac‑
tic acid production need not equal the changes in [lactate−] 
are considered in the following paragraphs.
Acutely when additional lactic acid is added to ISF, the 
lactic acid dissociates releasing lactate− and H+. Almost 
all of the H+ combines with HCO3− forming CO2, which 
diffuses away. Thus, as the lactic acid is added and lac‑
tate− is accumulating, the HCO3− removed equals the 
lactate− added and the initial changes in [lactate−] and 
[HCO3−] will be equal but opposite (see e.g. [423, 424]). 
However, the result can be quite different in the steady‑
state when [lactate−]ISF is constant as described below.
Sustained production of lactic acid may or may not pro‑
duce a sustained reduction in [HCO3−]ISF (see Fig. 24). In 
the steady‑state, lactic acid entering ISF from the cells will 
dissociate producing lactate− and H+. The H+ will react 
with HCO3− entering the brain from the blood. This reac‑
tion will remove some of the HCO3−, leaving H2O, CO2 
and lactate−. If these products are removed without regen‑
erating HCO3− and H+ as in Fig.  24a, [HCO3−]ISF will be 
below that seen in the absence of lactic acid production. 
Because the increase in lactic acid production can be rela‑
tively large compared to the rate of secretion of HCO3−, H+ 
release from lactic acid could be sufficient to result in a large 


















Fig. 24 Consequences of adding lactic acid to ISF. In a the lactic acid 
dissociates and the lactate− is transported out of the ISF leaving the 
H+ behind. H+ combines with HCO3
− and forms CO2 and H2O both 
of which can diffuse into the blood. Each molecule of lactic acid 
added reduces the number of HCO3
− ions present in ISF by one. In b 
the lactic acid is transported out of the ISF to blood as lactic acid (or 
by cotransport of lactate− and H+). There is no immediate relation-
ship between [HCO3
−]ISF and either the rate of addition of lactic acid 
or [lactate−]ISF
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and thus [lactate−]ISF were small ([382, 417–419], and dis‑
cussion following [401]). Indeed, from the estimates of nor‑
mal lactic acid production rate and of HCO3− secretion rate 
given at the start of this section, if all of the lactate− were 
removed from ISF leaving the H+ behind as in Fig.  24a, 
there would be far more H+ than could be removed by reac‑
tion with HCO3−. It is important that when lactic acid is 
added to ISF and dissociates either (a) the H+ released can 
be removed by some means other than reaction with HCO3− 
or (b) the rate of secretion of HCO3− can be increased.
l‑Lactate− transport across the blood–brain barrier 
is now known to be mediated by MCT1 that transports 
one H+ for each lactate− [425–427]. The H+ trans‑
ported is supplied by conversion of CO2 to HCO3− thus 
regenerating the HCO3− lost when the lactic acid was 
added to the ISF. As indicated in Fig.  24b, the com‑
bination of release of lactic acid into ISF from brain 
cells and its removal from the brain across the blood–
brain barrier by MCT1 does not leave H+ for reaction 
with HCO3− and thus can not account for a long‑term 
reduction in ISF [HCO3−] [417, 418].
Although MCT1 transport of lactate− and H+ across 
the blood–brain barrier is equivalent to removal of lactic 
acid, it is still convenient to refer to it as transport of lac‑
tate because [lactate−] is much greater than [lactic acid] in 
ISF and plasma and thus the concentration changes seen 
as a result of transport are primarily those of lactate−. At 
low concentrations the rate constant for lactate transport, 
i.e. (rate of change of [lactate−])/[lactate−], is about one‑
third of that for glucose transport mediated by GLUT1 
[41, 428–431]. Lactate transport via MCT1 is saturable 
[430] with a Michaelis–Menten constant near 2.5–3 mM 
[428, 432]. Thus, even with the increased lactic acid pro‑
duction seen in all but extreme hypocapnia or hypoxia, 
the mechanism for efflux of lactic acid across the blood–
brain barrier is not saturated. However, in severe hypoxia 
or locally in response to nervous activity, lactic acid pro‑
duction can exceed the capacity for removal by MCT1.
During increased nervous activity, lactic acid pro‑
duction is increased (see [56, 57] for references). This 
would be expected to increase efflux of lactic acid 
across the blood–brain barrier, and this would tend 
to make the arteriovenous difference in [lactic acid] 
more negative. However, this may not be observed if, 
for any reason, [lactic acid] in blood is also increased 
so increasing influx and tending to make the arterio‑
venous difference more positive (see e.g. [56]).
The relative rates of introduction of lactic acid and 
HCO3− into ISF and CSF under normal conditions have 
not been accurately determined and furthermore lit‑
tle is known about the fractions of lactate removed to 
blood (regardless of route) as lactic acid or lactate−. Ball 
et al. [57] estimated that when [lactate] was elevated in 
spreading depression about half was removed by efflux 
directly to blood, i.e. across the blood–brain barrier pre‑
sumably in the form of lactic acid by MCT1, and about 
half was effluxed indirectly, presumably as lactate−, via 
perivascular spaces. Similar proportions were seen in 
earlier work from the same group [433]. Clear, independ‑
ent evidence that some of the lactate reaches the lym‑
phatics has been obtained by assaying the lactate content 
of the cervical lymph nodes. Furthermore the proportion 
removed by this route was shown to be altered by many 
of the same factors that alter removal of inulin, which is 
thought to be removed via the perivascular spaces [434].
Studies on the production of lactic acid and removal of 
lactate have not yielded a clear answer for how much of 
the generated H+ must be removed by reaction with 
HCO3−.26 The evidence available indicates that the H+ 
from lactic acid is important when pCO2 is reduced below 
ca. 20  mmHg and in severe hypoxia (for discussion see 
Siesjö [417] and Mines and Sørensen [419]. However as 
shown by Pappenheimer, Fencl and colleagues [351, 352] 
(see Fig.  23) in metabolic acidosis and alkalosis the 
changes in [HCO3−]CSF appear to be closely matched by 
changes in the opposite direction of [Cl−]CSF. Their data 
were obtained for a wide range of [HCO3−]arterial and for 
pCO2 between 20 and 45 mmHg [352]. These results leave 
little if any room for changes in [lactate−] and hence for 
lactic acid production to have significant effects on 
steady‑state [HCO3−] or pH in CSF and ISF. The changes 
in [Cl−]CSF and [HCO3−]CSF reflect altered transport at the 
blood–brain barrier, the choroid plexuses or both. Events 
26 Blood–brain barrier permeability for lactate and rapid distribution of 
lactate via astrocytes The permeability-surface-area products, PS, for lac-
tate transport by MCT1, about 0.06 ml g−1 min−1 in adult rats [429, 430] 
and 0.1 ml g−1 min−1 in humans [431], and the volume of ISF per gram of 
tissue, ~0.2  ml  g−1, corresponds to a half-time for removal of lactate less 
than 10 min. (For a different view of the rate of removal see [522]). Some 
removal of lactate− as such will occur as part of the outflow of ISF from the 
interstitial spaces of the parenchyma. However, as that has a half-time more 
than tenfold longer (judged by e.g. removal of markers like sucrose and 
mannitol, see Sect. 4.1 here and section 4.1.1 in [15]), such outflow will only 
make a relatively small contribution. However there may be another pos-
sible route of elimination of lactate−. Lactate− or lactic acid can be removed 
from its site of production and distributed through the network of astro-
cytes (see e.g. [106, 521, 523, 524]) with release at sites close to perivascu-
lar spaces of larger blood vessels. From these spaces it may be able to leave 
the brain rapidly to blood or cervical lymph [57, 521]. The factors shown by 
Lundgaard et al. [434] to affect similarly the rates of removal of lactate and 
inulin may be acting at this final stage—i.e. on transport via the perivascular 
spaces. Distribution or spreading out of lactate from its site of production 
was proposed earlier [433] together with another complicating factor in the 
experimental studies, partial metabolism of lactate with storage of the radi-
olabel in metabolic intermediates [56].
In the steady-state the net rate at which lactic acid production and lactate− 
removal provides H+ that can deplete HCO3− is difficult to determine from 
the available evidence. It is likely to be substantially less than the rate of 
production of lactic acid until this rate approaches the transport capacity 
of MCT1 in the endothelial cells but, for severe hypocapnia or hypoxia with 
high [lactate−], depletion of HCO3− and reduction of pHISF are likely to be 
substantial.
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at the barriers can, of course, be affected by changes in 
electrical potential differences, and the concentrations of 
all ions, including [lactate−], will affect these potentials.
6.4  Involvement of HCO3
− transport across the blood–
brain interfaces in ISF and CSF pH regulation
Transport of HCO3− across the blood–brain interfaces and 
its removal by outflow of CSF and ISF are the dominant 
processes determining [HCO3−] in CSF and ISF in the long 
term. As described in Sects. 3 and  4 transcellular transport 
of HCO3− across both the choroid plexuses and the blood–
brain barrier is directly coupled to the transport of other 
ions, primarily Na+ and Cl−.
Many of the early publications considered how the over‑
all potential difference between CSF and blood (the PD) 
varies with plasma pH and the contribution this might 
make to regulation of pH in CSF. Held, Fencl and Pappen‑
heimer [286] showed that the PD in goats and dogs became 
increasingly positive as [H+] in the blood increased (see 
below). Their striking findings, confirmed in several other 
species (see [185, 388, 417]), invited the hypothesis that in 
acidosis increased PD, which would tend to increase net 
flux of HCO3− into CSF, accounts for an increase in the 
ratio [HCO3−]CSF/[HCO3−]plasma. This change would 
explain at least part of why the variation in pH in CSF is 
smaller than that in blood in metabolic acidosis and alkalo‑
sis. Certain aspects of these studies, including the evidence 
that the PD is produced by processes at the blood–brain 
barrier, are considered in footnote 27.
Footnote 27 continued
The lack of variation with pHCSF is then explained if the CSF facing membrane 
has a potential difference across it that does not vary with pH on either side. Sec-
ondly pHarterial may affect the permeability of the blood facing membrane or the 
paracellular transport route to other ions. Finally pHarterial might somehow alter 
the rate of an active current-carrying mechanism. The first explanation would 
require a very high permeability to H+ to compensate for its very low concentra-
tion. It is difficult to imagine that such a large permeability would have escaped 
notice in studies such as those discussed in Sects. 3 and 4. The second and third 
explanations are more easily accepted but lack direct experimental evidence.
There have also been three contenders for the location of the barrier across 
which the PD is generated: the ependyma and pia, which separate CSF and ISF, 
the choroid plexuses and the blood–brain barrier. The ependyma and pia are 
very unlikely sources because the barriers are leaky and non-selective between 
ions. The choroid plexus might generate a potential difference, but the available 
evidence indicates that it isn’t the main source for three reasons. Firstly, direct 
measurements of the potential difference across isolated choroid plexus have 
shown either no PD [526, 527] or a PD that does not show the variation with 
pHarterial that is seen in measurements of the PD between cisternal CSF and 
plasma [440, 492]. (In the dogfish the PD for isolated choroid plexus even has 
the opposite sign to the in vivo PD [528].) Secondly CSF production, measured 
by ventriculo-cisternal perfusion, is hardly changed when the PD is changed 
by altering pHarterial. In other words active secretion by the choroid plexus and 
the generation of the PD are not coupled [286]. Thirdly it would be difficult for 
a current source localized to the choroid plexuses within the ventricles to pro-
duce a potential elsewhere [529]. Furthermore if it is correct that the transport 
processes in the basolateral membranes of the epithelial cells are all electrically 
neutral [4] (see Sect. 4.3.2), transcellular transport at the choroid plexus cannot 
carry a current and whatever PD is produced by the choroid plexus can only be 
a diffusion potential across the paracellular pathway.
There are two principal arguments in favour of the blood–brain barrier as 
the source of the PD: elimination of the other possibilities and the observa-
tion that pial microvessels, which are thought to have similar properties to 
those in parenchyma, do generate a potential (lumen negative) [285]. The 
available evidence indicates that transport at both the luminal and ablumi-
nal membranes of the endothelial cells does transfer net charge (see Sect. 4).
The consequences of a PD that varies with pHarterial could be consider-
able for pH regulation. As indicated in Sect.  8, under normal conditions 
[HCO3−]CSF and thus presumably [HCO3−]ISF are less than would be at equi-
librium with [HCO3−]plasma and the PD. In the so-called "passive" theory 
for ISF pH regulation advanced by Siesjö and colleagues [417], the active 
process (which might be lactic acid production) that accounts for this dis-
equilibrium under normal conditions is assumed to be constant irrespec-
tive of pH, pCO2 and [HCO3−] in plasma or ISF with all changes in the 
ratio [HCO3−]ISF/ [HCO3−]plasma resulting directly from changes in passive 
transport.
If the PD were effective in driving a flux of HCO3− or H+ across the blood–
brain barrier, more positive PD would increase the ratio [HCO3−]ISF/ 
[HCO3−]plasma and more negative PD would decrease it. This would provide a 
simple mechanism for pH regulation in ISF (and hence CSF). If pHarterial were 
reduced by increasing pCO2, there would be an increase in [HCO3−]plasma but 
a larger increase in [HCO3−] ISF because the PD would be increased. Thus the 
pH change would be smaller in ISF than in plasma. Similarly if pHarterial were 
reduced by decreasing [HCO3−]plasma the decrease in [HCO3−]ISF and pHISF 
would be smaller. Smaller pH changes in ISF than in plasma is the definition 
of pH regulation of ISF. Probably because this explanation of pH regulation 
could be tested by experiments (see Sect.  6.4), it attracted a great deal of 
effort and attention. In many, but not all, studies the variation of [HCO3−]CSF/ 
[HCO3−]plasma was as expected from the variations in PD (see[185, 388, 417]).
27 Potential differences across membranes and across cell layers Move-
ments of ions across the membranes of either choroid plexus epithelial cells 
or blood–brain barrier endothelial cells via mechanisms that transport net 
charge must: (a) be sensitive to the electrical potential differences between 
the cell interiors and the blood on one side and CSF or ISF on the other and 
(b) affect the charge within the cells and hence the potentials across their 
membranes. There is thus no avoiding the need to consider the membrane 
potentials in any adequate discussion of mechanisms. Unfortunately, there 
are no available data for how the membrane potentials of the cells in vivo 
are affected by pCO2, pH or HCO3− or how the membrane potentials affect 
the rates of ion transport into or out of the cells. However, the potential 
difference between CSF (and to some extent ISF) and blood (called “the 
PD”) has been measured in a large number of studies. There are two issues 
to consider: whether and how pH, [HCO3−] or pCO2 in some way deter-
mine the PD and whether and how the PD affects the relation between the 
plasma and CSF values of pH and [HCO3−]. Data for ISF would be more 
interesting, but most relate to CSF.
In dogs and goats the PD between cisternal CSF and jugular vein blood at pH 7.4 
is between 3 and 6 mV (CSF positive) at pH 7.4. The PD changes with a slope of 
−32 mV (pH unit)−1 when pH is varied by making primary changes in pCO2 of 
blood and −43 mV (pH unit)−1 when the primary changes are in [HCO3−]arterial 
[286]. See [525] (discussion after [401]) [438, 439] and for many further refer-
ences [185, 388]. From the similar effects of increasing pCO2 and decreas-
ing [HCO3−]arterial, it is inferred that the variation in PD depends primarily on 
[H+]arterial rather than on [HCO3−]arterial or pCO2. (A possible explanation for 
the difference in slopes is that changes in pCO2 alter blood flow while those in 
[HCO3−] do not, see [189, 436] and the discussion after [401]). Three possible 
mechanisms by which pHarterial could affect the PD have been considered (see 
[185, 388]). Firstly the blood facing membrane of the barrier that generates the 
trans-barrier PD may have a higher conductance to H+ than to anything else. 
There are two persuasive arguments against this “sim‑
ple” mechanism as the principal explanation of pH 
regulation. Firstly a variation of the PD in the opposite 
direction to that seen in most species can occur in cats 
even though they still regulate pHCSF [189, 435, 436] (see 
pg 120 in [185]). Secondly by varying [K+]plasma the PD 
can be changed by as much as 9 mV with no effect on the 
distribution of Na+, H+ or Cl− [437–439]. This indicates 
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that changes in the PD do not produce the changes in 
[HCO3−]CSF and [H+]CSF needed for regulation.
6.4.1  HCO3
− transport across the choroid plexuses
The importance of the choroid plexuses compared to the 
blood–brain barrier in determining [HCO3−] and hence 
pH within the brain extracellular fluids is not known with 
certainty. The choroid plexuses do determine pH in the 
CSF immediately adjacent to them. Furthermore at con‑
stant plasma pCO2 even at distant locations changes in 
[HCO3−]CSF following changes in [HCO3−]plasma occur on 
the same timescale of hours as the turnover of CSF. This 
means that choroid plexus secretion could be important 
in determining the final composition. However, the cho‑
roid plexuses cannot account for any rapid changes far 
removed from the ventricles. Furthermore there are at 
least three lines of evidence suggesting that transport at 
the choroid plexuses is less important than at the blood–
brain barrier. Firstly, [K+]CSF and [HCO3−]CSF change as 
CSF flows from the ventricles to the cisterna magna [141, 
244, 440]. Secondly changes in ventilation ascribed to 
changes in ISF pH at constant pCO2, i.e. those resulting 
from changes in [HCO3−]ISF, are faster than changes in 
[HCO3−]CSF (see next section for further discussion) and 
electrode measurements of pHISF (see next section) indi‑
cate that this changes more rapidly than does pHCSF. 
Finally experiments collecting fluid directly adjacent to 
the choroid plexuses [440] have found little change in 
[HCO3−] in the secretion when [HCO3−]plasma was 
altered at constant pCO2 (for further discussion see 28) 
28 [HCO3−] in the primary secretion of the choroid plexus Variations in 
[HCO3−] in the primary secretion of the choroid plexus during hyperven-
tilation or with raised pCO2 in inspired air were investigated by Ames et al. 
[141] in cats. Taking samples from droplets of fluid secreted into a layer of 
Pantopaque oil covering a lateral ventricle choroid plexus, they found dur-
ing hyperventilation substantial decreases in the rates of secretion of both 
fluid and HCO3− with no change in [HCO3−] (determined from charge bal-
ance, see Sect. 6.1.2). With raised pCO2 there was a substantial increase in 
both the rate of fluid secretion and [HCO3−]. These experiments established 
that the choroid plexuses do secrete and that the effects of changing pCO2 
on choroid plexus secretion are at least in the correct direction to contrib-
ute to pH regulation in the brain. (But note these conditions correspond to 
respiratory alkalosis and acidosis for which regulation is poor, see Fig. 21.) 
However it has been suggested that the pantopaque oil used in these experi-
ments may have altered the function of the choroid plexuses because it can 
be toxic when injected into the ventricles ([217], but see [530] for details).
Exposure of the choroid plexus to this oil was avoided in other experiments 
but those entailed greater dissection of the brain to enclose a choroid plexus 
in a chamber that could capture the secreted fluid. Measuring secretion by 
the change in contents of the chamber Husted and Reed [440] found: (i) little 
change in the addition of HCO3− to the chamber when [HCO3−] in arterial 
blood was reduced; (ii) little change in pH of the net fluid added to the cham-
ber during hypocapnia and hypercapnia, implying that [HCO3−] in the secre-
tion varied in proportion to the change in pCO2; and (iii) a marked effect of 
[HCO3−] in the chamber on the net addition of HCO3−. Increased [HCO3−] 
in the chamber almost eliminated addition of HCO3−, while decreased 
[HCO3−] increased the amount added. The variations with [HCO3−] in the 
chamber suggest that there is a substantial backflux of HCO3− from chamber 
to blood that increases with the concentration in the chamber. It is possible 
that this represents an artefact produced during the dissection.
indicating that the changes in [HCO3−]CSF sampled at a 
distance from the choroid plexuses could not be due to 
alterations in choroid plexus secretion.
By contrast to the situation at constant plasma pCO2, 
results obtained when plasma pCO2 was altered showed 
that [HCO3−] in the choroid plexus secretion did change 
and in the same direction as pCO2 [141, 440] see also p. 
282 in [16]. No satisfactory explanation has been given 
for how [HCO3−] in the secretion can depend on plasma 
pCO2 but not on [HCO3−]plasma. The mechanisms dis‑
cussed in Sect. 3 suggest that increases in either pCO2 or 
[HCO3−] in plasma should increase the concentration of 
[HCO3−] in the choroid epithelial cells and hence in the 
secretion. These results and their interpretation are con‑
sidered further in footnote 28.
6.4.2  HCO3
− transport across the blood–brain barrier
There is near universal agreement that pCO2 throughout 
the brain rapidly reflects changes in pCO2 in blood because 
CO2 crosses the blood–brain barrier rapidly (see Sect. 2.2). 
By contrast the evidence concerning transport of HCO3− 
has been controversial with some studies supporting rapid, 
extensive transport (much faster than found for other ions 
like Na+, K+ and Cl− using radiotracers though of course 
still much slower than for CO2) while others have indicated 
slow, perhaps even no, transport (see summary of evidence 
in Table 3). The presence at the blood–brain barrier of mul‑
tiple HCO3− transporters (see  Sects. 4.4.2 and 4.5.2) ren‑
ders it most unlikely that there is no HCO3− transport and 
the evidence discussed below strongly supports the idea that 
such transport occurs at a rate comparable to that of Cl−.
The pieces of evidence are listed in Table  3. Four of 
these have been used to support the view that there 
Footnote 28 continued
All of the changes observed by Husted and Reed are in the correct direc-
tion to contribute towards pH regulation. However, in contrast to the ear-
lier results of Ames et al. [141], Husted and Reed [440] found no effect of 
changes in pCO2 on the rate of CSF production. This discrepancy remains 
to be resolved.
Increase in [HCO3−] in the secretion when pCO2 is increased is consist-
ent with what is now known about the transporters present at the choroid 
plexuses. Within the epithelial cells, increased pCO2 will increase [HCO3−] 
or decrease pH to maintain the equilibrium between CO2, H+ and HCO3− 
(carbonic anhydrase is present). Indeed if as favoured by current evidence 
the route of HCO3− entry across the basolateral membrane is NCBE (see 
Sects. 4.3.2, 4.3.3), the equilibrium is likely to be maintained primarily by an 
increase in [HCO3−] because any decrease in pH would increase the driv-
ing force for H+ and Cl− exit and HCO3− entry. Increased [HCO3−] within 
the cells will be accompanied by a decrease in [Cl−] (see Eq. 11). These con-
centration changes will be reflected in HCO3− being a larger proportion of 
the anions crossing the apical membrane, i.e. to an increase in [HCO3−] in 
the secretion. However, this explanation is called into question by the fail-
ure of similar reasoning to explain why an increase in plasma [HCO3−] and 
decrease in plasma [Cl−] at constant pCO2 does not increase [HCO3−] in 
the secretion.
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is rapid transport of HCO3− across the blood–brain 
barrier.
(1) The first argument was put forward in the landmark 
papers on pH regulation and the central control of venti‑
lation by Pappenheimer, Fencl and colleagues [351, 352] 
(see Figs. 21, 23). They used ventriculocisternal perfusion 
to look at the loss from or gain into the perfusion fluids 
of HCO3− and Cl−. If the perfusion fluid had the same 
concentrations as in a sample of CSF withdrawn shortly 
before the perfusion, there was no net loss or gain of 
either ion. When a concentration in the perfusion fluid 
was higher there was rapid loss, while if a concentration 
was less there was rapid gain. From the concentrations 
with neither loss nor gain, they inferred that in the 
steady‑state [HCO3−] and [Cl−] are the same in ISF and 
CSF, but different from those in plasma. For other con‑
centrations the initial rates of loss or gain represent 
exchange with the parenchyma. However, they reasoned 
that after 45 min of perfusion, the concentrations in the 
parenchyma would have stabilized and thus that at that 
time the continuing loss or gain of HCO3− and Cl− from 
the perfusion fluid had to be equal to their transfers 
across the blood–brain barrier. However, they did not 
demonstrate that the rates of loss or gain had reached 
constant values. It has been shown using radiotracers for 
K+ and Na+ that 45  min is not long enough [251, 441] 
and thus that the measured rates of loss from or gain into 
the perfusate of Cl− and HCO3− are likely to have 
exceeded substantially their rates of transfer across the 
blood–brain barrier. Thus at present this line of evidence 
must be discounted. This matter is considered semi‑
quantitatively in 29.
29 HCO3− and Cl− permeabilities estimated from loss from ventricular per‑
fusates Pappenheimer, Fencl and colleagues [351, 352] (see section  5.3.1) 
used ventriculocisternal perfusion to look at the loss from or gain into the 
perfusion fluids of HCO3− and Cl− measured after 45  min of perfusion. 
However, it is now clear that 45  min was not long enough for concentra-
tions in the parenchyma to reach steady-state. This is evident from experi-
ments following radiolabelled K+ [251] or Na+ [441]. The results for Na+ 
(2) Another type of evidence put forward in support of 
rapid transport of HCO3− across the blood–brain barrier 
was obtained using pH electrodes applied to the surface 
of the exposed cortex or pH microelectrodes below the 



























In these expressions: PS is the permeability-area product for Cl− at the 
blood–brain barrier, which has been determined by Smith and Rapoport as 
1.4 × 10−5 cm3 s−1 g−1 [261] ρ = 1 g cm−3 is the density of the region; A 
is the surface area of the perfused portion of the ventricles, taken here (a 
guess) as 35 cm2; δ is an equivalent thickness of the layer of parenchyma
Table 3 Summary of evidence that has been used to support or oppose the idea of rapid transport of HCO3
− follow-
ing changes in [HCO3
−]plasma at constant pCO2
For Against
High rate of HCO3
− loss from or gain to fluids perfused through the 
ventricles
Little or no change in total CO2 (almost all of which is HCO3
−) in the brain in 
response to altered [HCO3
−] in plasma
Rapid, easily seen changes in pH (measured by electrodes applied to the 
brain surface or microelectrodes within the parenchyma) in response to 
changes in [HCO3
−]plasma
Little or no change in pH (measured by electrodes applied to the brain sur-
face or microelectrodes within the parenchyma) in response to changes 
in [HCO3
−]plasma
Measurable first-pass extraction of H11CO3
− from blood No change in intracellular pH measured using 31P-NMR over an hour follow-
ing decrease in plasma [HCO3
−]
Acute changes in ventilation rate (after denervation of peripheral chemo-
receptors) when [HCO3
−]plasma is changed at constant pCO2
low measured permeability to Cl− determined using radiotracers
Footnote 29 continued
were particularly detailed. For periods much longer than 45 min the loss of 
tracer from the perfusate across the ependyma corresponded to increases 
in the concentration within the parenchyma rather than transport to the 
blood. Even after 4 h of perfusion the rate of loss from the ventricles had not 
decreased to the steady-state value. As blood–brain barrier permeabilities 
to Na+ and Cl− are now thought to be similar (see Sect. 4.3.2) and both ions 
are present at relatively high concentrations primarily in the extracellular 
fluid within the parenchyma, it follows that for Cl−, just as for Na+, perfu-
sions lasting for hours rather than the 45 min employed would be required 
to reveal the rate of transfer across the blood–brain barrier. For HCO3−, an 
adequate theoretical treatment of the data is more difficult because the con-
centrations of HCO3−, CO2 and H+ are interrelated and the local pH is buff-
ered by the presence of the cells.
The measured rate of loss of Cl− from the perfusion fluid was 
~6 µmol min−1 when the concentration in CSF exceeded the value for zero 
loss by cCSF = 40 mM. It is instructive to compare this measured value with 
estimates of the rate of loss, R, calculated assuming that it represents:
a.     steady-state transfer across the blood–brain barrier, approximately:
R ≈ PS × ρ × A× δ × cCSF
or
b.    diffusion into parenchyma with no transfer across the blood–brain bar-
rier:
from which transfer to the blood occurs, which after 45  min will be less 
than 2 mm [441]; cCSF = 40 mM is the concentration excess in the perfusate; 
erfc(y) is the complement error function [441]; D ~ 5 × 10−6 cm2  s−1 is the 
diffusion constant, and t = 45 min is the time after the start of the infusion 
at which the rate of loss is determined.
Inserting values into the expression for loss by steady-state transfer across 
the blood–brain barrier, 
R ≈ 1.4× 10−5cm3s−1g−1 × 35 cm2 × 0.2 cm× 1 g cm−3 × 40µmol cm−3
≈ 4× 10−3 µmol s−1 = 0.24µmolmin−1
This is much smaller than the measured value.
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changes in pHISF. When [HCO3−]plasma was altered at 
nearly constant pCO2, Ahmad and Loeschcke [442], 
Teppema and coworkers [443, 444] and Davies and Nolan 
[445] all found rapid changes (e.g. within 30  s) in pHISF 
and in one case also [Cl−]ISF [442]. The inferred changes 
in [HCO3–]ISF were large, major fractions of the change 
imposed in plasma. The discrepancies between these 
results and those discussed as item 2) of evidence against 
have still not been explained (see 30).
(3) Normally it is not possible to vary pCO2 and 
[HCO3−] independently of each other in blood because 
there is rapid interconversion between H+  +  HCO3− 
and CO2 (see Sect. 6.1.1). However, after total inhibition 
of carbonic anhydrase, it is possible to have disequilib‑
rium concentrations of CO2 and HCO3− for tens of sec‑
onds and this strategy has been used by Johnson et  al. 
[51] to investigate the penetration of H11CO3− and 
11CO2 into the brains of dogs. They injected total 11CO2 
(11CO2 + H11CO3−) in acid or alkaline solution into the 
30 Rates of HCO3− and Cl− transport inferred from pH electrode meas‑
urements Ahmad and Loeschcke [442] using surface electrodes investi-
gated changes when plasma [HCO3−] was abruptly increased from ~16 
to ~23.5  mM at nearly constant pCO2. ISF [HCO3−] increased and [Cl−] 
decreased by about 3 mM (pH increase of 0.07) with a half-time of about 
20  s. This was interpreted as rapid exchange of HCO3− and Cl− between 
plasma and ISF. Teppema et  al. [443, 444] also saw rapid changes in pH. 
Davies and Nolan [445] using pH sensitive microelectrodes with pH sensi-
tive tips about 1–2 µm diameter and 40 µm in length found that ISF pH 
responded to isocapnic, iv infusions of HCl or NaHCO3 with lags of only a 
few minutes (ΔpHISF was 40–80% of ΔpHarterial at the end of 30 min with no 
change in pHCSF).
These changes are much faster and larger than those seen at constant pCO2 
by Javaheri and colleagues [455, 457]. No satisfactory reconciliation of these 
results has been provided [389]. The rapid changes might be explained if 
somehow the electrodes were responding, at least partially, to changes in 
the pH of plasma or peripheral tissue extracellular fluid. However, how this 
could have occurred is unknown. Presumably worry about such an artefact 
explains why Javaheri et al. always looked for a positive Rapoport test (see 
Sect. 6.4.2).
The rapid changes in [Cl−] reported by Ahmad and Loeschcke [442] are 
not consistent with the reported tracer permeability to this ion. More gen-
erally the permeability of the blood–brain barrier to all small ions (see e.g. 
[16, 261, 269], and thus by inference to HCO3−, is difficult to reconcile 
with the reports of large, rapid changes in ISF pH at constant pCO2. Fur-
thermore it is very difficult to understand how under these circumstances, 
given free movement of small ions across the ependyma, rapid and large 
changes in ISF could occur without some change with a similar time course 
in [HCO3−]CSF. All agree that no such variation is observed (see e.g. [185, 
386, 413, 414].
aorta followed by very rapid recording of 11C in the head 
using positron emission scanning. The signal rose to a 
maximum within a few seconds as the bolus dose reached 
the head. After a further 10–15 s most of the signal left 
in the head was tracer that had crossed the blood–brain 
barrier. They found, as expected, that without carbonic 
anhydrase inhibition, the different injections all led to 
the same very rapid penetration, with extraction of more 
than 80% of the total 11CO2 in the bolus in a single pass. 
After carbonic anhydrase inhibition using acetazolamide, 
penetration was reduced and the reduction was much 
more marked when the total 11CO2 was injected in alka‑
line rather than acid solution, i.e. primarily as H11CO3− 
rather than 11CO2 indicating as expected that CO2 can 
penetrate rapidly. However, the rate of penetration when 
most of total 11CO2 was in the form of H11CO3− was 
greater than could be accounted for by movement of 
the small proportion of 11CO2 calculated to be present. 
They concluded from these results that H11CO3− could 
penetrate rapidly enough to extract about 16% of that 
arriving in the blood. Their calculated permeability for 
H11CO3− was about 30 times larger than the permeability 
for 36Cl− [261]. Johnson et  al. suggested that such large 
fluxes could not represent a net flux of HCO3− and thus 
would have to involve some form of exchange.
There may be alternative explanations for the above 
results that do not invoke rapid movement of HCO3−. 
Firstly there may not have been total inhibition of 
carbonic anhydrase in which case the conversion of 
H11CO3− to 11CO2 in the alkaline injection experiment 
would have been more extensive than calculated and the 
higher [11CO2] might then explain the observed pen‑
etration. It would have been reassuring had data been 
presented showing that higher concentrations of aceta‑
zolamide did not produce further inhibition. Secondly 
the results could be explained without penetration of 
H11CO3− if there were a high permeability to H2CO3. 
At equilibrium H2CO3 is at a concentration about 400 
times less than [CO2] [446] but during the disequilib‑
rium period it could be present at a higher concentration. 
Apparently nothing is known about the membrane per‑
meability of H2CO3. Fluxes of H2CO3 do not carry charge 
and with functional carbonic anhydrase would be very 
difficult to distinguish from the larger fluxes of CO2.
(4) Indirect evidence that HCO3− (or, of course, H+) can 
cross the blood–brain barrier rapidly comes from studies 
following changes in ventilation when [HCO3−]plasma is 
altered. It is widely believed that ventilation rate is deter‑
mined by signals from both peripheral and central chem‑
oreceptors and that the central chemoreceptors respond 
to pH (see e.g. pg 239 in [447]). In animals whose periph‑
eral chemoreceptors have been denervated, additions 
of acid to plasma produced rapid [448] or acute [449] 
Footnote 29 continued
Inserting values into the expression for loss from the ventricles by diffusion 
into the parenchyma
R ≈ 35 cm2 × 40µmol cm−3 ×
√
2× 5× 10−6cm2s−1/(3.14× 2700 s)
≈ 0.05µmol s−1 = 2.9µmolmin−1
This is much closer to the measured value. From this comparison it would 
appear that the measured rate of loss from the ventricular perfusate after 
45  min was more than tenfold greater than the rate of transfer across the 
blood–brain barrier and could be accounted for by accumulation (or deple-
tion) of Cl− in the parenchyma. These numbers shouldn’t be taken too 
seriously. What was needed in the studies by Pappenheimer, Fencl and col-
leagues was experimental evidence that the rate of loss or gain had reached 
a steady-state. No such evidence was presented.
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increases in ventilation without measurable changes in 
CSF pH. The changes could not be explained as responses 
to changes in pCO2 in plasma and it was concluded that 
“central” chemoreceptors can respond quickly or acutely 
to changes in pH and/or [HCO3−] in plasma. One inter‑
pretation of this result is that the central receptors are 
exposed to ISF and that pH and [HCO3−] in ISF change 
more rapidly than in CSF. However, it is not clear how 
much change in pHISF is required or even if there need 
be any rapid change if some of the central chemorecep‑
tors are in regions not protected by the blood–brain bar‑
rier and so can monitor changes in [HCO3–]plasma directly 
(see e.g. pp. 235–6 and 244 in [447]).
At least four lines of evidence exist that support the 
view that transport of HCO3− across the blood–brain 
barrier is either slow or non‑existent.
(1) Measuring total CO2 (most of which is HCO3−) in 
brain tissue, Siesjö and colleagues [450–452] found no 
change after 6  h exposure to high or low HCO3− in 
plasma. However, while these results exclude fractional 
changes in [HCO3−] in the parenchyma as large as 
those in plasma, the sensitivity of the measurements 
was not sufficient for the results to argue against the 
existence of the smaller changes considered in points 
(ii)–(iv) below.31 Small changes in [HCO3−]CSF are 
known to occur, see Fig. 21.
(2) A number of studies using either pH electrodes 
applied to the cortical surface or pH microelectrodes 
inserted into the cortex support slow penetration of 
the blood–brain barrier by HCO3−. In the first study 
using pH electrodes placed against the surface of the 
cortex, Rapoport [453] (see also [454]) found that intra‑
venous injection of HCl or NaOH led to the expected 
decrease or increase in pHplasma and produced transient 
pH changes at the cortical surface in the same direction 
as in plasma. By contrast injection of NaHCO3 lead‑
ing to the expected alkaline shift in plasma produced a 
clear, transient acid shift at the cortical surface. These 
are the expected results if the blood–brain barrier is 
intact and CO2 can cross this barrier much more rap‑
idly than HCO3−. In brief, injections of NaHCO3 or 
of HCl by reaction with HCO3− will increase pCO2 
in the blood while those of NaOH by reaction with 
CO2 will decrease it and these changes in CO2 will 
31 Rate of HCO3− transport (or lack of ) estimated from measurement of 
total CO2 in the brain Siesjö asserted that the methods used would have 
quantified a change corresponding to the same concentration change as 
in plasma in a volume of 5% of the water content of brain and concluded 
that only a little HCO3−, if any, crossed the blood–brain barrier during the 
experiments. It is now known that the volume of ISF is about 20% of the 
aqueous volume of the parenchyma, which means a change in [HCO3−] in 
ISF of about 25% of that in plasma might not have been seen. The change 
expected is about 30% of that in plasma if the change in [HCO3−]ISF is the 
same as the steady-state change in [HCO3−]CSF [185].
produce changes in pHISF. Such changes will be tran‑
sient because the excess or deficit of CO2 will be off‑
set by distribution of CO2 and HCO3− throughout the 
body and by ventilation. Javaheri et al. [455] have called 
these results “a positive Rapoport test”. Rapoport’s 
results demonstrate that CO2 crosses the blood–brain 
barrier much more rapidly than HCO3− but they do 
not exclude slow HCO3−penetration that would only be 
apparent on time scales longer than the 10 min he used.
Another pH electrode study, this time using microelec‑
trodes inserted into the parenchyma to study pHISF [456] 
found definite but slow penetration of HCO3− across the 
blood–brain barrier. In this study the transient acidifica‑
tion of ISF described by Rapoport following addition of 
NaHCO3 to blood was not detected, possibly because 
of the limitations of using high impedance electrodes to 
measure small changes in pH in an environment with 
both electrical and mechanical “noise”.
A further study by Javaheri et  al. [455] used pH elec‑
trodes on the cortical surface with pCO2 held constant 
to exclude changes in pCO2 as a factor changing pHISF. 
They found that intravenous infusions of acid or base for 
30  min produced significant shifts in the surface pH in 
the same direction as in plasma. Much smaller changes 
were noted in pHCSF. To check that the blood–brain bar‑
rier was intact, before the infusion in each experiment 
they used the Rapoport test as described above. In a sub‑
sequent study using pH microelectrodes with tips located 
5  mm below the cortical surface, Javaheri et  al. [457] 
found smaller but significant changes in pHISF that were 
still increasing at the end of an hour. These were much 
larger than the changes, if any, over the same period in 
CSF, but much smaller than those in plasma.
(3) Using 31P‑NMR to monitor intracellular pH within 
the brain Adler et al. [458] found no change over an hour 
when pHplasma was reduced by 0.25 units. They noted 
that they would not have been able to see changes cor‑
responding to those reported by Javaheri et  al. (see just 
above). By contrast it is very difficult to reconcile this 
result with the large, rapid change in pHISF reported by 
Ahmad and Loeschcke [442].
(4) A strong argument against large rapid changes in 
[HCO3−]ISF in response to changes in [HCO3−]plasma is 
that these must be accompanied by changes in the oppo‑
site direction in [Cl−]ISF (see Sect.  6.1). The permeabil‑
ity of the blood–brain barrier to Cl− has been measured 
using radiotracers [269] and is much too small to support 
the rapid changes reported by Ahmad and Loeschcke 
[442] (see also footnote 30) and Johnson et al. [51].
To summarize, the balance of evidence from the in vivo 
results suggests that there is slow transfer of HCO3− 
across the blood–brain barrier, presumably at rates of the 
same order as for Cl−. Despite extensive research on the 
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regulation of pHISF carried out between 1950 and 1998 
(see [185, 393, 394]), some of which has been discussed 
above, there is still uncertainty about the changes in the 
rate of HCO3− and Cl− transport across the blood–brain 
barrier in  situ when [HCO3−]plasma is changed. With 
brain endothelial cells in culture, transport of HCO3− 
can occur by multiple transporters. These could support 
a net transport adequate for fluid secretion as large as 
200 ml day−1 (see Sect. 4.1.1) and could account for the 
estimates of HCO3− transport reported by Javaheri and 
coworkers [455, 457] from their in  vivo studies on pH 
regulation.
In contrast to responses to changes in [HCO3−]plasma, 
when pCO2 is altered there are rapid and sustained 
changes in [HCO3−]ISF [16, 185]. Initially a substantial 
part of the change may result from physiological buffer‑
ing but in the long term the changes result from altered 
transfer of HCO3− across the blood–brain interfaces 
with that across the blood–brain barrier likely to be more 
important. In both schemes in Figs.  17 and 18 depict‑
ing mechanisms for transport across the blood–brain 
barrier, the rate of HCO3− transport would increase 
with increases in either pCO2 or [HCO3−] in plasma. By 
contrast the fluid secretion rate across the blood–brain 
barrier is predicted to be relatively insensitive to these 
changes (at least at constant pH) because the principal 
transporters for Na+ and Cl− do not depend on the pres‑
ence of CO2 or HCO3−. The present state of knowledge of 
transport mechanisms at the blood–brain barrier is not 
sufficient to predict the sizes of changes in [HCO3−]ISF 
relative to those in plasma.
7  Summary
The two blood–brain interfaces, the blood–brain barrier 
and the choroid plexuses, fulfil very different roles.
These are reflected in their differing properties and 
locations in the brain as itemized and summarized in 
Table 4.
8  Conclusions
The primary roles of the blood–brain barrier are to 
restrict entry of unwanted substances circulating in the 
blood, prevent loss of required substances and at the 
same time provide the means for rapid transfers of O2, 
CO2 and glucose to support the metabolic needs of cells 
in the brain (Sect. 2). In this way it is able to control the 
composition of the interstitial fluid surrounding the brain 
cells thus allowing them to function effectively. Large 
fractions of the water, O2, CO2 and glucose that arrive in 
the cerebral blood flow are transferred into the brain in a 
single pass and there are comparable fluxes in the oppo‑
site direction (see Sect. 2). The choroid plexuses cannot 
replace the principal actions of the blood–brain barrier 
for these functions. The primary role of the choroid plex‑
uses is to secrete fluid.
The total rate of fluid secretion into the brain is approx‑
imately 0.1% of cerebral blood flow. Most of this secre‑
tion is by the choroid plexuses that receive about 1% of 
cerebral blood flow. The remaining 99% of the blood flow 
is separated from the brain by the blood–brain barrier. 
The rate of net fluid transport across the blood–brain 
barrier is still unknown.
The water permeability of the blood–brain barrier is 
much lower than that of peripheral capillaries but still 
sufficiently large that even very small osmotic gradients 
could drive net water movement into the brain. How‑
ever, the permeability to small ions is low which greatly 
reduces any possible hydrostatic pressure driven flow. 
Instead fluid transfer across the blood–brain barrier 
requires transport of solutes, particularly NaCl, with the 
water following osmotically.
From knowledge of the identities and locations of the 
transporters responsible for ion transport across the 
epithelial cells of the choroid plexuses, a description of 
events driving fluid transport can be constructed. Of 
note: Na+ is transported across the apical (CSF facing) 
membrane of the epithelial cells primarily by the Na+ 
pump and across the basolateral (stroma and capillary 
facing) membrane by cotransport with HCO3−. There 
is presumably a paracellular back‑leak of Na+. Cl− is 
transported across the basolateral membrane by Cl−/
HCO3− exchange and across the apical membrane by 
multiple mechanisms. Transcellular transport of K+ is in 
the direction from CSF to blood because the only means 
for its transport across the basolateral membrane is K+, 
Cl−‑cotransport, which mediates a net efflux from the 
epithelial cells. However net K+ secretion is from blood 
to CSF across the choroid plexuses, so it follows that par‑
acellular transport of K+ from blood to CSF must exceed 
the transcellular transport. This description of choroid 
plexus fluid secretion does not explain all of the available 
evidence. It fails to explain the relative independence of 
both [HCO3−] in the secretion and CSF secretion rate 
from changes in [HCO3−]plasma (see Sect. 6.4.1 and foot‑
note 28). Furthermore it has not been established that the 
mechanisms for HCO3− transport require conversions 
between CO2 and HCO3−. If they do not, this description 
provides no explanation for the inhibition of secretion 
by the carbonic anhydrase inhibitor, acetazolamide (see 
Sect. 3.6.3).
More than one comparable description of events can 
be constructed for fluid transfer across the blood–brain 
barrier. The endothelial cells lining the brain microves‑
sels have a complement of ion transporters that if appro‑
priately arranged would allow active secretion of fluid. 
The Na+‑pumps that are present are capable of expelling 
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substantially more Na+ from the cells than would be 
needed for secretion. However, much is still unknown: 
exactly how the transporters are distributed between 
the luminal and abluminal membranes, the extent of the 
net transfers of Na+ and Cl− across the barrier, and the 
rate of fluid secretion. There is strong but still inconclu‑
sive in  vivo evidence that the blood–brain barrier does 
secrete fluid (see Sect. 4.1).
K+ enters the endothelial cells of the blood–brain 
barrier via Na+, K+‑ATPase located primarily in the 
abluminal (brain side) membrane and via Na+, K+, 2Cl−‑
cotransporters across the luminal (blood side) mem‑
brane. Efflux from the cells is thought to be primarily via 
different K+ channels in the membranes. Small changes 
in any of these components of K+ transport may produce 
relatively large changes in net flux, which could be from 
brain to blood or blood to brain as required.
HCO3− enters the endothelial cells primarily by Na+, 
HCO3− cotransport and leaves the cells either by Cl−/
HCO3− exchange or by Na+, HCO3− cotransport in 1 
Na+, 3 HCO3− mode.
Na+ and Cl− entry to the brain across the blood–brain 
barrier is similar to or somewhat greater than Na+ and 
Cl− entry across the choroid plexuses. However, at the 
blood–brain barrier almost the same amount leaves as 
enters the brain and the relatively small net transfers have 
proved difficult to measure. By contrast at the choroid 
plexuses less comes out of CSF than goes in and the net 
fluxes represent a larger proportion of the influxes.
The role of astrocyte endfeet in the function of the 
blood–brain barrier is still poorly understood. It is likely 
that much of the glucose that crosses the blood–brain 
barrier enters the endfeet. AQP4 in endfeet membranes 
may be there to allow water produced during glucose oxi‑
dation to enter the basement membrane separating end‑
feet from endothelial cells. There it would either dilute 
hyperosmotic secretion across the blood–brain barrier or 
be part of a hypoosmotic absorbate. The function served 
by the high density of K+ channels in the endfeet is still 
unknown but there are speculative suggestions (Sect. 5).
Regulation of [K+]ISF appears to occur primarily by 
control of influx and efflux across the blood–brain bar‑
rier. K+ efflux from the brain increases markedly for 
small increases in [K+]ISF, but there is little change in K+ 
influx in response to sustained changes in [K+]plasma‑ pre‑
sumably because there is a reduction in either the num‑
ber or activity of K+ transporters or channels (Sect. 5).
The determinants of pHISF are pCO2 and [HCO3−]ISF: 
pCO2 is in turn determined primarily by the metabolic 
and ventilation rates, with a relatively constant differ‑
ence in value between pCO2 in arterial blood and ISF. 
The available evidence indicates that [HCO3−]ISF is deter‑
mined primarily by transport across the blood–brain 
barrier. While some evidence has suggested very rapid 
transfers of HCO3−, the balance of evidence strongly 
favours slow transport with rates similar to those for 
other ions. However, this slow transport is still ade‑
quate for the blood–brain barrier to be the main site of 
[HCO3−]ISF regulation.
Neither the blood–brain barrier nor the choroid plex‑
uses provide the major route for net fluid outflow which 
occurs by pressure driven fluid flow by a variety of routes, 
including the arachnoid villi, meningeal lymphatics, 
nerve tracts through the cribriform plate, perineural 
pathways in the spinal cord and probably also other peri‑
neural and perivascular pathways (see Figs. 8 and 9).
Although the blood–brain barrier is vital for effective 
brain function, it is less clear that the choroid plexuses 
are needed in the adult. Thus while secretion by the cho‑
roid plexuses does account for most of the net fluid entry 
into the brain, a suitable arrangement of transporters at 
the blood–brain barrier could easily produce a similar 
secretion. One must look for somewhat more subtle rea‑
sons for having choroid plexuses as the major source of 
CSF. Firstly it may allow the blood–brain barrier to serve 
local needs free from constraints of having to maintain 
fluid secretion, e.g. in response to changes in nervous 
activity. Secondly, it avoids the need to provide pathways 
and sufficient pressure gradients for flow through the 
parenchyma of all the fluid entering the brain. Thirdly 
fluid secretion directly into the ventricles may help to 
maintain their patency. Having such spaces of variable 
volume with little resistance to flow between them allows 
compensation for changes in blood volume during the 
cardiac and respiratory cycles and in response to changes 
in posture. It should also be noted that the choroid plex‑
uses are needed to secrete fluid during CNS development 
and it may be an economical solution to allow them to 
continue to do so in the adult. Finally it may be efficient 
for the choroid plexuses to have a role in hormonal sig‑
nalling. Because the choroid plexuses are accessible for 
studies of transport and importantly they express ion 
transporters at sufficiently high levels to allow clear, con‑
vincing immunohistochemistry, it is not surprising that 
much more is known about the mechanisms of transport 
across them than across the blood–brain barrier.
More attention needs to be paid to the function of the 
blood–brain barrier, if volume, composition and flow 
changes in ISF occurring in disorders such as hydro‑
cephalus and oedema following stroke are to be under‑
stood. The relative importance of blood–brain barrier 
fluid secretion and CSF recirculation through the paren‑
chyma in the clearance of high molecular wastes is an 
area currently receiving a great deal of attention. Cer‑
tainly there are many areas where experimental results 
are needed to extend our knowledge. These include: 
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direct measurements of net fluxes across the blood–
brain barrier; recordings of intracellular potentials dur‑
ing transport across the blood–brain barrier and the 
choroid plexuses under conditions close to those obtain‑
ing in  vivo; localization of transporters at the blood–
brain barrier to the luminal or abluminal membranes 
in particular the distribution of Na+‑pump activity and 
whether this can be altered in response to different chal‑
lenges; determination of clearance of solutes from brain 
parenchyma without barbiturate anaesthesia; clarifying 
whether outflow of ISF from the parenchyma is periarte‑
rial, perivenular, or both; obtaining quantitative measure‑
ments of fluid flows via perivascular pathways.
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